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Forwards
Professor Peter Ebeling  
Medical Director, Osteoporosis Australia
Previous studies have underestimated the burden of osteoporosis. 
This study focuses on the over 50 population and shows osteoporosis and osteopenia 
(low bone density) currently affect over 66% of adults over 50, accounting for 4.74 million 
Australians and resulting in 140,822 fractures (2012). 
The study accurately quantifies the cost of this significant health burden – total direct and 
indirect costs of $2.754 billion (2012). The report also clearly demonstrates that osteoporosis 
is a common disease resulting in ‘first fractures’, and of more concern repeat fractures. It 
is important to recognise these fractures are costly to repair – $1.617 billion in total direct 
fracture cost alone (2012). Hip fractures remain the most costly type of fracture and all types 
of fracture (hip, wrist, spinal and other) will continue to rise as the Australian population ages. 
Osteoporosis can be diagnosed and managed to reduce fracture rates, and in many 
cases could be prevented. However osteoporosis remains under-diagnosed, even when  
a fracture has occurred. 
We urgently need to support re-fracture prevention and community education to break 
the cycle of poor bone health and fractures in Australia. 
John Hewson  
Chairman, Osteoporosis Australia
It is time the nation took bone health seriously. This report outlines the staggering cost 
of osteoporosis, osteopenia and fractures, and predicts the significant rise in the cost 
burden over the coming decade (2013-2022) if action is not taken.
Millions of Australians are affected by poor bone health. Poor bone health costs the 
community and governments, and comes at a great personal cost to those diagnosed 
with osteoporosis or osteopenia and potentially dealing with debilitating fractures.  
In 2012 the total costs of osteoporosis, osteopenia and fractures in Australians over 50 years 
of age were $2.75 billion. It is predicted that in 2022, the total costs will be $3.84 billion 
(2012$) for that year alone. The total costs over the next 10 years will be $33.6 billion (2012$).
Costs include ambulance services, hospitalisations, emergency department and 
outpatient services, rehabilitation, aged care and community services.
Osteoporosis Australia is calling on the Federal Government to renew its commitment 
to osteoporosis as a national health priority. We are calling on health care professionals 
to make bone health a higher priority and the community to be aware of the risk factors 
and prevention strategies.
Action today can reduce the impact of this disease, both in the short-term and for the 
future of bone health in Australia.
 
2Executive Summary
This report updates previous burden of disease analysis 
undertaken in 2001 and 2007, and shows little progress 
is being made in preventing and managing osteoporosis in 
Australia.  With an ageing population, it is now critical that 
real steps are taken to address this silent and often under-
diagnosed disease affecting women and men that is costing 
governments, the community and comes at a great personal 
cost to the individuals affected.
The new information in this report on the current and future 
costs of osteoporosis in Australia will aid government policy 
makers, funding bodies, clinicians, researchers and health 
care organisations in assessing the importance of reducing 
osteoporosis and osteoporosis – related fractures, promoting  
bone health and in identifying future resource needs.
Key Findings
Poor bone health: 2012-2022
•	 4.74 million Australians over 50 years of age (66% of people 
over 50) have osteoporosis or osteopenia or poor bone health.
•	 Based on the 4.74 million Australians with poor bone health, 
22% have osteoporosis and 78% have osteopenia.
•	 By 2022, it is estimated there will be 6.2 million Australians 
over the age of 50 with osteoporosis or osteopenia. That is  
a 31% increase from 2012.
High fracture rates: 2012-2022
•	 In 2013 there is 1 fracture every 3.6 minutes in Australia. This 
equates to 395 fractures per day or 2,765 fractures per week.
•	 By 2022 there will be 1 fracture every 2.9 minutes. That is 
501 fractures per day and 3,521 fracture per week.
•	 This compares to a fracture every 8.1 minutes in 2001 and  
a fracture every 5-6 minutes in 2007.
•	 In 2012 there were 140,822 fractures that occurred as a 
result of osteoporosis or osteopenia. In 2022 it is expected 
there will be a 30% increase in the annual number of 
fractures resulting in 183,105 fractures per annum.
•	 The estimated total number of fractures over the next  
10 years is over 1.6 million. This includes new fractures  
and re-fractures.
•	 Osteoporosis and osteopenia is not just a ‘women’s disease.’ 
Men account for up to 30% of all fractures related to 
osteoporosis and osteopenia, and their associated costs.
Alarming costs to Government, the community 
and to individuals
•	 In 2012, the total costs of osteoporosis and osteopenia  
in Australians over 50 years of age were $2.75 billion.
•	 It is predicted that in 2022, the total costs will be 
$3.84 billion (2012$).
•	 That is a total cost of fractures of $22.7 billion over the 
next 10 years. These costs include ambulance services, 
hospitalisations, emergency department and outpatient 
services, rehabilitation, aged care and community services.
•	 Total direct and indirect cost of osteoporosis, osteopenia and 
associated fractures over 10 years is $33.6 billion (2012$).
Call to action
Previous reports have included recommendations for action. 
What is telling is that the recommendations here are the same  
as previous reports.
•	 That a re-fracture prevention initiative be funded to follow-up 
and co-ordinate the care of every Australian who has sustained 
their first fragility fracture.
•	 That bone density testing for menopausal women aged 50 
with risk factors for osteoporosis be reimbursed.
•	 That more funding be provided for education and awareness 
programs about healthy bones as prevention is best, and the 
high rates of osteopenia are alarming.
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Australians over 50 who currently have 
osteoporosis and osteopenia
66% 4.74 million 
                                 Australians over 50
Number of fractures due to  
osteoporosis and osteopenia
0 25,000 50,000 75,000 100,000 125,000 150,000 175,000 200,000
2012 140,882
2022 183,105
1.6 million 
   estimated fractures over 10 years
Total direct and indirect costs osteoporosis, osteopenia  
and fractures, 2013-2022 (2012$) $millions
Mean direct cost per fracture type (Table 1, 2012$)
Fracture 
type
Female Male
50-69 years 70+ years 50-69 years 70+ years
Hip $23,276 $33,576 $23,243 $31,562
Wrist $5,289 $7,084 $4,386 $5,147
Vertebral $5,651 $9,176 $7,105 $5,630
Other $8,996 $12,295 $7,052 $12,195
4Contents
Forwards 1
Professor Peter Ebeling, Medical Director 1
John Hewson, Chairman 1
Executive Summary 2
Key Findings 2
Poor bone health: 2012-2022 2
High fracture rates: 2012-2022 2
Alarming costs to Government, the community  
and to individuals 2
Call to action 2
Contents 4
Background 6
Objectives 7
Method 8
Population Estimates for Osteoporosis  
by Age and Gender 8
Australian population data 8
Incidence/prevalence data for osteoporosis  
and osteopenia 8
Fracture incidence 8
Proportion of each fracture type 9
Cost and Resource Utilisation Estimates for 
Osteoporosis and Osteopenia in 2012 12
Data sources for cost and service utilisation rates 12
Direct health care service costs 12
Acute care 12
Sub-acute care (rehabilitation) 13
Aged care and community services 14
Community fracture management 14
Health care services for osteoporosis and osteopenia 
management  15
Medical services 15
Diagnostic imaging 15
Pathology 15
Pharmaceuticals and supplements for osteoporosis/
osteopenia prevention and treatment 15
Osteoporosis prevention 15
Osteoporosis treatment 15
Direct non-health care costs 16
Community non-health services (Home Help,  
Meals on Wheels) 16
Informal community care 16
Indirect costs from production loss 16
Mortality 16
Burden of Osteoporosis and Osteopenia in Australia 
from 2013 to 2022 17
Population 2013-2022 17
Medication use 17
Fracture numbers: new fractures and re-fractures 18
Cost of osteoporosis, osteopenia and associated fractures, 
2013-2022 18
Results 19
Total Cost of Osteoporosis and Osteopenia in 2012 20
Direct health care costs 21
Acute care 21
Community health care services for fracture management  23
Aged care and community services 23
Community non-health services (home help,  
meals on wheels) 24
Costs by fracture type 24
Mean costs of low trauma fractures 28
Health care services for osteoporosis and osteopenia 
management  29
Pharmaceuticals for osteoporosis/osteopenia prevention 
and treatment  30
Direct non-health care costs 31
Informal community care  31
Indirect costs 31
Production loss 31
Sensitivity Analysis 31
Burden of Osteoporosis and Osteopenia  
in Australia from 2013 to 2022 Population 
Trends 32
Osteoporosis (Bone Active) Medication 33
Fractures Numbers and Costs 2013-2022 33
All fractures 34
Hip fractures 36
Wrist fractures 38
Vertebral fractures 40
‘Other’ fractures 42
Community Service Costs for Osteoporosis and 
Osteopenia 44
Fractures Averted due to Osteoporosis (Bone Active) 
Pharmaceuticals 48
5Osteoporosis costing all Australians A new
 burden of disease analysis – 2012 to 2022
Discussion 50
Cost of Management of Osteoporosis and Osteopenia 50
Costs Related to Fracture Treatment  
and Subsequent Care 50
Fractures at Sites other than Hip, Wrist and Vertebrae 51
Projections 2013 to 2022 51
Strengths of the Analysis 51
Limitations of the Study 52
Conclusion 52
References 53
List of Tables 56
List of Figures 57
List of Abbreviations 58
Appendix 59
Appendix A: Utilisation Rates for Service use Following 
Fractures, by Fracture Type, Age and Gender 59
Appendix B: Unit Costs, Source and Assumptions for 
Each Component of the Model 60
Appendix C1: Unit Costs, Source and Assumptions for 
Pharmaceuticals/Supplements used for Osteoporosis/ 
Osteopenia, 2012 61
Appendix C2: List of Osteoporosis (bone-active) 
Pharmaceuticals used for Osteoporosis/ Osteopenia, 2012 62
Appendix C2.1: More on Osteoporosis (bone active) 
Pharmaceuticals 62
Appendix D: Clinical Pathway for Hip Fracture: Men, 
Aged 50-69 Years, with Osteoporosis 63
Appendix E (Part 1): Clinical Pathway for Wrist Fracture: 
Women, Aged 50-69 Years, with Osteopenia (Via Ambulance) 64
Appendix E (Part 2): Clinical Pathway for Wrist Fracture: 
Women, Aged 50-69 Years, with Osteopenia (No Ambulance) 65
Appendices F: Annual Cost (Direct and Indirect) 
Breakdown for New Fractures and Re-fractures, by Fracture 
Type, Gender and Age Group, 2013-2022 66
6Background
Osteoporosis is a disease in which the density and quality of bone 
are reduced, leading to weakness of the skeleton and increased 
risk of fracture, particularly at the hip, spine and wrist.8-10 The 
World Health Organisation defines osteoporosis and osteopenia 
in terms of bone mineral density (BMD). Using dual-energy X-ray 
absorptiometry (DXA), osteoporosis is defined as a T-score at 
the hip and/or lumbar spine at or below 2.5 standard deviations 
(T-score) below the average values for a young healthy adult 
reference population, and osteopenia when the bone mineral 
density is between 1 and 2.5 standard deviations below the 
reference population.9 
Osteoporosis is a relatively common disease that is usually 
silent until a fracture occurs. The Geelong Osteoporosis Study 
(GOS) measured BMD in a random sample of men and women. 
When extrapolating the results to the Australian population 
in 2006 they estimated that approximately 6% of men and 
23% of women over 50 years would be expected to have 
osteoporosis, increasing to 13% of men and 43% of women 
aged over 70 years.6 Other sources of prevalence data based 
on self-report of osteoporosis11 are likely to be a significant 
underestimate as the diagnosis is often made following a 
fracture (in both men and women).11 Therefore of the 1.2 million 
Australians likely to have osteoporosis, most will not know 
that they have the disease.6 Without intervention, this number 
is expected to increase to 3 million by 2021 as a result of 
population ageing.12 In addition, it is estimated that there are now 
6.3 million Australians with thin bones (osteopenia). The disease 
predominantly affects women over the age of 55 years, though 
increasingly men are also affected.12, 13 This report focuses only 
on the burden of osteoporosis and its precursor, osteopenia in 
Australian adults aged 50 years and older.
The most common fracture sites associated with osteoporosis 
and osteopenia are hip, wrist, spine, humerus and pelvis though 
other skeletal sites are also affected. While 20% of women with 
fracture aged 50 to 59 years, have osteoporosis (defined by 
BMD), this proportion increases to almost 70% in those aged 
over 80 years. The prevalence of osteoporosis in women with 
fracture is twice that observed in the population although most 
fractures occur in women whose BMD does not fall into the 
osteoporosis BMD definition.14 This reflects the high number of 
older adults with osteopenia. Reducing the population burden  
of fractures requires attention to those with osteopenia as well 
as osteoporosis because over half of the fragility fractures in the 
population arise in these individuals, and women with osteopenia 
plus a prevalent fracture have the same fracture risk as women 
with osteoporosis.2 
While some international studies have shown an increase in 
the age-adjusted hip fracture incidence for countries such as 
Finland, Germany and Taiwan15-17 several other population-based 
studies in USA, Canada, Sweden, Denmark18 and Switzerland 
have shown evidence of declining age-standardised hip fracture 
rates. In Australia the incidence of hip fractures appears to have 
declined over the last decade by 13 to 25%.5, 19, 20 Population 
ageing has contributed to an increase in the number of fractures 
since most of the burden of fractures (almost 70%) arises from 
older adults14. The increased number of people surviving into 
their seventies, eighties and nineties translates to an increased 
number of hip fracture cases.3, 20-26 Less information is available 
for total fracture rates since, unlike hip fracture, hospital 
separation data is not a reliable indicator of the total number 
of people with incident fracture. Rates of wrist fracture appear 
relatively stable in North America, Australia, Scandinavia and 
The Netherlands 27 but age-standardised hospitalisation rates for 
pelvic fractures in New South Wales have increased by 50%.28
The decline in hip fracture rates has been partly attributed to an 
increase in diagnosis and treatment of osteoporosis,24 including 
bone-active agents, the increased prevalence of obesity 20 and 
preventive programs that have increased awareness of the risk 
factors of falls.21 A recent Canadian study has reported declines 
in major osteoporotic fracture rates and attributed this primarily 
to still unexplained improvements in BMD.29 Other possible 
explanations include improvement in functional abilities among 
older adults, a cohort effect of a healthier ageing population, 
better nutrition and protective effect of increased body weight 
and hence higher BMI or due to unknown protective factors.23, 30-32 
Previous studies have reported lower hip fracture rates in rural 
compared to urban communities. In south eastern Australia, hip 
fracture rates were 32% lower and the total fracture rate was 
15% lower among rural than urban residents.33 Such studies 
suggest that a rural environment is associated with a lower 
fracture risk in the elderly (possibly through bone health or lower 
risk of falls in the elderly population). If the national rate of hip 
fracture could be reduced to that of the rural population the 
authors postulate that hip fracture numbers would remain stable 
despite the aging Australian population.33 A review of the secular 
trends in osteoporotic fracture rates highlights the substantial 
temporal trends in hip fracture rates during recent decades. 
Cooper and colleagues note that the extent to which the risk 
factors studied to date (including smoking, alcohol, physical 
activity, obesity and migration status), as well as the changing 
rates of risk assessment and treatment contribute to these 
temporal trends remains uncertain.27
Worldwide, osteoporotic fractures have been shown to account 
for 0.83% of the global burden of non-communicable disease 
and 1.75% of the global burden in Europe.34 Osteoporotic 
fractures in Europe have been reported to account for more 
DALYs lost than common cancers (except lung cancer) with 
DALYs lost due to osteoporosis estimated at 2 million compared 
to DALYs lost to osteoarthritis and rheumatoid arthritis at 3.1 and 
1.0 million respectively. Osteoporosis has been demonstrated as 
a significant cause of morbidity and mortality.34
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Osteoporosis is a common disease that manifests itself as 
fractures, occurring at multiple skeletal sites. In older age groups 
the burden of disease attributable to osteoporosis is significant, 
not only the consequent health service utilisation but also the 
burden on individual utility, health related quality of life, family and 
households. This burden can be measured in monetary units ($) 
as lost productivity or impact on household income, or as disutility 
(impact on quality of life). Osteoporosis places a financial burden 
on individuals, families and governments. Earlier studies estimated 
the cost of osteoporosis in Australia to range from $227 million 
AUD in 1994 to 700 million AUD in 1995 35, 36 while direct costs 
relating to osteoporotic fractures have been estimated at 1.9 million 
dollars each year in Australia.12, 37 In addition, the contribution 
of the Australian government towards the cost of alendronate, 
medication prescribed for osteoporosis was $105 million AUD  
in 2007, while $5.5 million AUD was spent by the government  
in 2007 to support osteoporosis research.38 
A Swedish study has estimated indirect costs (loss in value of 
production due to sick leave) comprise about 10% of the total 
cost for a fracture.39 The study estimated the mean fracture-
related cost the year after a hip, vertebral and wrist fracture as 
€14,221, €12,544 and€€2,147 respectively. The corresponding 
mean reduction in quality of life due to the fractures was 
0.17, 0.26 and 0.06 for the hip, vertebral and wrist fracture 
respectively. Although hip fractures have the greatest burden to 
society the study revealed that the loss in quality of life in the 
year after a hospitalised spine fracture is the same or greater 
than that following a hip fracture.39 The annual burden of 
osteoporosis in Sweden was estimated at€€0.5 billion. Another 
similar study demonstrated that the mortality caused by hip 
fractures accounted for approximately 1% of all deaths and  
1000 life-years lost per year in Sweden40, 41 with fractures shown 
to account for approximately 1-2% of the total health care costs 
of which the dominant costs are inpatient care costs.
The Australian study of cost and utilities related to osteoporotic 
fractures is the Australian arm of the International Costs and 
Utilities Related to Osteoporotic fractures Study (AusICUROS) 
initiated through the International Osteoporosis Foundation (IOF).42 
Results from the first 505 participants (79% women) have been 
used in this analysis. Using a uniform study design to estimate 
costs and quality of life related to fractures, AusICUROS is being 
conducted at eight centres across Australia (Nepean and Royal 
North Shore Hospitals in Sydney; Austin Health and Western Health 
in Melbourne; Barwon Health in Geelong; Sir Charles Gairdner 
in Perth; Toowoomba Health Service, Queensland; and Menzies 
Research Institute in Hobart, Tasmania (see Acknowledgements). 
Prospective data is collected from patients with recent fracture at 
four time points: Phase 1 collects information within two weeks 
of fracture and documents quality of life before (recollected) and 
immediately after fracture and phases 2 to 4 collect data 4-, 12- 
and 18-months post-fracture. Self-reported health and community 
service resource use is collected at phases 2 to 4. This includes 
direct health care costs as well as informal care and community 
services. At most study centres hospital service utilisation has 
been verified using medical records. Eligibility includes diagnosis 
of a low energy fracture and age at least 50 years. Recruitment 
occurs largely through emergency departments and orthopaedic 
wards of acute hospitals. Not all fractures are admitted to hospital, 
some are managed as outpatients without an inpatient episode. 
Australian studies, including prospective longitudinal cohort 
studies such as the Geelong Osteoporosis Study and Dubbo 
Osteoporosis Epidemiology Study have provided an accumulating 
picture of osteoporosis in Australia, including both disease 
prevalence and fracture incidence. This burden of disease 
study aims to bring together data from these multiple Australian 
sources, and with the new data from the AusICUROS cohort 
on health service utilisation, community service utilisation and 
morbidity, construct a cost model using a bottom up approach 
to determine the total direct and indirect costs of osteoporosis, 
osteopenia and related low trauma fractures for the Australian 
population in 2012. 
Objectives
The primary aim of this study is to determine the annual burden 
of disease of osteoporosis from a societal perspective in the 
Australian population in 2012, and then model the assumptions 
from this analysis to predict the annual disease burden from 
2013 to 2022. The objectives of the analysis are:
1 to use the best available Australian data on incidence and 
prevalence and health service utilisation to estimate the 
burden of disease relating to osteoporosis and low trauma 
fractures (prevention and management) and the total disease 
burden attributable to osteoporosis in Australia in 2012; 
2 to model the burden forward 10 years from 2013 to 2022 
to estimate the population numbers of osteoporosis and 
osteopenia (and associated fractures both new and re-
fractures) and the total costs (direct and indirect), and
3 to model the impact of bisphosphonate medication (as the  
total number of fractures avoided) from 2013 to 2022.
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This represents the method for the determination of the annual 
burden of disease attributable to osteoporosis in Australia 
in 2012. There are two major components to the method to 
determine costs in 2012: the data sources that have been used 
as a basis for the population rates of osteoporosis, osteopenia 
and fractures; and the methods used to analyse the cost data. 
These data were used to determine the average direct health 
care and non-health care total costs and the indirect costs of 
a fracture in 2012, as well as the average community health 
service costs of managing someone with osteoporosis or 
osteopenia. The costs were then used as the basis to model  
the burden of osteoporosis for 10 years from 2013 to 2022. 
Population Estimates for Osteoporosis  
by Age and Gender
Australian population data
Australian population data were used from the estimated 
resident population for Australia at June 30th 2012 based  
on the 2011 census.4 Population data by gender and 5-year 
age bands from aged 50 years and over were used to generate 
population estimates for men and women in two age groups 
(50-69 years and 70+ years). Refer to Figure 1.
Incidence/prevalence data for osteoporosis  
and osteopenia
The Geelong Osteoporosis Study (GOS) measured BMD in a 
random sample of men and women recruited from the Barwon 
Statistical Division (Geelong and surrounding district).43 When 
extrapolating the results to the Australian population in 2006 
it was estimated that approximately 6% of men and 23% 
of women aged over 50 years would be expected to have 
osteoporosis, increasing to 13% of men and 43% of women  
in those aged over 70 years.6 To determine the proportion of the 
Australian population in 2012 with osteoporosis and osteopenia, 
the 5-year age interval data from the Geelong Osteoporosis 
Study 6 were used. The 5-year rates were then applied to the 
5-year population cohorts from the ABS44 to determine the 
weighted average proportions (by population) for osteoporosis 
and osteopenia for men and women in two age groups (50-69 
years and 70+ years) (refer to Tables 2 and 3).
Table 2: Estimated resident Australian population by age 
group and gender, June 30 2012 4
Age Groups
50-69 70+ All Ages
Men 2,486,789 945,293 3,432,082
Women 2,522,923 1,188,267 3,711,190
Total 5,009,712 2,133,560 7,143,272
Table 3: Osteoporosis and osteopenia age and gender 
standardised prevalence (percentage) 6
Age Group
Osteoporosis Osteopenia
Men % Women % Men % Women %
50-69 years 3.2 13.0 54.6 48.9
70+ years 12.9 43.2 59.1 46.1
Fracture incidence
The Geelong Osteoporosis Study cohort 43 was followed 
prospectively for approximately five years after baseline for 
fracture ascertainment.1, 2 Fracture cases were categorised 
according to their BMD scores at baseline (categorised as 
normal, osteopenia and osteoporosis). The proportion of all 
fractures in each BMD category was used to estimate the 
population-standardised number of fractures in each BMD 
category over a 5-year period. The rate of incident (first) 
fractures by age (50-69 years and 70+ years) for men and 
women and within each BMD category at the femoral neck 
(normal BMD, osteopenia and osteoporosis) occurring over 
5 years were provided from the Geelong Osteoporosis Study 
cohorts.1, 2 All fractures were confirmed by radiology.45 From the 
5-year incident rates for incident (first) fracture the annual rate 
was determined and then attributed to the 2012 population data 
for fracture incidence within the categories of osteoporosis, 
osteopenia and ‘normal’ BMD (see Table 4 for annual fracture 
incidence rates). The fractures arising from those with BMD 
in the normal category (BMD above a t-score of -1) were not 
attributed to osteoporosis and not included in the analysis of cost 
and burden of osteoporosis.
Table 4: Annual incidence of first fracture by gender, age 
group and BMD category (percentage)1
Age Group 
(years)
Normal BMD 
%
Osteopenia 
%
Osteoporosis 
%
Men
50-69 0.7 1.1 8.6
70+ 1.5 2.3 5.3
Women
50-69 1.3 2.0 5.5
70+ 2.4 4.0 6.8
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Proportion of each fracture type
The next stage of the population analysis was to estimate, from 
the population with osteoporosis and osteopenia who fracture, 
the proportion or distribution of each fracture type (hip, wrist, 
vertebral and ‘other’). These proportions were stratified by 
gender and 5-year age groups and data from the Sanders et al 
study were used.3 These data were from population estimates 
in 1994 to 1996 and since then Crisp et al have found declining 
incidence of hip fracture rates by 20% and 13% in women and 
men respectively.5 The proportion of hip fractures observed by 
Sanders et al was reduced by 20% in each 5-year age cohort 
for females and by 13% in each 5-year age cohort for males 
to account for these changes. The proportion of non-hip 
fractures was then increased so that the overall number of 
fractures remained the same as observed in the prospective 
population group with osteoporosis and osteopenia.1 The fracture 
distribution was assumed to be the same in both osteoporosis 
and osteopenia populations but varied by gender and age (in 
5-year age bands).
The distribution of fractures by site, gender, 5-year age intervals 
and BMD category are shown in Table 5 below. The proportion of 
people classified as having ‘other’ fractures was high relative to the 
proportion with hip, wrist and vertebral fractures. ‘Other’ fractures 
observed in the Sanders et al study13 included humerus, ankle, 
lower limb, as well as other ‘low trauma’ fractures such as rib, 
pelvic, forearm (not classified as wrist), patella, foot and hand 
fractures. Skull and facial fractures were not included. The total 
number of fractures categorised as ‘other’ was high, however 
the proportion of any single one of these fracture types observed 
in the population was low. Given the estimate of total fractures, 
the data were used to estimate the proportion of each fracture 
type, thus any redistribution of fractures from the ‘other’ category 
would have the effect of increasing the number of hip, wrist and 
vertebral fractures. 
Table 5: Fracture site distribution by gender and 5-year age 
groups (percentage)
Fracture Type
Age Group
50-54 % 55-59 % 60-64 % 65-69 % 70-74 % 75-79 % 80-84 % 85+ %
Women
Hip 1.4 3.9 2.5 8.7 11.8 22.2 30.4 44.9
Vertebral 10.3 11.3 20.2 21.1 24.5 28.1 23.6 16.4
Wrist 20.5 18.6 18.1 21.8 19.1 14.0 19.5 13.2
Other1 67.9 66.2 59.2 48.3 44.6 35.7 26.6 25.5
Men         
Hip 3.3 5.8 6.2 9.7 21.8 26.7 25.9 49.5
Vertebral 4.0 8.3 16.4 16.0 19.8 15.8 16.2 17.9
Wrist 4.0 9.6 5.7 1.0 5.8 4.6 5.5 7.1
Other1 88.8 76.3 71.7 73.8 52.6 52.9 52.4 25.5
1 Other fracture are all non-hip, non-wrist and non-vertebral fractures
Figure 1 shows a diagrammatic representation of the method 
used to ascertain population estimates with osteoporosis, 
osteopenia with or without a fracture (hip, wrist, vertebral and 
other) by age group, gender and BMD category (osteoporosis  
or osteopenia). 
Figure 1: Flow diagram showing data sources for  
population estimates with osteoporosis, osteopenia  
and fractures, by age group and gender
Australian Population Data
Gender/5-year age bands 4
Osteoporosis and osteopenia prevalence
Rates by gender/5-year age bands (age 50+ years)
GOS 6
Fracture incidence
Rates by BMD category/gender/age (50-69; 70+ 
years)1, 2
Proportion of each fracture type
Gender and 5-year age bands 3 with proportion  
of hip fractures adjusted based on Crisp et al 20125
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Figures 2a and 2b are flow diagrams that show the starting 
population from the ABS estimated resident population at June 
30th 20124 for both men and women, the number in each age 
group (50-69 years and 70+ years), the number and proportion 
in each BMD category (normal, osteoporosis and osteopenia) 
based on the prevalence data,6 the predicted number of fractures 
(Pasco et al under review) and the predicted number and type 
of fracture (hip, wrist, vertebral and ‘other’) (Sanders et al MJA 
1999) associated with each population group. These represent 
the population numbers and proportions assumed in each  
sub-category that were used to determine the total burden  
of disease attributable to osteoporosis over a one year period  
in 2012.
Figure 2a: Female population aged 50+ years with normal 
BMD, osteoporosis and osteopenia, and numbers of hip, wrist, 
vertebral, and ‘other’ fractures, and non-fracture populations
2012 Australian
 Female Population
 Aged 50+ years
N=3,711,190
Women Aged
 50-69 years
N=2,522,923
Women Aged
 70+ years
N=1,188,267
Osteoporosis
N=328,447
(13.0%)
Osteoporosis
N=513,874
(43.2%)
Hip
N=5,697
(1.0%)
Wrist
N=3,665
(0.7%)
Vertebral
N=5,181
(0.9%)
Other
N=7,579
(1.4%)
No Fracture
N=525,898
(96.0%)
Normal BMD
N=961,134
(38.1%)
Not Included
Osteopenia
N=1,233,342
(48.9%)
Normal BMD
N=126,374
(10.6%)
Not Included
Osteopenia
N=548,019
(46.1%)
Hip
N=674
(0.2%)
Wrist
N=3,561
(1.1%)
Vertebral
N=2,725
(0.8%)
Other
N=11,161
(3.4%)
Hip
N=922
(0.07%)
Wrist
N=4,873
(0.4%)
Vertebral
N=3,729
(0.3%)
Other
N=15,273
(1.2%)
No Fracture
N=1,208,545
(98.0%)
No Fracture
N=310,326
(94.0%)
Hip
N=9,018
(1.8%)
Wrist
N=5,801
(1.1%)
Vertebral
N=8,202
(1.6%)
Other
N=11,998
(2.3%)
No Fracture
N=478,854
(93.2%)
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Figure 2b: Male population aged 50+ years with normal 
BMD, osteoporosis and osteopenia, and numbers of hip, wrist, 
vertebral, and ‘other’ fractures, and non-fracture populations
2012 Australian
Male Population
Aged 50+ years
N=3,432,082
Men Aged
50 - 69 years
N=2,486,789
Men Aged
70+ years
N=945,293
Osteoporosis
N=79,960
(3.2%)
Osteopenia
N=1,358,500
(54.6%)
Osteoporosis
N=122,019
(12.9%)
Osteopenia
N=558,278
(59.1%)
Normal BMD
N=264,996
(28.0%)
Not Included
Normal BMD
N=1,048,328
(42.2%) 
Not Included
Hip
N=404
(0.5%)
Wrist
N=358
(0.4%)
Vertebral
N=717
(0.9%)
Other
N=5,374
(6.7%)
No Fracture
N=73,107
(91.0%)
Hip
N=862
(0.06%)
Wrist
N=764
(0.06%)
Vertebral
N=1,531
(0.1%)
Other
N=11,464 
(0.8%)
No Fracture
N=1,343,880
(99.0%)
Hip
N=1,814
(1.5%)
Wrist
N=362
(0.3%)
Vertebral
N=1,147
(0.9%)
Other
N=3,152
(2.6%)
No Fracture
N=115,545
(94.7%)
Hip
N=3,590
(0.6%)
Wrist
N=716
(0.1%)
Vertebral
N=2,270
(0.4%)
Other
N=6,237
(1.1%)
No Fracture
N=545,465
(97.7%)
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Cost and Resource Utilisation Estimates 
for Osteoporosis and Osteopenia in 2012
Data sources for cost and service utilisation rates
Data from existing sources (published) and from new data 
collections on fractures (AusICUROS) and associated health 
service utilisation have been used and combined with cost/price 
data from the MBS, PBS and hospital costing to attribute costs 
to treatment of fractures (by fracture type), drug treatment for 
management of osteoporosis and screening for osteoporosis. 
A bottom-up costing approach was used to determine the total 
burden attributable to fractures based on service utilisation data 
reported to the AusICUROS study. From this study at August 
2012 there were completed baseline to 12 month follow-up 
data for 505 people with low trauma fractures (refer to Table 6 
below). Fractures included hip, wrist, vertebral and ‘other’. The 
distribution of the ‘other’ group of fractures in the AusICUROS 
fracture cohort is indicated in Table 7. 
Table 6: Fracture numbers from AusICUROS on which  
health care and service utilisation is based
Fracture 
Type
Age 50-69 years Age 70+ years Total
Men Women Both Men Women Both
Hip 5 20 25 16 71 87 112
Wrist 23 122 145 8 76 84 229
Vertebral 12 12 24 10 15 25 49
Other 21 50 71 12 32 44 115
ALL 61 204 265 46 194 240 505
Table 7: Distribution of ‘other’ group of fracture in the 
AusICUROS cohort
Fracture Type Number
% of all 
fractures
Foot and ankle 44 8.7
Humeral 27 5.3
Tibia/Fibula 14 2.8
Other femoral and pelvis 11 2.2
Rib 7 1.4
Clavicle 3 0.6
Forearm (not wrist) 2 0.4
Other (not specified) 7 1.4
Total 115 22.8
Data from AusICUROS included patient records and self-reported 
questionnaires about health and non-health service use following 
fractures from eight Australian study sites. From these data the 
resources collected included:
•	 Direct health care utilisation (hospitalisation, ambulance, 
imaging, medical services, pharmaceuticals and supplements, 
non-admitted, sub-acute/rehabilitation and community-based 
services including GP and physiotherapy services);
•	 Direct non-health care utilisation rates (residential care, meals 
on wheels, and other community services); and
•	 Indirect costs (Informal care and production loss).
Fracture numbers in Table 6 were categorised according to 
fracture type (hip, wrist/colles, vertebral and ‘other’), age group 
(50-69 years and 70 years and over), and gender. There were 
low numbers of fractures for men aged 50-69 years with a hip 
fracture (n=5) and men aged 70+ years with a wrist fracture 
(n=8). For all other fracture types by age/gender split there 
were 10 cases or more. Where there were missing data or low 
utilisation rates for some services the age groups, gender and/
or fracture type were combined to determine the utilisation rate 
and/or the service cost. 
Where there were a large number of missing data from the 
AusICUROS cohort (particularly in the follow-up period from  
4 to 12 months post-fracture) or low utilisation rates these  
have been compared to other data sources (where available). 
This is particularly relevant for assumptions around nursing  
home utilisation. In general there are more published sources  
for health care utilisation and residential care following hip 
fractures than for the other fracture sites. Therefore in most 
cases the assumption has been made that AusICUROS data 
represent the best source (even though numbers are low for 
some fracture populations). 
Itemised tables by category of resource are provided with the 
average resource utilisation rate for the fracture population in 
2012 in Appendix A and the unit cost for each resource (as AUD 
2012) in Appendix B. Assumptions made for each rate and cost 
are included in the Appendices as well as the source of the data. 
All costs are reported as AUD 2012, where secondary sources 
have been used with costs reported in earlier years these have 
been inflated using the general inflation rate for Australia by 
financial year.46
Direct health care service costs
Acute care
Pre-hospital (ambulance) and hospitalisation
The rate for ambulance paramedic transport for each fracture 
type by age group and gender was determined from AusICUROS 
data. People with hip fractures were the most likely group to 
utilise ambulance paramedic services and wrist fractures the 
least likely. Rates for ambulance use are included in Appendix A 
and unit costs are reported in Appendix B. The cost attributed to 
all ambulance paramedic services was $689 per case47 which 
was the inflated average cost of all cases transported by road 
in Victoria in 2011.1 All people transported by ambulance were 
assumed to have been taken to a hospital emergency department.
The rate for admitted hospital care for each fracture type 
by age group and gender was determined from AusICUROS 
data. All men and women with hip fractures were admitted 
to a hospital in both age groups. Admission rates for non-hip 
fractures differed by both age and gender. In general women 
were more likely to be admitted than men in the same age 
group with the exception of vertebral fractures in the younger 
age group. Hospital admission rates for each fracture by gender 
and age are included in Appendix A.
1 The 2011 reported cost of $675 was inflated to 2012 AUD.
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Barwon Health Geelong, one of the hospitals participating in 
the AusICUROS study, had the highest number of participants 
who were hospitalised. Case level hospital costs were obtained 
from Barwon Health for all participants in the AusICUROS 
cohort admitted to a Barwon Health facility. Unit costing data 
from admitted patient systems that use a bottom-up approach 
to hospital costing generally represent good quality hospital 
cost data, from which both a mean cost, mean length of stay 
and standard deviations in a population sub-group can be 
determined. This contrasts to data reported at the diagnosis 
related group (DRG) level. Therefore patient level data from 
Barwon Health are likely to be a better representation of the 
average cost of patients in a given age group with low trauma 
fractures (more likely to be caused by osteoporosis/osteopenia) 
than the average cost for the DRG. Hospital costs were assumed 
to vary by fracture type and age group, but to determine the 
mean total cost of hospitalisation the hospital cost data for men 
and women were pooled. 
The number of fractures in each subgroup, mean total hospital 
cost, mean length of stay and relevant standard deviations (SD) 
from Barwon Health data are shown in Table 8. Case numbers for 
people with a vertebral fracture from Barwon Health who were 
hospitalised were low (N=6) and all in the 70 years and over age 
group therefore the mean cost was assumed for all vertebral 
fracture admissions. For hip, wrist and ‘other’ fractures the mean 
costs and length of stay for hospital admissions were calculated 
and reported separately for each age group (50-69 years and 
70+ years).
The mean costs of patients admitted to hospital included costs 
for Emergency Department care, pathology, imaging, and allied 
health so where a person was admitted to hospital for a fracture, 
these costs were assumed in the total inpatient cost for fracture 
management, not separately included (to avoid double counting).
Table 8: Costs of acute hospital episode and length of stay  
by fracture, and age group 
Men and Women
50-69 years 70+ years
Mean Hospital 
Cost 2011/12$ 
(SD)
Mean LOS 
(days)  
(SD)
Mean Hospital 
Cost 2011/12$ 
(SD)
Mean LOS 
(days)  
(SD)
Hip 
Mean (SD)
N=8 
17123 (9306) 6.9 (2.7)
N=32 
22532 (12002) 11.5 (5.7)
Colles 
Mean (SD)
N=30 
7310 (1888) 1.6 (0.6)
N=22 
6885 (2884) 2.4 (1.5)
Vertebral 
Mean (SD)
N=6 
6684 (3408) 5.4 (3.8)
Other 
Mean (SD)
N=41 
10184 (7314) 4.5 (5.2)
N=31 
11605 (11480) 11.1 (10.8)
Source: Barwon Health AusICUROS cohort
Non-admitted hospital services (Emergency  
Department and Outpatient Services)
The rates for Emergency Department (ED) care for fractures, 
where the person was not subsequently admitted to hospital, 
were determined from AusICUROS data. All people with a fracture 
transported by ambulance were assumed to go to a hospital 
Emergency Department, AusICUROS showed those who were 
admitted, the remainder were assumed to have been managed 
in the ED and then discharged and managed in the community or 
as an outpatient. Emergency Department costs were attributed to 
these people, as a non-admitted patient service. 
For people in the AusICUROS cohorts who attended the Emergency 
Department but were not transported by ambulance, the same 
rates of hospitalisation were used as observed in the AusICUROS 
cohort. Of the remainder they were assumed to have attended  
the hospital ED2 or to have been treated in the community by a 
general practitioner.
Rates of Emergency Department use for non-admitted people 
were separately calculated for wrist, vertebral and ‘other’ 
fractures (all people with a hip fracture were admitted to hospital) 
by age group and gender. These rates are included in Appendix A. 
Emergency Department costs were attributed to those managed 
in the ED but not admitted, as a non-admitted patient service. 
Costs attributed to Emergency Department attendance were 
taken from the Australian Independent Hospital Pricing Authority.48 
Wrist fractures were assumed to be Triage Category 5 and 
vertebra and ‘other’ fractures Triage Category 4 (all hip fractures 
were admitted, so no assumption regarding the triage category 
was required). Therefore, the cost for a non-admitted Emergency 
Department attendance relating to a wrist fracture was $251 and 
for vertebral or ‘other’ fracture was $361. These costs are shown 
in Appendix B.
Whether a fracture was managed in a hospital outpatient clinic 
was also reported in the AusICUROS cohort. Outpatient clinic 
fracture management occurred following a hospital admission 
or for those people seen in the Emergency Department without 
an admission. An average rate of outpatient attendance was 
determined for all people with a fracture irrespective of whether 
there had been an admission. The rates differed by fracture 
type, but were the same for both age groups and gender. Sixty 
one percent of people with a hip fracture visited an outpatient 
clinic. These rates are shown in Appendix A. Costs for outpatient 
department attendance were determined from the Australian 
IHPA 201248 based on the rate of $191 for an orthopaedic 
clinic. These are shown in Appendix B. It was assumed that 
all outpatient department attendees had 3 visits for fracture 
management, irrespective of fracture type, age and gender. 
Sub-acute care (rehabilitation)
Of those people admitted to hospital for fracture management 
a certain proportion were discharged to a subacute care facility 
for inpatient rehabilitation. The rates reported in the AusICUROS 
2 Some of the AusICUROS sites only recruited through the ED.
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cohort differed for hip and non-hip fractures and by age group. 
Thirty nine percent of people with a hip fracture aged 50-69 
years and 32% of those aged over 70 years were discharged 
from acute care to a rehabilitation facility. For non-hip fractures 
the rates were 18% and 14% respectively (see Appendix A). The 
cost of a rehabilitation episode was determined from the Barwon 
Health costing data for a small number of people (N=30) who 
had been admitted to the Barwon Health rehabilitation facility. 
The mean cost $12375 (SD: 8557) for a rehabilitation episode 
was determined across all fracture types and both age groups. 
So although the rate of rehabilitation differed for hip and non-hip 
fractures the same rehabilitation episode cost was assumed.
Aged care and community services 
Residential aged care
The rates assumed for residential aged care following a fracture 
were 11% for hip fracture49 and 1% for non-hip fractures 
(AusICUROS) in the 70 years and over age group only. The 
rates are shown in Appendix A. The average length of stay over 
12 months in a residential aged care facility following a fracture 
in 2012 was assumed to be 6 months. It was assumed that once 
admitted to a residential aged care facility that the person would 
remain in residence there for the remainder of 2012. As fractures 
occurred throughout 2012, a length of stay of 6 months was 
chosen as a midpoint. The average cost per day was $16350 based 
on the mean annual cost of a low level care resident in 2010.3  
It was assumed that once admitted to residential aged care there 
was no further health care service use specific to the fracture. 
However management costs for osteoporosis/osteopenia whilst 
in residential aged care were assumed to continue.
Community fracture management
Medical care for fracture management (general 
practitioner and medical specialist)
Fracture management that occurred in the community rather 
than in the hospital setting (either admitted or non-admitted) 
was assumed for the remainder of people who did not report 
attending a hospital ED or who had a hospital admission from 
the AusICUROS cohort. Community fracture management 
was assumed to be by a general practitioner. The rates were 
small for each fracture type (ranging from 0.02 to 0.09) 
reflecting a possible recruitment bias in favour of people with 
a fracture presenting to a hospital ED. Attributed resource use 
for community fracture management was assumed to be three 
general practitioner visits and one radiological examination. The 
cost assumed for each general practitioner visit was $36 (the 
recommended Schedule fee for Item Number 23; MBS Online 
2012),51 and for radiological examination the MBS recommended 
Schedule fee was used specific to the fracture site (refer 
Appendix B). 
3 The 2010 reported per diem cost of $117 was inflated to 2012 AUD.
Participants in the AusICUROS cohort reported visits to an 
orthopaedic medical specialist following discharge to the 
community from either a hospital emergency department, acute 
or sub-acute care ward. Where reported it was assumed that this 
was a private medical specialist and that these people did not also 
attend a hospital outpatient clinic. The rates varied for fracture type 
but were not significantly different by age or gender. The average 
number of visits reported in AusICUROS across all fracture types 
was 2.5 visits and the cost attributed was $84 (the recommended 
Schedule fee for Item number 104; MBS Online 2012).51 
Physiotherapy
Participants in the AusICUROS cohort also reported visits to 
physiotherapists post-discharge from hospital. An assumption 
was made that if a person attended a private physiotherapist 
then they did not also attend a hospital outpatient clinic. The 
attributed rate was an average for each fracture type from 
the AusICUROS cohort with no differentiation for age group or 
gender (see Appendix A). People post discharge from a sub-
acute facility, or in conjunction with private medical specialist  
or general practitioner fracture management may have attended 
private physiotherapy sessions. The cost attributed per session 
was $62 (Item Number 10960; MBS Online)51 and the average 
reported number of sessions was taken from the AusICUROS 
cohort (9 sessions following a hip fracture, 5 sessions following 
a wrist fracture, 4 sessions following a vertebral fracture and  
6 following ‘other’ fractures).
Pharmaceutical management of fracture
Pharmaceutical use following a fracture was taken from self-
reported data in the AusICUROS study. All reported medications 
were recorded and sorted according to whether they were 
for fracture management or supplements for osteoporosis 
prevention or treatment (bone active medications). Drugs specific 
to fracture management included analgesia (including over-
the-counter (OTC) medications, and opioids) and non-steroidal 
anti-inflammatory drugs (NSAIDs). Rates were determined by 
fracture type and gender, and whether the medication was taken 
on a routine basis or ‘as needed.’ From self-reported rates for all 
medications falling into the fracture management category, the 
average daily rate was determined for each drug type (weighted 
by whether taken regularly or as needed). The mean cost per day 
was determined for each drug based on routine use with prices 
taken from the Pharmaceutical Benefits Scheme website52 or 
an online pharmacy direct site53 (for common over-the-counter 
medications). A weighted mean cost per day was then determined 
for the fracture management medication group as a whole and 
used to derive a total cost over the 4 months following a fracture. 
Rates of use and weighted mean costs were specified for fracture 
type, age and gender. 
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Health care services for osteoporosis and 
osteopenia management 
Medical services
In addition to specialist medical services (assumed to be 
orthopaedic specialist visits) reported in the AusICUROS study 
there were other self-reported doctor visits also recorded. It 
was assumed that these medical services were for general 
practitioner attendance, for either fracture management or 
ongoing management of osteoporosis/osteopenia. The average 
number of reported medical visits was 2.4 per year; this 
was attributed to the entire population with osteoporosis or 
osteopenia and/or a fracture. The assumption was based on the 
need for likely follow-up investigations and/or pharmacological 
scripts for the management of osteoporosis/osteopenia. 
Diagnostic imaging
The relevant diagnostic imaging procedure for osteoporosis/
osteopenia is Dual-energy X-ray Absorptiometry (DXA). The 
total cost for DXA in 2011/12 was taken from the MBS total 
expenditure54 on Item Numbers 12306, 12309, 12321, and 
12323. The assumption for this was that the majority of DXAs 
are undertaken for osteoporosis. To determine the total cost  
of screening the patient gap contributions of 15% were added  
to the total expenditure reported in the Medicare statistics. 
Pathology
Assumptions were made about the type and number of 
pathology tests that could be attributed to osteoporosis 
based on expert opinion. Firstly for Vitamin D tests, it was 
assumed one test every 2 years for the entire population with 
osteoporosis or osteopenia. The other relevant pathology test 
was a general blood test for renal function and serum calcium, 
and it was assumed that the entire population with osteoporosis 
or osteopenia would have this test twice per year. The MBS 
schedule fee in 2012 was used, for Vitamin D (MBS item number 
66608) the fee was $39 and for a routine pathology test (based 
on 3 tests from one blood sample) the schedule fee (MBS Item 
number 66506) was $14 51. Refer Appendix B for unit costs.
Pharmaceuticals and supplements for 
osteoporosis/osteopenia prevention  
and treatment
Osteoporosis prevention
Self-reported pharmaceutical use from the AusICUROS cohort 
relating to the prevention/treatment of osteoporosis was used to 
determine the rate of osteoporosis prevention supplements use 
pre-fracture. Supplements for osteoporosis prevention included 
calcium and vitamin D separately and in combination. Thirty nine 
per cent of AusICUROS participants reported that they were on 
calcium or vitamin D prior to their fracture.55 It was assumed 
that people who reported taking these supplements on a regular 
basis were likely to use the recommended dose over a 12 month 
period. Dosage used was the recommended daily dose for each 
drug. The cost was determined from drug prices from either 
the PBS52 or pharmacy online,53 and the cost over 12 months 
was determined by weighting the relative rate of use (from the 
AusICUROS cohort) for each medication. 
Osteoporosis treatment
To determine the total utilisation of osteoporosis (bone-active) 
medications for osteoporosis treatment, the volume of dispensed 
scripts by the PBS and Repatriation Pharmaceutical Benefit 
Scheme (RPBS) the Item Reports from Medicare Australia54 
were used for the 2011/12 financial year. Medications where 
osteoporosis (including post-menopausal and steroid-induced 
osteoporosis) was listed under the authority restriction included:
•	 Alendronate preparations
•	 Denosumab
•	 Etidronate preparations4
•	 Raloxifene
•	 Risedronate preparations
•	 Strontium ranelate
•	 Teriparatide
•	 Zoledronic acid
To determine the annual cost, the reported number of services 
from the PBS and RPBS was multiplied by the schedule fee for 
each unit of service to determine the total cost.54 No costs have 
been attributed for the use of hormone replacement therapy (HRT) 
with the exception of raloxifene (where osteoporosis was listed 
under the authority restriction). See Appendix C for osteoporosis 
(bone-active) medications including the relevant PBS codes for  
use in osteoporosis and the schedule fee. 
This method for cost, medication based on the PBS and 
RPBS scripts is conservative as it does not include the cost of 
medications that may have been administered by a hospital and 
therefore not included in the PBS/RPBS volume reports. Particularly 
the injection formulations such as denosumab and zoledronic acid 
may have been administered in the hospital environment to achieve 
compliance.56 The cost method also does not take into account any 
additional co-payment made by the patient. 
4 Etidronate is no longer available on the PBS in Australia in 2013.
16
Indirect costs comprised of two components namely; the value 
of time lost from work as a result of caring for a person with an 
osteoporotic fracture (referred to as informal community care) 
and the value of time lost due to hospitalisation in acute care 
or subacute care (rehabilitation) as a result of an osteoporotic 
fracture (referred to as production loss).
Direct non-health care costs
Community non-health services (home help,  
meals on wheels)
The use of community (non-health) services post-fracture were 
also available from the AusICUROS data. From these data the 
average rate of use for each home help and meals on wheels 
could be determined. In the AusICUROS cohort the number of 
hours used per week for home help was collected at 4 months 
and then at 12 months. The utilisation rates for home help 
are shown in Appendix A. The weighted average number of 
hours used over the 12 month period was calculated for those 
individuals who self-reported any home help and determined by 
fracture, age group and gender (see Table 9). The casual rate  
for home help in 2012 was approximately $25 per hour.57 
Table 9: Community non-health services (‘home help’) mean 
hours per week (weighted over 12 months) by fracture type, 
gender and age-group
Fracture Type
Age 50-69 years Age 70+ years
Men Women Men Women
Hip 0.00 0.50 1.62 1.18
Wrist 0.00 0.61 0.33 0.79
Vertebral 0.00 1.89 0.99 1.30
Other 0.34 1.10 0.37 0.78
For meals on wheels the daily cost was $16.50 (Geelong City, 
2012) and it was assumed that people would use the service for 
12 months. In the AusICUROS data only people in the age group 
70 years and over self-reported using meals on wheels, and 
there were more women than men using these services. 
Informal community care
Informal community care was estimated from self-reported 
data in the AusICUROS study. The method was similar to that 
reported for community (non-health) service use post-fracture. 
The number of hours of use reported at 4 months and then again 
at 12 months was weighted to determine the average hours per 
week over 12 months by fracture, age group and gender (see 
Table 10). The rates are shown in Appendix A. The same hourly 
rate ($25) was used as for home help57 on the assumption that 
if informal care by a family member was not possible then the 
person would have required paid community services. 
Table 10: Informal community care mean hours per week 
(weighted over 12 months) by fracture type, gender and  
age-group
Fracture Type
Age 50-69 years Age 70+ years
Men Women Men Women
Hip 1.90 1.90 4.58 7.79
Wrist 0.83 5.51 0.00 3.44
Vertebral 10.31 7.36 4.08 3.67
Other 3.70 3.70 3.70 3.70
Indirect costs from production loss
Productivity losses were estimated for the total number of days 
spent in acute and subacute care as a result of the fracture. 
This was estimated for anyone who fractured aged 50 years 
and over. This method assumes that all adults have some kind 
of productivity irrespective of their age, employment status 
or labour force participation. These costs were calculated by 
multiplying the average length of stay (ALOS) in hospital as days 
by the average daily earnings in Australian dollars (AUD).58 The 
costs were categorised by fracture type, age groups and BMD 
category. The ALOS data for acute and subacute care were 
obtained from Barwon Health – Geelong Hospital (see Table 
11 below). The average daily earnings was calculated from the 
average weekly total earning at May 2012 ($1058.7)58 divided 
by 7 to account for hospitalisation that may extend beyond 
a normal 5-day working week. A 7-day week also does not 
differentiate paid or unpaid work.
Table 11: Average length of stay (days) by fracture type  
and age groups 
Fracture Type
50-69 years old 70+ years old
Number 
of cases ALOS (SD)
Number 
of cases ALOS (SD)
Hip 8 6.89 (2.67) 32 11.54 (5.7)
Wrist 30 1.58 (0.56) 22 2.39 (1.50)
Vertebral 6 5.43 (3.80)
Other 41 4.47 (5.17) 31 11.07 (10.8)
Mortality
Mortality rates used were those reported in the AusICUROS 
study. Mortality recorded in the AusICUROS study occurred 
during the first 12 months following hospitalisation due to the 
fracture. It was therefore assumed to occur as a result of the 
fracture. Numbers were small so the same mortality rate for 
all fractures was used for 50-69 year olds (rate=0.01) while 
different mortality rates were determined for hip and non-hip 
fracture for adults aged 70 years and over (hip 0.08; non-hip 
0.05). The numbers of people presumed to have died as a 
result of fracture in Australia in 2012 were determined by BMD 
category, fracture type, age and gender. For the purposes of this 
Burden of Disease Study indirect costs due to lost productivity 
have not been attributed to those who die.
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Burden of Osteoporosis and Osteopenia 
in Australia from 2013 to 2022
The second part of the Burden of Disease study was to project 
the burden of osteoporosis and osteopenia and related fractures 
forward for 10 years from 2013 to 2022. The model was based 
on the populations (fracture and non-fracture) by gender, age 
group and BMD and the costs determined from 2012. 
Population 2013-2022
The ABS annual population projection series B5 were used for 
the Australian population from 2013 to 2022.59 To determine 
the annual prevalence of osteoporosis and osteopenia in men 
and women aged 50-69 years and aged 70 years and over, the 
projected population in 5-year age intervals were used and the 
rates from the Geelong Osteoporosis Study applied6 as for 2012. 
The incidence of new fractures by gender, age and BMD was 
determined using the same rates as for 2012.1, 2 The proportion 
of each fracture type was applied to each age group (50-69 
years and 70 years and over) based on the Sanders et al3 data 
with the Crisp et al5 adjustments, and weighted by the 5-year 
population fracture distribution observed in 2012 (see Table 12).
Each year the previous year’s population (alive at the end of 
the period) was carried forward into the model in the following 
cohorts (by age group, gender and fracture type) with associated 
assumptions concerning osteoporosis (bone active) medications:
1 Osteoporosis with previous fracture6 – 100% on osteoporosis 
(bone active) medications
2 Osteopenia with previous fracture – 100% on osteoporosis 
(bone active) medications
3 Osteoporosis no fracture – 35% on osteoporosis (bone active) 
medications7
4 Osteoporosis no fracture – 65% not on osteoporosis (bone 
active) medications
5 Osteopenia no fracture – 100% not on osteoporosis (bone 
active) medications
Table 12: Distribution of fracture type by gender  
and age group 3, 5
Fracture Type
Women Men
50-69 years 70+ years 50-69 years 70+ years
Hip 4% 26% 6% 28%
Wrist 20% 17% 5% 6%
Vertebral 15% 23% 10% 18%
Other 62% 34% 78% 49%
100% 100% 100% 100%
5 Series B reflects current population trends for life expectancy, birth rates, 
migration and mortality.
6 This was based on the fractures first observed in 2012, and then increased by 
fractures occurring in each year thereafter.
7 This 35% is the assumed prevalence of osteoporosis (bone active) medications  
in the community.
Medication use
The total use of osteoporosis (bone active) medication based on 
the assumptions described above8 was approximately 500,000 
people in 2012. By applying the annual cost of alendronate 
(approx. $365) per individual to this population the total 
cost of osteoporosis (bone active) medications in 2012 was 
approximately $180 million (which was consistent with the total 
cost of $179 million in 2012). This assumption meant that the 
individual use of medication could be attributed in the model and 
the effect carried through the model in terms of costs and the 
number of fractures (including the number of fractures ‘avoided’ 
as a consequence of the medication). 
Similar to an assumption made in a Canadian study,60 alendronate 
was chosen as the most widely prescribed generic bisphosphonate 
in Australia, for which there is the most evidence as to its 
effectiveness in reducing fractures, including a Cochrane Review.61 
Thirty five percent use of the cohort with no fracture (Cohort #3) 
were assumed to be taking osteoporosis (bone active) medication. 
This cohort was assumed the prevalence group, and the new 
fractures from 2012 were assumed to commence medication in 
2012 as a result of the fracture. A non-adherence rate of 40%60 
after the first year of use of osteoporosis (bone active) medication 
was attributed to the group commencing medications, but not the 
medication prevalence group. 
The effect of the osteoporosis (bone active) medications is 
to reduce the fracture and re-fracture rates attributable to 
osteoporosis and osteopenia. The reduction in fracture risk 
assumed was based on the rates reported in a Cochrane Review  
of alendronate61 and shown in Table 13 below as a weighted 
relative risk in fracture reduction. 
Table 13: Weighted relative risk reduction (%) of fracture for 
alendronate by fracture type and year 61
Fracture Type
Weighted relative risk reduction
Year 1 Year 2 Year 3
Hip 29 50 55
Wrist (non vertebral) 45 31* 18
Vertebral 21 62 48
Other (non vertebral) 45 31* 18
*The Cochrane Review was not able to determine a rate in Year 2 for non-
vertebral, non-hip fractures, therefore a linear relationship between Years 1  
and 3 was assumed 
In the first year of the model (2013) it was assumed that 
everyone on osteoporosis (bone active) medications had the 
benefit of the medication for one year (Year 1 relative risk 
reduction in fractures) attributed to the re-fracture rate (for those 
who had a fracture from 2012) and to the osteoporosis fracture 
rate (for those who had not fractured in 2012). In the second 
year of the model (2014) 40% of the fracture group from 2012 
had ceased medication, so resumed the fracture risk without 
medication, and the remaining 60%, as well all the osteoporosis 
group without a fracture from 2012, had the benefit of the 
8 These assumptions are also consistent with the PBS prescribing restrictions for 
bisphosphonates in osteoporosis.
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medication for 2 years (Year 2 relative risk reduction in fracture). 
No further decline in osteoporosis (bone active) medication use 
was assumed, so both groups had the benefit of medication use 
in the 3rd year. This method for determining the total number 
of fractures (first fractures and re-fractures) in each population 
group (age, gender and BMD) was carried forward for each 
year of the model, for 10 years from 2013 to 2022. The same 
assumptions were used, that is new medication use in the new 
fracture group each year and a constant 35% prevalence of 
medication use in the osteoporosis population.
The effects of osteoporosis (bone active) medications were able 
to be attributed according to each population cohort, carried 
forward through the model. From these assumptions the number 
of new fracture and re-fractures could be determined (with and 
without bisphosphonate therapy).
Fracture numbers: new fractures  
and re-fractures
For each year of the model (2013-2022) the number of fractures 
was determined by fracture site, BMD, gender and age group 
(as ‘first fracture’ and ‘re-fracture’). The predicted number of 
first fractures was determined for each year of the model based 
on the same assumptions used in 2012 and described above, 
with the benefit assumed from bisphosphonate therapy (also 
described above). 
To determine the number and type of re-fractures, the relative 
risk of re-fracture rates applied were 1.97 for women and 3.47 
for men irrespective of age group and BMD.62 These were 
adjusted for bisphosphonate therapy accordingly. The distribution 
of fracture type was assumed the same as for first fracture.
For each year the number of first fractures and re-fractures were 
determined according to gender, age group (5-year age groups 
for new fractures; and 50-69 years and 70 years and over for 
re-fractures), BMD (osteoporosis and osteopenia), whether on 
therapy or not, and by the type of fracture (hip, wrist, vertebral 
and ‘other’).
Additional analysis was also undertaken on the assumption of 
‘no medication’ and the consequent number of first fracture and 
re-fractures (by gender, age group, BMD and type of fracture) that 
would be expected to occur. Each year the difference between the 
medication and no medication assumptions were calculated as the 
potential fractures avoided as a result of bisphosphonate therapy. 
Cost of osteoporosis, osteopenia and 
associated fractures, 2013-2022
The average annual direct and indirect costs of a fracture (by 
gender, age group and fracture type) determined from 2012 
were attributed to the fractures that occurred each year. The 
annual average direct cost included nursing home in the year of 
the fracture as well community services related to the fracture. 
The average annual indirect cost assumed lost productivity 
as a result of the fracture. The same total fracture costs were 
assumed for both first fractures and for re-fractures. The total 
cost (direct and indirect) for each year was determined by 
fracture site, age and gender. 
For the community management of osteoporosis or osteopenia 
(irrespective of fracture) the following assumptions were made 
concerning medication, investigations and medical care. The total 
costs of bisphosphonate therapy as well as the total population 
assumed to be on medication each year from 2013 to 2022 
were determined. It was assumed that everyone with a new 
fracture would have one DXA in the year of the fracture, and 
that the rest of the population with osteoporosis or osteopenia 
(including the re-fracture population) would have one DXA every 
three years (an annual rate of 0.33).9 Pathology tests for Vitamin 
D were assumed once every 2 years for the entire population 
with osteoporosis or osteopenia, and routine pathology tests 
were based on the same assumption as for 2012 (i.e. two routine 
tests annually). General practitioner visits were assumed at a 
rate of 2.4 visits annually for the population with osteoporosis or 
osteopenia irrespective of fracture (as assumed in 2012). 
Nursing Home costs were included in the average annual direct 
cost of a fracture determined from 2012 in the year that the 
fracture occurred. For each subsequent year the annual cost of 
a nursing home was attributed to those in residential care, with 
a 10% annual attrition rate assumed. The costs of subsequent 
residential care each year were also determined. 
All costs were determined in 2012 dollars for comparability and 
then an annual inflation rate of 3.4%46 applied to the total annual 
cost for each year (2013-2022). The total cost for each year from 
2013 to 2022 was determined. To compare with the total costs 
from 2012, the total cost less nursing home and re-fracture 
costs, was used as these costs were not included in the 2012 
total cost.
9 The total cost of DXA in 2012 was determined from the MBS expenditure data and 
not attributed to individuals.
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Results
Table 14 below shows the Australian population data that were used to determine the total burden of disease of osteoporosis 
by gender, age-groups (50-69 years and 70+ years), and BMD category (osteoporosis, osteopenia) in Australia in 2012. The 
total population consists of the population 50 years and over with fracture (hip, wrist, vertebral and ‘other’) and without fracture 
(osteoporosis and osteopenia only). 
Table 15 indicates the number in the starting population by osteoporosis and osteopenia, gender and age group with fractures and 
without fractures. The number of hospitalisations, admissions to residential aged care and deaths during 2012 are also shown. The 
numbers of individuals with osteoporosis or osteopenia that were presumed alive at the end of 2012 are included, these were the 
numbers carried forward in the 10-year projection model. 
Table 14: 2012 Australian populations by gender, age group and BMD category
Age Group
Osteoporosis Osteopenia Normal BMD Total Population
Women Men Women Men Women Men Women Men Both
50-69 years 328,447 79,960 1,233,342 1,358,500 961,134 1,048,329 2,522,923 2,486,789 5,009,712
70+ years 513,874 122,019 548,019 558,278 126,374 264,996 1,188,267 945,293 2,133,560
Totals 842,321 201,979 1,781,361 1,916,778 1,087,508 1,313,325 3,711,190 3,432,082 7,143,272
Table 15: 2012 Populations by gender, age group BMD category and fracture type
Population
Women Men All
50-69 years 70+ years Total 50-69 years 70+ years Total 
TotalOsteoporosis Osteopenia Osteoporosis Osteopenia All Women Osteoporosis Osteopenia Osteoporosis Osteopenia All Men
Total Population 328,447  1,233,342  513,874  548,019  2,623,682  79,960  1,358,500  122,019  558,278  2,118,758  4,742,441 
Population with 
fracture (Total) 18,121  24,797  35,020  22,122  100,060  6,854  14,621  6,474  12,813  40,762  140,822 
Hip
Starting population 674  922  9,018  5,697  16,311  404  862  1,814  3,590  6,670  22,981 
Hospitalised  607  830  8,387  5,697  15,520  404  862  1,814  3,590  6,670  22,190 
Died  8  12  745  471  1,235  5  11  150  297  462  1,698 
Nursing home  -  -  992  627  1,619  -  -  200  395  594  2,213 
Alive at year end  666  911  8,273  5,226  15,076  399  851  1,664  3,293  6,208  21,284 
Wrist
Starting population 3,561  4,873  5,801  3,665  17,900  358  764  362  716  2,199  20,099 
Hospitalised  1,602  2,193  3,655  2,309  9,759  140  298  181  358  976  10,735 
Died  20  27  173  109  330  2  4  9  17  31  360 
Nursing home  -  -  48  30  78  -  -  2  5  7  85 
Alive at year end  3,541  4,845  5,629  3,556  17,570  356  760  353  699  2,168 19,738 
Vertebral
Starting population 2,725  3,729  8,202  5,181  19,837  717  1,531  1,147  2,270  5,665  25,502 
Hospitalised  899  1,231  5,495  3,471  11,097  359  765  573  1,135  2,832  13,929 
Died  11  15  260  164  451  4  10  27  54  94  545 
Nursing home  -  -  71  45  117  -  -  7  15  22  139 
Alive at year end  2,714  3,714  7,942  5,017  19,387  713  1,521  1,120  2,216  5,570  24,957 
Other
Starting population 11,161  15,273  11,998  7,579  46,012  5,374  11,464  3,152  6,237  26,228  72,240 
Hospitalised  6,474  8,859  8,639  5,457  29,428  2,311  4,930  2,112  4,179  13,531  42,959 
Died  81  111  267  258  717  29  62  26  52  169  886 
Nursing home  -  -  112  71  183  -  -  27  54  82  265 
Alive at year end  11,080  15,163  11,731  7,321  45,295  5,345  11,403  3,125  6,185  26,058  71,353 
Population  
without fracture 310,326  1,208,545  478,854  525,897  2,523,622  73,107  1,343,880  115,545  545,465  2,077,996  4,601,619
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A total of (66%) of the Australian population aged 50 years 
and over in 2012 had osteoporosis or osteopenia. Of these 
4,742,441 adults, 78% had osteopenia (n=3,698,140) and 
55% (n=2,623,682) were female. Osteopenia in those aged 
50-69 years formed the group with the largest number of 
people, comprising 1,358,500 men (55% of the male population 
aged 50-69 years) and 1,233,342 women (49% of the female 
population aged 50-69 years). Although substantially fewer 
people in this age group had osteoporosis, there were over four 
times as many women as men, with almost 330,000 women 
having osteoporosis compared to 80,000 men, representing 
13% and 3% of Australian women and men aged 50 to 69 years, 
respectively. There were about the same number of women as 
men with osteopenia aged over 70 years, approximately half a 
million each (Table 15) representing 46% and 59% of women 
and men in this age group, respectively. It was estimated that 
another half a million women aged 70 years and over had 
osteoporosis in 2012 (n=513,874), representing 43% of this 
population group compared with 122,019 older men who had 
osteoporosis (13%). 
Of the total population with osteoporosis and osteopenia aged 
50 years and over in 2012, 3% (140,882) had fractures of which 
16.3% had a hip fracture with the remainder sustaining non-hip 
fractures (14.3% wrist, 18.1% vertebral and 51.3% with ‘other’ 
fracture types). The fracture rate varied by gender and age group 
ranging from the lowest proportion of 1.1% in men aged 50 
to 69 years to the highest in women aged 70 years and over 
(6.8%) (Table 4). Due to the higher prevalence of osteopenia 
compared to osteoporosis, fracture numbers were highest 
among those with osteopenia in each age and gender subgroup 
except for women aged 70+ years, where 60% more fractures 
occurred in women with osteoporosis compared to osteopenia 
(Table 15). There were twice as many fractures in men with 
osteopenia than osteoporosis (27,434 vs 13,328; respectively). 
In women the fracture numbers were more balanced due to the 
combination of higher population in the older age group and the 
very high fracture rate among these older women (and men) with 
osteoporosis (46,919 vs 53,141; osteopenia vs osteoporosis). 
Absolute fracture numbers were consistently higher in women 
than men (ratio women to men: 2.4 hip; 8.1 wrist; 3.5 vertebral 
and 1.8 ‘other’ fracture sites).
There were 3,48910 deaths resulting from fractures attributable 
to osteoporosis or osteopenia in 2012, of which the vast majority 
occurred in those aged 70 years and over (n=3,079) with 1,698 
(49%) associated with a fracture of the hip, and 545 (16%) 
associated with a vertebral fracture. Seventy per cent of these 
deaths occurred in women aged 70 years and over (n=2,447). 
Within the fracture population, 97.5% were alive at the end  
of 2012.
10 Differences in whole numbers due to rounding.
Total Cost of Osteoporosis and 
Osteopenia in 2012
The total cost of osteoporosis in Australia in 2012 was $2.754 
billion, of which $2.589 billion (94%) are direct costs. This 
included the direct costs of managing fractures (health and  
non-health care), as well as the non-fracture costs relating  
to the management of osteoporosis and osteopenia. These 
include the costs of bone health medications (pharmaceuticals 
predominantly bisphosphonates), DXA scans and routine 
pathology tests (including Vitamin D tests). Other fracture 
management direct (non-health care) costs included were 
for informal care in the community. With informal care costs 
excluded the direct costs in 2012 were $2.447 billion. The 
indirect costs from productivity losses associated with fractures 
due to hospitalisation (acute and rehabilitation) in 2012 were 
$165 million, which represented 6% of the total cost. This cost 
breakdown is shown in Table 16, more detail about the costs 
of each fracture by gender and age, as well as sector costs are 
shown in subsequent tables. 
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Table 16: Total costs (Direct and Indirect) of osteoporosis  
and osteopenia in Australia in 2012
Cost Total Cost ($)
% Total Cost 
(direct and 
indirect)
Total Direct Fracture Cost 
(excluding informal care) $1,617,821,009 58.7
- Hip fractures $695,403,602
- Wrist fractures $114,791,953
- Vertebral fractures $164,974,699
- Other fractures $642,650,754
Total Cost Informal Care $141,751,682 5.1
- Hip fractures $35,799,492
- Wrist fractures $7,330,465
- Vertebral fractures $29,509,846
- Other fractures $69,111,879
Total Direct Fracture Cost 
(including informal care) $1,759,572,690 63.9
- Hip fractures $731,203,094
- Wrist fractures $122,122,418
- Vertebral fractures $194,484,545
- Other fractures $711,762,633
Total Direct  
Non-Fracture Cost $829,645,097 30.1
- Routine medical and pathology 
(includes Vitamin D tests) $626,703,911
- DXA $23,625,769
- Pharmaceuticals – bone health 
(includes bisphosphonates) $179,315,417
TOTAL DIRECT COSTS $2,589,217,788 94.0
TOTAL DIRECT COSTS 
(excluding informal care)* $2,447,466,106
Total Indirect cost 
(Productivity Loss due  
to Fractures) $165,173,079 6.0
- Hip fractures $64,033,917
- Wrist fractures $9,003,419
- Vertebral fractures $18,497,828
- Other fractures $73,637,915
TOTAL DIRECT and  
INDIRECT COST $2,754,390,866
TOTAL DIRECT and INDIRECT 
COST (DUE TO FRACTURES) $1,924,745,769 69.9
* Total direct cost (excluding informal care) was used as the denominator in  
percentage calculations in all tables (unless otherwise stated)
Direct health care costs
Acute care
Acute hospital services (including Emergency Department 
and non-admitted services)
The total cost of acute hospital care for fractures associated with 
osteoporosis or osteopenia in 2012 was $1.18 billion, of which 
the total for acute inpatient hospitalisation was $1.14 billion 
(96% of total hospital costs). The remainder of $43 million was 
for non-admitted services (including emergency departments). 
Total costs of hospital care for fractures represented 46.5% 
of the direct total costs attributed to osteoporosis in 2012. 
Fractures accounted for 89,813 acute admissions to hospital  
in 2012, representing almost 670,000 bed-days, with an 
average length of stay of 7.4 days.
Hip fractures represented 44% of total acute hospital costs and 
36% of bed-days, vertebral fractures 8% of hospital costs and 
11% of bed-days, wrist fractures 7% of hospital costs and 3% 
of bed-days and ‘other’ fractures 41% of total acute hospital 
costs and 49% of acute bed-days. People aged 70 years and 
over accounted for 70% of total acute hospital inpatient costs, 
and costs for women were 72% of the total. The highest single 
category was acute inpatient care for women aged over 70 years 
with a hip fracture, with a total cost of $332 million representing 
29% of total hospital costs. See Table 17 below for a summary  
of costs relating to hospital management of fractures. 
Pre-hospital (ambulance paramedic) 
The total cost of pre-hospital ambulance paramedic care for 
people with a fracture likely to be caused by osteoporosis or 
osteopenia in 2012 was $50 million, representing 2% of the total 
direct costs for osteoporosis in 2012. Ambulance transport for  
people aged over 70 years was $33 million, representing 67% of 
total ambulance costs. Although people with a hip fracture were 
more likely to use an ambulance the ‘other’ fracture category 
represented 44% of total ambulance costs, with hip fractures 
30% of total costs and vertebral fractures 19% of the total 
ambulance costs. See Table 18 for a summary of costs relating 
to pre-hospital ambulance paramedic care.
Sub-acute care (rehabilitation)
Rehabilitation or subacute care for the management of fractures 
relating to osteoporosis or osteopenia cost $229 million in 
2012, which represented 9.3% of the total direct cost. The 
cost of rehabilitation for people aged 70 years and over was 
$143 million (63% of total) of which nearly half (49%) was 
the cost of rehabilitation care for women. Women in both 
aged groups accounted for $167 million or 73% of the total 
costs of rehabilitation. The highest costs were associated with 
rehabilitation for hip fractures ($92.7 million or 41%), with the cost 
of rehabilitation following ‘other’ fractures $89.3 million or 39% 
of total rehabilitation costs. Summary total costs for rehabilitation 
are shown in Table 19. Rehabilitation in a sub-acute care 
facility following a fracture, caused by osteoporosis/osteopenia, 
accounted for 18,491 admissions in 2012, and 428,500 bed-days. 
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Table 17: Hospital (admitted and non-admitted) costs for fracture management by gender, age group and fracture type
Women (Total Cost) Men (Total Cost) All % Total 
Direct
Costs50-69 years % Total 70+ years % Total 50-69 years % total 70+ years % Total Total Cost % Total
Hospital 
Inpatient – 
Total Cost $225,456,606 20 $596,121,421 52 $106,130,784 9 $209,894,324 18 $1,137,603,135 100 46.5
- Hip 27,337,136 2 331,546,201 29 21,682,984 2 121,761,583 11  $502,327,904 44
- Wrist 27,741,192 2 41,060,608 4 3,198,142 <0.01 3,708,758 <0.01  $75,708,700 7
- Vertebral 14,235,985 1 59,934,170 5 7,512,752 1 11,419,263 1  $93,102,170 8
- Other 156,142,293 14 163,580,442 14 73,736,906 6 73,004,720 6  $466,464,361 41
Hospital 
(Non-admitted 
services) – 
Total Cost $14,863,663 34 $14,620,048 34 $8,278,259 19 $5,512,715 13 $43,274,686 100 1.8
- Hip 301,143 1 2,342,229 5 265,397 1 924,938 2  $3,833,708 9
- Wrist 2,644,424 6 2,474,778 6 344,686 1 322,988 1  $5,786,876 13
- Vertebral 2,867,141 7 4,234,166 10 872,151 2 1,313,113 3  $9,286,570 21
- Other 9,050,955 21 5,568,875 13 6,796,025 16 2,951,676 7  $24,367,531 56
All Hospital – 
Total Cost $240,320,269 20 $610,741,469 52 $114,409,043 10 $215,407,040 18 $1,180,877,821 100 48.2
- Hip 27,638,279 2 333,888,431 28 21,948,381 2 122,686,521 10  $506,161,612 43
- Wrist 30,385,616 3 43,535,386 4 3,542,828 <0.01 4,031,746 <0.01  $81,495,576 7
- Vertebral 17,103,126 1 64,168,336 5 8,384,903 1 12,732,375 1  $102,388,740 9
- Other 165,193,248 14 169,149,317 14 80,532,931 7 75,956,397 6 $490,831,892 42
Table 18: Pre-hospital ambulance/paramedic costs following fracture by gender, age group and fracture type
Women (Total Cost) Men (Total Cost) All % Total 
Direct
Costs50-69 years % Total 70+ years % total 50-69 years % Total 70+ years % Total Total Cost % Total
Ambulance $10,603,507 21 $23,469,688 47 $6,275,348 13 $9,777,031 20 $50,125,574 100 2.0
- Hip 989,281 2 9,421,742 19 871,853 2 3,720,613 7  $15,003,488 30
- Wrist 812,881 2 2,020,443 4 100,407 <0.01  267,031 1  $3,200,761 6
- Vertebral 2,977,254 6 4,883,634 10 897,686 2 941,013 2  $9,699,587 19
- Other 5,824,090 12 7,143,870 14 4,405,403 9 4,848,375 10 $22,221,738 44
Table 19: Subacute care (rehabilitation) costs following fracture by gender, age group and fracture type 
Women (Total Cost) Men (Total Cost) All % Total 
Direct 
Costs50-69 years % Total 70+ years % Total 50-69 years % Total 70+ years % Total Total Cost % Total
Subacute 
(Rehabilitation) 
Total $54,347,995 24 $112,773,917 49 $25,406,393 11 $30,233,211 14 $228,831,254 100 9.3
- Hip 7,655,791 3 57,795,822 25 6,072,340 3 14,143,178 7  $92,749,685 41
- Wrist 8,335,877 4 10,531,509 5 961,001 <0.01  3,610,263 2  $20,779,636 9
- Vertebral 4,678,371 2 15,834,605 7 2,468,915 1 3,653,925 2  $25,998,860 11
- Other 33,677,956 15 28,611,981 13 15,904,136 7 8,825,844 4 $89,303,074 39
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Table 20: Community health care service costs for fracture management (GPs, radiology, physiotherapy, pharmacy) by 
gender, age group and fracture type
Women (Total Cost) Men (Total Cost) All % Total 
Direct 
Costs50-69 years % Total 70+ years % Total 50-69 years % Total 70+ years % Total Total Cost % Total
Community care of 
fractures (GPs, Imaging, 
Physiotherapy, Drugs) $8,278,743 36 $8,252,088 36 $3,959,762 17 $2,588,252 11 $23,078,844 100 0.9
- Hip 488,407 2 1,656,081 7 384,832 2 388,177 2  $2,917,496 13
- Wrist 1,643,982 7 1,731,405 8 206,120 1  186,065 1  $3,767,572 16
- Vertebral 909,456 4 1,147,569 5 311,824 1 317,025 1  $2,685,873 12
- Other 5,236,898 23 3,717,033 16 3,056,987 13 1,696,985 7 $13,707,904 59
Community health care services for fracture management 
Community fracture management included the management of fractures by general practitioners (where people were not admitted 
to hospital); radiological examination of fractures; ongoing management of fractures by GPs or medical specialists post discharge 
from acute or subacute care; physiotherapy and pharmaceutical management of fractures (analgesia). Each of these service 
categories on their own represented a small proportion of total direct costs, combined they were $23 million (1% of total direct 
costs). Wrist fractures were the largest single fracture group, with a total cost of $3.8 million (16% of total community health 
service costs). Table 20 shows the summary costs for community care relating to fracture management.
The total cost attributed to pharmaceuticals for fracture management (predominantly analgesia) post hospitalisation or for non-
admitted fractures was $0.24 million (see Table 21) with females 70 years and older contributing the highest cost, 46% of the total 
fracture management cost. Fracture management medication use in women accounted for 82% of the total fracture management 
cost. The largest single fracture category contributing to the cost of these medications was hip fractures for osteoporotic women 
70 years and older, which accounted for 16% of the total fracture management cost. 
Table 21: Fracture management drug costs ($) by gender, age group and fracture type
Women (Total Cost) Men (Total Cost) All
50-69 years % Total 70+ years % Total 50-69 years % Total 70+ years % Total Total Cost % total
Pharmaceutical 
Management of 
Fractures $88,096 36 $112,330 46 $24,903 10 $19,166 8 $244,495 100
- Hip 4,647 2 39,786 16 1,128 <0.01 4,473 2  $50,034 20
- Wrist 18,452 8 20,209 8 716 <0.01  675 <0.01  $40,052 16
- Vertebral 3,990 2 8,045 3 1,279 1 1,910 1  $15,224 6
- Other 61,007 25 44,290 18 21,780 9 12,108 5 $139,185 57
Aged care and community services
Nursing home 
The total nursing home cost due to osteoporosis in 2012 was estimated at $77.3 million which is 2.7% of the total direct cost.11 
Females contributed the greatest cost which was 77% of the total nursing home costs and 2.4% of the total direct costs (refer to 
Table 22). Relating to the fracture type, hip fractures contributed the greatest cost to nursing home care, accounting for 85% of 
the total nursing home costs (23% and 62% of the total nursing home costs for males and females respectively). 
Table 22: Nursing home costs by fracture type and gender for adults aged 70 years and over
Fracture Type
Women (Total Cost) Men (Total Cost) All % Total  
Direct CostsTotal Cost % Total Total Cost % Total Total Cost % Total
Hip $48,263,317 62 $17,724,884 23 $65,988,201 85 2.7
Wrist $2,311,772 3 $2,715 <0.01 $2,314,486 3 0.1
Vertebral $3,475,854 4 $8,609 <0.01 $3,484,464 5 0.1
Other $5,463,988 7 $31,701 <0.01 $5,495,689 7 0.2
Sub-total $59,514,931 77 $17,767,909 23 $77,282,840 100 3.2
11 Total direct costs are $2.4 billion; these include all costs except the indirect costs. 
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Community non-health services (home help, meals on wheels)
Home help 
The total cost of home help in 2012 was estimated at $33.4 million, which is 1.4% of the total direct costs (see Table 23). More 
than three quarters (76%) of the home help cost was in the older age group of 70 years and older, women accounted for 89% of 
all home help costs. Osteoporosis accounted for 54% of the total home help cost, women 70 years and older with osteoporosis 
accounting for the largest cost which was 40% of the total home help cost. Considering fracture type, vertebral fractures had the 
highest cost of home help (37%), followed by other fracture (33%), hip (26%) and wrist (4%).
Meals on wheels 
Similar to nursing home, meals on wheels costs were only estimated for those aged 70 years and above. The total cost of meals 
on wheels was estimated at $14 million, and this comprised 0.6% of the total direct costs. Females accounted for 67% of the 
total meals on wheels cost with females with osteoporosis being the most costly contributing 41% of the total cost of meals on 
wheels (Table 24). Osteoporosis accounted for 52% of the total meals on wheels cost. Vertebral fractures were the most costly 
with 47% of the total cost for meals on wheels followed by other fractures (33%), hip (18%) and wrist (2%). 
Table 23: Home help costs by fracture type, gender and age groups 
Women (Total Cost) Men (Total Cost) All
50-69 years % total 70+ years % total 50-69 years % total 70+ years % total Total Cost
% Total 
Direct
Hip $76,857 0.2 $5,980,111 17.9 - - $2,494,791 7.5  $8,551,760 0.3
Wrist $108,062 0.3 $1,312,525 3.9 - - $28,015 0.1 $1,448,602 0.1
Vertebral $2,638,752 7.9 $9,389,350 28.1 - - $213,248 0.6  $12,241,350 0.5
Other $4,872,667 14.6 $5,346,614 16.0 $173,589 0.5 $742,270 2.2 $11,135,140 0.5
Sub-total $7,696,338 23.1 $22,028,600 66.0 $173,589 0.5 $3,478,325 10.4 $33,376,852 1.4
Table 24: Meals on wheels costs by fracture type and gender for adults 70 years and older
Fracture Type
Women (Total Cost) Men (Total Cost) All % Total Direct 
CostsTotal Cost %total Total Cost %total Total Cost
Hip $2,439,899 17.5 - - $2,439,899 0.1
Wrist $309,416 2.2 - - $309,416 <0.1
Vertebral $6,609,719 47.3 - - $6,609,719 0.3
Other - - $4,619,957 33.0 $4,619,957 0.2
Sub-total $9,359,035 67.0 $4,619,957 33.0 $13,978,991 0.6
Costs by fracture type
Direct and indirect cost data are also presented for all fractures as well as by fracture type (hip, wrist, vertebral, and ‘other’), by 
gender and age groups in Tables 25, 26, 27, 28 and 29. The direct total cost for fractures includes all health care and community 
services (directly related to fracture care), as well as costs attributable to nursing home or residential care. Community fracture 
management includes care delivered by GPs or medical specialists (which may be instead of or in addition to hospitalisation), 
physiotherapy and radiology. Pharmaceuticals/supplements include those directly attributable to the fracture outside the 
hospital setting (analgesia) and vitamin D and calcium supplements. Other bone medications were considered attributable to 
the management of osteoporosis or osteopenia rather than the fracture, hence costs have been considered separately. Similarly 
vitamin D testing and DXA were considered part of the costs attributable to osteoporosis or osteopenia rather than specific to the 
fracture. Informal care and productivity losses due to hospitalisation or rehabilitation following a fracture are shown separately, as 
well as the total direct and indirect cost for each fracture type. 
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Table 25: Total cost of all fractures by gender, age group and sector
All Fractures
Women Men All
Ages 50-69 years Age 70+ years Ages 50-69 years Age 70+ years
Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost
Hospital Total $240,320,269 14.9 $610,741,469 37.8 $114,409,043 7.1 $215,407,040 13.3 $1,180,877,821 73.0
Ambulance $10,603,507 0.7  $23,469,688 1.5  $6,275,348 0.4  $9,777,031 0.6  $50,125,574 3.1
Community Fracture 
Mgt (incl GP, Physio, 
Med Spec, X-ray) $8,190,646 0.5  $8,139,758 0.5  $3,934,859 0.2  $2,569,086 0.2  $22,834,349 1.4
Rehabilitation $54,347,995 3.4 $112,773,917 7.0 $25,406,393 1.6 $36,302,949 2.2 $228,831,254 14.1
Nursing Home $-  $59,514,931 3.7  $-  $17,767,909 1.1  $77,282,840 4.8
Community Services 
(home help and MOW) $7,696,338 0.5  $31,387,635 1.9  $173,589 <0.01  $8,098,282 0.5  $47,355,844 2.9
Pharmaceuticals –  
Fracture Management $88,096 <0.01  $112,330 <0.01  $24,903 <0.01  $19,166 <0.01  $244,495 <0.01
Supplements –  
Vitamin D and Calcium $3,187,825 0.2  $4,089,705 0.3  $1,596,311 0.1  $1,394,991 0.1  $10,268,832 0.6
Total Direct Health 
Care Cost (excludes 
informal care) $324,434,677 20.1  $850,229,433 52.6  $151,820,446 9.4  $291,336,453 18.0  $1,617,821,009 100.0
Informal care $31,603,792  $74,392,420  $17,253,390  $18,502,080  $141,751,682
Total Direct Cost 
(includes informal care) $356,038,469 $924,621,853 $169,073,836 $309,838,532 $1,759,572,690 
Productivity Loss due 
to Fracture ( Indirect) $29,440,970  $89,578,483  $14,272,389  $31,881,236  $165,173,079 
Total Cost (Direct 
and Indirect) $385,479,438 $1,014,200,337 $183,346,226 $341,719,768 $1,924,745,769 
The direct total cost of all fractures (without informal care) was $1.618 billion, when both informal care and productivity losses 
were included the total cost was $1.925 billion (Table 25). Seventy three per cent of the total direct cost of all fractures is for 
hospital care, and 14% is for rehabilitation. Fractures in women aged 70 years and over represent almost 53% of the direct  
costs of fracture management. 
The total direct cost of hip fractures was $695 million representing 43% of total direct costs of all fractures (Table 26). Hospital 
care represented 73% of direct costs for hip fractures, of which 48% of the total direct costs was hospital care for women aged 
70 years and over. Informal care and lost productivity due to hip fractures was $100 million, predominantly attributed to women 
aged 70 years and over.
Wrist fractures represented only 7% ($114,791,953) of the total direct costs of all fractures (Table 27). Acute hospital care for wrist 
fractures represented 71% and rehabilitation 18% of the total direct costs for wrist fracture management. The total cost of wrist 
fractures for women (in both age groups) was $105 million (91% of the total direct costs). Informal care and lost productivity due 
to wrist fractures was $16 million.
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Table 26: Total cost of hip fractures by gender, age group and sector
Hip Fractures
Women Men All
Ages 50-69 years Age 70+ years Ages 50-69 years Age 70+ years
Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost
Hospital Total $27,638,279 4.0 $333,888,431 48.0  $21,948,381 3.2 $122,686,521 17.6  $506,161,616 72.8
Ambulance $989,281 0.1  $9,421,742 1.4  $871,853 0.1  $3,720,613 0.5  $15,003,489 2.2
Community Fracture 
Mgt (incl GP, Physio, 
Med Spec, X-ray) $483,760 0.1  $1,616,294 0.2  $383,704 0.1  $383,704 0.1  $2,867,463 0.4
Rehabilitation $7,655,791 1.1  $57,795,822 8.3  $6,072,340 0.9  $21,225,732 3.1  $92,749,686 13.3
Nursing Home $-  $48,263,317 6.9  $-  $17,724,884 2.5  $65,988,201 9.5
Community Services 
(home help and MOW) $76,857 <0.01  $8,420,011 1.2  $-  $2,494,791 0.4  $10,991,659 1.6
Pharmaceuticals –  
Fracture Management $4,647 <0.01  $39,786 <0.01  $1,128 <0.01  $4,473 <0.01  $50,034 <0.01
Supplements –  
Vitamin D and Calcium $117,885 <0.01  $1,009,375 0.1  $93,503 <0.01  $370,697 0.1  $1,591,460 0.2
Total Direct Health 
Care Cost (excludes 
informal care) $36,966,500 5.3  $460,454,777 66.2  $29,370,909 4.2  $168,611,415 24.2  $695,403,602 100.0
Informal care $194,449  $33,596,053  $61,692  $1,947,297  $35,799,492 
Total Direct Cost 
(includes informal care) $37,160,949  $494,050,831  $29,432,602  $170,558,712  $731,203,094
Productivity Loss due 
to Fracture ( Indirect) $3,742,896  $41,532,665  $3,100,708  $15,657,648  $64,033,917 
Total Cost (Direct 
and Indirect) $40,903,845  $535,583,495  $32,533,310  $186,216,360  $795,237,010 
Table 27: Total cost of wrist fractures by gender, age group and sector
Wrist Fractures
Women Men All
Ages 50-69 years Age 70+ years Ages 50-69 years Age 70+ years
Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost
Hospital Total $30,385,616 26.5  $43,535,386 37.9  $3,542,828 3.1  $4,031,746 3.5  $81,495,576 71.0
Ambulance $812,881 0.7  $2,020,443 1.8  $100,407 0.1  $267,031 0.2  $3,200,761 2.8
Community Fracture 
Mgt (incl GP, Physio, 
Med Spec, X-ray) $1,625,530 1.4  $1,711,196 1.5  $205,404 0.2  $185,391 0.2  $3,727,520 3.2
Rehabilitation  $8,335,877 7.3  $10,531,509 9.2  $961,001 0.8  $951,248 0.8  $20,779,636 18.1
Nursing Home $-  $2,311,772 2.0  $-  $2,715 <0.01  $2,314,486 2.0
Community Services 
(home help and MOW) $108,062 0.1  $1,621,942 1.4  $-  $28,015 <0.01  $1,758,019 1.5
Pharmaceuticals –  
Fracture Management $18,452 <0.01  $20,209 <0.01  $716 <0.01  $675 <0.01  $40,052 <0.01
Supplements –  
Vitamin D and Calcium $627,040 0.5  $686,740 0.6  $83,472 0.1  $78,652 0.1  $1,475,904 1.3
Total Direct Health 
Care Cost (excludes 
informal care) $41,913,458 36.5  $62,439,195 54.4  $4,893,828 4.3  $5,545,472 4.8  $114,791,953 100.0
Informal care $2,685,992  $4,618,432  $26,041  $-  $7,330,465 
Total Direct Cost 
(includes informal care) $44,599,451  $67,057,628  $4,919,868  $5,545,472  $122,122,418 
Productivity Loss due 
to Fracture ( Indirect) $3,170,009  $5,014,982  $365,454  $452,973  $9,003,419 
Total Cost (Direct 
and Indirect) $47,769,460  $72,072,610  $5,285,322  $5,998,445  $131,125,837 
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The direct costs of managing vertebral fractures in 2012 were $165 million, with informal care of $30 million included the  
direct costs were almost $195 million (Table 28). The largest single group were women aged 70 years and over, with a total cost 
of $106 million (65% of the total).
The total cost of ‘other’ fractures was almost $643 million (Table 29). The total cost of ‘other’ fractures for women in both age 
groups was 68% of total direct costs. With informal care and lost productivity included the total cost of ‘other’ fractures was  
$785 million, representing approximately 41% of the total cost of all fractures.
Table 28: Total cost of vertebral fractures by gender, age group and sector
Vertebral Fractures
Women Men All
Ages 50-69 years Age 70+ years Ages 50-69 years Age 70+ years
Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost
Hospital Total $17,103,126 10.4  $64,168,336 38.9  $8,384,903 5.1  $12,732,375 7.7  $102,388,740 62.1
Ambulance $2,977,254 1.8  $4,883,634 3.0  $897,686 0.5  $941,013 0.6  $9,699,587 5.9
Community Fracture 
Mgt (incl GP, Physio, 
Med Spec, X-ray) $905,465 0.5  $1,139,524 0.7  $310,545 0.2  $315,114 0.2  $2,670,649 1.6
Rehabilitation $4,678,371 2.8  $15,834,605 9.6  $2,468,915 1.5  $3,016,969 1.8  $25,998,860 15.8
Nursing Home $-  $3,475,854 2.1  $-  $8,609 <0.01  $3,484,464 2.1
Community Services 
(home help and MOW) $2,638,752 1.6  $15,999,069 9.7  $-  $213,248 0.1  $18,851,069 11.4
Pharmaceuticals –  
Fracture Management $3,990 <0.01  $8,045 <0.01  $1,279 <0.01  $1,910 <0.01  $15,224 <0.01
Supplements –  
Vitamin D and Calcium $480,609 0.3  $969,007 0.6  $167,040 0.1  $249,452 0.2  $1,866,106 1.1
Total Direct Health 
Care Cost (excludes 
informal care) $28,787,567 17.4  $106,478,073 64.5  $12,230,368 7.4  $17,478,690 10.6  $164,974,699 100.0
Informal care $7,687,288  $16,324,560  $3,740,857  $1,757,141  $29,509,846 
Total Direct Cost 
(includes informal care) $36,474,855  $122,802,633  $15,971,225  $19,235,831  $194,484,545 
Productivity Loss due 
to Fracture ( Indirect) $3,019,300  $11,663,001  $1,593,374  $2,222,153  $18,497,828 
Total Cost (Direct 
and Indirect) $39,494,155  $134,465,634  $17,564,599  $21,457,984  $212,982,373 
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Table 29: Total cost of ‘other’ fractures by gender, age group and sector
Other Fractures
Women Men All
Ages 50-69 years Age 70+ years Ages 50-69 years Age 70+ years
Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost Total Cost
% Direct 
Total 
Cost
Hospital Total $165,193,248 25.7  $169,149,317 26.3  $80,532,931 12.5  $75,956,397 11.8  $490,831,892 76.4
Ambulance $5,824,090 0.9  $7,143,870 1.1  $4,405,403 0.7  $4,848,375 0.8  $22,221,738 3.5
Community Fracture 
Mgt (incl GP, Physio, 
Med Spec, X-ray) $5,175,891 0.8  $3,672,744 0.6  $3,035,207 0.5  $1,684,877 0.3  $13,568,718 2.1
Rehabilitation $33,677,956 5.2  $28,611,981 4.5  $15,904,136 2.5  $11,109,000 1.7  $89,303,074 13.9
Nursing Home $-  $5,463,988 0.9  $-  $31,701 <0.01  $5,495,689 0.9
Community Services 
(home help and MOW) $4,872,667 0.8  $5,346,614 0.8  $173,589 <0.01  $5,362,227 0.8  $15,755,096 2.5
Pharmaceuticals –  
Fracture Management $61,007 <0.01  $44,290 <0.01  $21,780 <0.01  $12,108 <0.01  $139,185 <0.01
Supplements –  
Vitamin D and Calcium $1,962,292 0.3  $1,424,584 0.2  $1,252,296 0.2  $696,190 0.1  $5,335,362 0.8
Total Direct Health 
Care Cost (excludes 
informal care) $216,767,151 33.7  $220,857,387 34.4  $105,325,341 16.4  $99,700,875 15.5  $642,650,754 100.0
Informal care $21,036,063  $19,853,375  $13,424,800  $14,797,641  $69,111,879 
Total Direct Cost 
(includes informal care) $237,803,214  $240,710,762  $118,750,141  $114,498,517  $711,762,633 
Productivity Loss due 
to Fracture ( Indirect) $19,508,765  $31,367,835  $9,212,853  $13,548,462  $73,637,915 
Total Cost (Direct 
and Indirect) $257,311,979  $272,078,597  $127,962,994  $128,046,979  $785,400,548 
Mean costs of low trauma fractures
The average annual direct (health care and non-health care) and indirect costs and average total cost for each fracture by age 
and gender are shown in Table 30. The denominator in the calculations for the mean annual cost was based on the number in the 
fracture population at the beginning of the period, therefore includes those who subsequently died as a result of the fracture. The 
total costs in the numerator included the direct health care costs, without Nursing Home (attributed to everyone with a fracture), 
as well as Nursing Home and direct non-health and indirect costs (attributed to those with a fracture and alive at the end of 
the period). Average direct health care costs for fractures included acute hospital admitted and non-admitted care, subacute/
rehabilitation, ambulance, community health care services following a fracture, pharmaceuticals for fracture management and 
supplements for osteoporosis prevention. A separate average annual direct health care cost for each fracture by age and gender 
was also determined which included nursing home costs (in the year of the fracture). The average direct (non-health care) total 
cost for each fracture type by age and gender includes the cost of community non-health care services following fractures. The 
average indirect cost includes productivity loss that occurred as a result of admission to acute and subacute (rehabilitation) care. 
Hip fractures have the highest average total direct cost for both males and females, ranging from $23,243 to $33,576 and is 
highest in the 70 years and older age-group for both genders. Wrist fractures in males aged 50-69 years (mean cost $4,386) had 
the lowest average annual direct total cost. When productivity losses are considered the fracture group with the highest total cost 
were women aged 70 years and older with a hip fracture (mean annual total cost $36,398).
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Table 30: Mean annual direct health care cost of low trauma fractures by gender and age group
Fracture Type Cost Category
Women Men
50-69 years 
(2012$)
70+ years 
(2012$)
50-69 years 
(2012$)
70+ years 
(2012$)
Hip Average Direct (Health Care) Total Cost without Nursing Home 23,106  27,440  23,194  27,460
Average Direct (Health Care) Total Cost with Nursing Home 23,106  30,720  23,194  30,740 
Average Direct (Non-Health Care) Total Cost  170  2,855  49  822 
Average Direct Total Cost  23,276  33,576  23,243  31,562 
Average Indirect Cost (Productivity Loss)  2,344  2,823  2,449  2,897 
Average Total Cost (Direct and Indirect)  25,621  36,398  25,691  34,459
Wrist Average Direct (Health Care) Total Cost without Nursing Home 4,957  6,180  4,362  5,119 
Average Direct (Health Care) Total Cost with Nursing Home  4,957  6,425  4,362  5,121 
Average Direct (Non-Health Care) Total Cost  331  659  23  26 
Average Direct Total Cost  5,289  7,084  4,386  5,147 
Average Indirect Cost (Productivity Loss)  376  530  326  420 
Average Total Cost (Direct and Indirect)  5,664  7,614  4,711  5,568 
Vertebral Average Direct (Health Care) Total Cost without Nursing Home 4,051  6,501  5,441  5,050 
Average Direct (Health Care) Total Cost with Nursing Home  4,051  6,761  5,441  5,053 
Average Direct (Non-Health Care) Total Cost  1,600  2,415  1,664  577 
Average Direct Total Cost  5,651  9,176  7,105  5,630 
Average Indirect Cost (Productivity Loss)  468  871  709  650 
Average Total Cost (Direct and Indirect)  6,119  10,047  7,814  6,280 
Other Average Direct (Health Care) Total Cost without Nursing Home 8,016  10,729  6,245  10,044 
Average Direct (Health Care) Total Cost with Nursing Home  8,016  11,008  6,245  10,048 
Average Direct (Non-Health Care) Total Cost  980  1,287  808  2,147 
Average Direct Total Cost  8,996  12,295  7,052  12,195 
Average Indirect Cost (Productivity Loss)  738  1,602  547  1,443 
Average Total Cost (Direct and Indirect)  9,734  13,898  7,600  13,638
Health care services for osteoporosis and osteopenia management 
Medical services
The total cost of general practitioner services for the management of osteoporosis in 2012 was estimated at $404.9 million, 
representing 49% of the total community health care costs and 17% of total direct costs. GP costs for people aged  
50-69 were $256 million, representing 63% of total GP costs (see Table 31). The cost attributed to females for GP services  
was $223.9 million, accounting for 55% of total GP costs (Table 31). Considering those who fractured, their GP costs represented 
only 2.9% of the total GP costs. 
Diagnostic imaging 
According to Medicare data, there were 235,724 DXA scans (Item numbers: 12306, 12309, 12321 and 12323) in 2011/2012 
for a total cost of $20.1 million. Assuming that the gap paid by the individual is 15%, the total cost of DXA scans in 2011/2012 
was estimated at $23.6 million, which is 2.8% and 1% of the total community health care cost and total direct costs respectively 
(see Table 31). 
Pathology 
The total cost associated with routine vitamin D pathology tests was estimated at $92.5 million, 11% of the total community health 
care costs and 3.8% of the total direct costs. Sixty three per cent ($58.6 million) of the vitamin D costs were associated with  
50-69 year olds and 55% ($51.1 million) with females (see Table 31). The cost associated with routine pathology test was estimated 
at $129.3 million, which is 15.5% of the total community health care costs and 5.3% of total direct costs (see Table 31). 
Generally, health care services for osteoporosis and osteopenia management accounted for 26% of the total direct costs while the 
total community health care cost represented 33.9% of the total direct costs.
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Table 31: Community health care costs for the management of osteoporosis/osteopenia by gender, age group and  
with or without fracture
Women Men All
% Total 
Direct 
Cost
50-69 years % 
Total
70+ years % 
Total
50-69 years % 
Total
70+ years % 
Total Total CostFracture No Fracture Fracture No Fracture Fracture No Fracture Fracture No Fracture
General 
Practitioner 3,642,556 129,772,316  16.1 4,673,086  85,845,972 10.9 1,824,060  121,067,318 14.8 1,593,981 56,476,696  7.0 404,895,984  16.5 
Routine  
Vitamin D  
Blood Test 832,408  29,655,951  3.7 1,028,937  19,617,774  2.5  416,839  27,666,659  3.4  364,261 12,906,221  1.6  92,489,050  3.8 
Routine  
Pathology 
Test 1,163,878  41,465,171  5.1 1,438,667  27,429,717  3.5  582,828  38,683,729  4.7  509,313 18,045,573  2.2 129,318,877  5.3 
Sub-total 5,638,842 200,893,439  25 7,140,689 132,893,464  17 2,823,727  187,417,706  23 2,467,555 87,428,490  11 626,703,911  25.6 
DXA Scan (Medicare+gap) cost 2011/2012  2.8 23,625,769  1.0 
Pharmaceutical-Osteoporosis treatment PBS costs 2011/2012  21.6 23,625,769  7.3 
Total 100.0 829,645,097  33.9 
Pharmaceuticals for osteoporosis/osteopenia prevention and treatment 
Osteoporosis prevention – calcium and vitamin D supplements
The total cost associated with calcium and vitamin D supplementation for osteoporosis prevention in 2012 was estimated at 
$10.3 million (0.4% total direct costs) for those who fracture (see Table 32) and $310.8 million for individuals who had low bone 
density but with no fracture. The overall cost was $321 million, 13% of the total direct costs (see Table 33). Considering those 
who fractured, 24% of this cost was accounted for by females 70 years and older with osteoporosis, while males from the same 
age group and BMD accounted for the least cost (5%). Overall, 71% of the cost was attributed to females. In terms of fracture 
type, hip, wrist and vertebral fractures represented 15%, 14% and 18% of the total cost respectively. ‘Other’ fractures made 
up the highest cost of $5.3 million, which was 52% of the total cost of supplements for osteoporosis prevention, for individuals 
that fractured. The costs associated with individuals that had no fracture represented 96% of the total costs of supplements for 
osteoporosis management with both males and females contributing 48% of this cost. 
Osteoporosis management/treatment – bone medications
Pharmaceutical costs relating to osteoporosis management such as bisphosphonates were obtained from the Medicare 
Australia Statistics website using the Pharmaceutical Benefits Schedule (PBS) Item Reports. The PBS cost in 2011/2012 for 
pharmaceuticals relating to osteoporosis management excluding hormonal therapy was $179.3 million.12 The cost is 21.6% and 
7.3% of the total community health care costs and total direct costs respectively, representing the most costly component of the 
pharmaceutical costs (Table 31). 
Table 32: Calcium and vitamin D supplement costs ($) by fracture type, gender and age groups
Women Men All
50-69 years 70+ years % Total 50-69 years 70+ years % Total Total Cost
% Total 
Cost
Hip 117,885  1,009,375 11  93,503  370,697 5  1,591,460 15
Wrist  627,040  686,740 13  83,472  78,652 2  1,475,904 14
Vertebral 480,609  969,007 14  167,040  249,452 4  1,866,106 18
Other 1,962,292  1,424,584 33  1,252,296  696,190 19  5,335,362 52
Total 3,187,825  4,089,705  71  1,596,311  1,394,991  29 10,268,832 100
Table 33: Calcium and vitamin D supplement costs ($) by gender, age groups and with or without fracture
Women Men All
50-69 years 70+ years % Total 50-69 years 70+ years % Total Total Cost
% Total 
Direct Cost
No fracture 113,571,752  41,833,855 48 105,953,472  49,426,237 48  310,785,316 13
Fracture 3,187,825  4,089,705 2  1,596,311  1,394,991 1  10,268,832 <0.01
Total 116,759,577  45,923,560  51 107,549,782  50,821,228  49 321,054,148 13
12 The PBS data could not be identified according to BMD, gender, age group or fracture, however authority restrictions suggest that those with osteoporosis aged 70 
years or over and with a fracture are more likely to be prescribed osteoporosis (bone active) pharmaceuticals.
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Direct non-health care costs
Informal community care 
The total cost of informal community care due to osteoporosis in 2012 was estimated at $141.8 million, representing 5.8% of 
the total direct costs (see Table 34). Females accounted for most of the cost (74%), with females aged 70 years and older with 
osteoporosis having the largest cost at $45.6 million. This was almost one third of the total informal community care cost and 2% 
of total direct costs. On the other hand, males aged 70 years and older with osteoporosis had the least cost which was 4% of the 
total informal community care cost. Considering the fracture type, the ‘other’ fractures contributed the highest informal care cost 
(49%), followed by hip (25%), vertebral (21%) and wrist (5%) fractures. 
Indirect costs
Production loss
The cost associated with time lost from work due to hospitalisation for fractures due to osteoporosis in acute and sub-acute 
care in 2012 was estimated at $165.2 million, which is 6.0% of total direct and indirect costs (See Table 35). Similar to informal 
community care costs, older females aged 70 years and over with osteoporosis contributed the highest cost (54% of total 
production loss) while younger males aged 50-69 years old with osteoporosis had the least production loss (9% of the total 
production loss). Higher production loss was mostly associated with ‘other’ fractures and hip fractures (45% and 39% of total 
production loss respectively). 
Table 34: Informal community care cost by fracture type, gender, BMD categories and age groups
Fracture 
Type
Women (Total Cost) Men (Total Cost) All
% Total 
Cost
% Total 
Direct & 
Indirect 
Cost
50-69 years
% 
Total
70+ years
% 
Total
50-69 years
% 
Total
70+ years
% 
Total Total CostOsteoporosis Osteopenia Osteoporosis Osteopenia Osteoporosis Osteopenia Osteoporosis Osteopenia
Hip 82,101  112,348 <0.01 20,589,586  13,006,467 24  19,690  42,003 <0.01  653,677  1,293,620 1  35,799,492 25.3 1.3
Wrist 1,134,088  1,551,904 2  2,830,440  1,787,992 3  8,311  17,729 <0.01  -  - -  7,330,465 5.2 0.3
Vertebral  3,245,752  4,441,536 5  10,004,625  6,319,934 12  1,193,930  2,546,927 3  589,845  1,167,296 1  29,509,846 20.8 1.1
Other 8,881,916  12,154,147 15  12,224,841  7,628,534 14  4,284,651  9,140,149 9  4,967,336  9,830,305 10  69,111,879 48.8 2.5
Sub-total 13,343,857 18,259,935 22 45,649,492  28,742,928 52  5,506,581  11,746,809 12  6,210,858 12,291,222 13  141,751,682 100.0 5.1
Table 35: Production loss due to hospitalisation by fracture type, gender and age groups 
Women Men All
50-69 years 70+ years % Total 50-69 years 70+ years % Total Total Costs
% Total 
Costs
% Total Direct  
& Indirect Costs
Hip 3,742,896  41,532,665  27  3,100,708  15,657,648  11  64,033,917  38.8 2.3
Wrist 3,170,009  5,014,982  5  365,454  452,973  <0.01  9,003,419  5.5 0.3
Vertebral 3,019,300  11,663,001  9  1,593,374  2,222,153  2  18,497,827  11.2 0.7
Other 19,508,765  31,367,835  31  9,212,853  13,548,462  14  73,637,914  44.6 2.7
Sub-total 29,440,969  89,578,483  72  14,272,389  31,881,236  28 165,173,077  100.0 6.0
Sensitivity Analysis
To undertake a sensitivity analysis the total number of hip fractures in both males and females was changed by 25% (both 
increased and decreased) to ±5,745 hip fractures to estimate the effect on the total cost of all fractures. The impact of this  
25% change on the number of hip fractures was a 10% change in the total direct cost of all fractures. The total direct costs 
associated with the 25% increase in hip fractures were $1.942 billion, and $1.577 billion when decreased by 25% (Table 36). 
The change in the number of hip fractures caused the total cost (direct and indirect) to change by 7%. Although the number  
of actual fractures was relatively small, the impact on costs was substantial ($180 million) in 2012.
Table 36: Impact on total cost of a 25% change in the total number of hip fractures
Change in Total Cost ($)
2012 Results Hip Fractures Increase by 25% Hip Fractures Decrease by 25%
2012$ 2012$ % 2012$ %
Total Direct Fracture Cost (including informal care) 1,759,572,690  1,941,974,095  10  1,577,176,063 -10
TOTAL DIRECT COSTS 2,589,217,788  2,772,304,077  7  2,406,136,360 -7
TOTAL DIRECT and INDIRECT COST 2,754,390,866  2,937,477,154  7  2,571,309,437 -7
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Burden of Osteoporosis and Osteopenia in  
Australia from 2013 to 2022 Population Trends
Table 37 shows the projected total population with osteoporosis and osteopenia by gender and age group from 2013 to 2022. 
Based on current prevalence rates it is predicted that by 2022, 6.2 million people in the population aged 50 years and over 
will have osteoporosis or osteopenia, with women representing 55% of the total population (n=3,437,828). This represents a 
percentage increase in osteoporosis and osteopenia of 31% over the period from 2012 to 2022. Figure 3 shows the predicted 
trend in population growth for osteoporosis and osteopenia by age group and gender over the period from 2012 to 2022. The 
largest single percentage increase is in men over 50 years with osteoporosis, representing a change of 41% over the same period. 
As was the case in 2012, in absolute terms the largest single population group by 2022 will be men aged 50-69 years with 
osteopenia (n=1,611,761), followed by women aged 50-69 years with osteopenia (n=1,490,078). Men in both age groups  
with osteoporosis represent the smallest populations with 94,867 mean aged 50-69 years and 190,224 mean aged 70 years  
and over predicted to have osteoporosis by 2022. 
Figure 3: Predicted population growth of osteoporosis and osteopenia in men and women aged 50-69 years and  
70 years and over, 2012-2022
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Table 37: Projected Australian population by gender, age group and BMD category, 2013-2022
Year
Women Men All
50-69 years 70+ years Total 50-69 years 70+ years Total Total Women 
and MenOsteoporosis Osteopenia Osteoporosis Osteopenia All Women Osteoporosis Osteopenia Osteoporosis Osteopenia All Men
2012 328,447 1,233,342 513,874 548,019 2,623,682 79,960 1,358,500 122,019 558,278 2,118,758 4,742,441
2013 348,963 1,310,381 548,153 584,577 2,792,074 84,246 1,431,304 131,964 603,781 2,251,295 5,043,370
2014 356,313 1,337,979 564,880 602,415 2,861,588 85,889 1,459,217 137,027 626,943 2,309,075 5,170,662
2015 362,610 1,361,626 582,805 621,531 2,928,571 87,261 1,482,529 142,428 651,657 2,363,875 5,292,446
2016 368,313 1,383,043 601,731 641,714 2,994,801 88,460 1,502,898 148,243 678,262 2,417,863 5,412,664
2017 371,410 1,394,672 628,635 670,406 3,065,124 89,087 1,513,565 156,172 714,540 2,473,365 5,538,488
2018 375,431 1,409,770 653,041 696,434 3,134,676 89,954 1,528,285 163,282 747,069 2,528,589 5,663,265
2019 380,374 1,428,330 676,525 721,478 3,206,707 91,067 1,547,194 169,924 777,458 2,585,643 5,792,350
2020 385,179 1,446,376 701,228 747,823 3,280,607 92,199 1,566,423 176,785 808,849 2,644,256 5,924,863
2021 391,139 1,468,753 725,969 774,208 3,360,069 93,568 1,589,693 183,534 839,727 2,706,522 6,066,591
2022 396,818 1,490,078 750,531 800,402 3,437,828 94,867 1,611,761 190,224 870,338 2,767,190 6,205,018
Osteoporosis (Bone Active) Medication
Table 38 shows the population numbers assumed to be taking osteoporosis (bone active) pharmaceuticals each year for the  
10-year projection model from 2013 to 2022. This was based on a starting population of approximately 500,000 people 
from 2012, including an assumed ‘medication’ prevalence rate of 35% of the population with osteoporosis, and new people 
commencing medication following a fracture (with a 40% non-adherence rate after one year). The population numbers shown 
in Table 38 suggest an average annual growth rate in osteoporosis medication use of 2.6%, which would mean a 26% change 
in the total population taking medications from 2013 to 2022. The total population assumed taking osteoporosis (bone active) 
medications in 2022 was 818,600 people, representing only 13% of the total population with osteoporosis or osteopenia in 2022.
Table 38: Population numbers and annual percentage change assumed on osteoporosis medication by gender  
and age group, 2013 to 2022
Year
Women Men All
50-69 years 70+ years Total all Women 50-69 years 70+ years Total all Men
Total Women  
and Men Annual % change
2013 202,224 292,344 494,568 70,888 83,333 154,221 648,789
2014 204,274 295,939 500,213 71,389 85,726 157,115 657,328 1.3
2015 207,954 305,171 513,124 72,575 89,017 161,592 674,716 2.6
2016 211,303 315,099 526,403 73,617 92,646 166,263 692,666 2.7
2017 213,375 328,558 541,933 74,278 97,350 171,627 713,561 3.0
2018 215,553 341,725 557,278 74,931 101,968 176,899 734,177 2.9
2019 218,303 354,125 572,427 75,805 106,209 182,014 754,441 2.8
2020 221,093 367,000 588,094 76,750 110,496 187,246 775,340 2.8
2021 224,388 380,029 604,417 77,836 114,767 192,602 797,020 2.8
2022 227,701 392,966 620,666 78,943 118,989 197,932 818,598 2.7
Fractures Numbers and Costs 2013-2022
The predicted number of fractures and associated costs each year were determined for each fracture type and by gender and age 
group from 2013 to 2022. These are shown separately for all fractures (Tables 39 and 40) and by each fracture type in Tables 
41 and 42 (hip), Tables 43 and 44 (wrist), Tables 45 and 46 (vertebral) and Tables 47 and 48 (‘other’ fractures). These numbers 
are based on the predicted populations with osteoporosis and osteopenia and the assumed number of the population taking 
osteoporosis (bone active) medications. The same assumptions regarding population rates and fracture distribution have been 
attributed as for 2012. Costs are reported as direct, indirect and total for each fracture type, using the average annual cost of a 
fracture from the 2012 burden of disease results. Average costs were attributed by gender, age group and fracture type. All costs 
are reported in 2012 AUD for comparability with the 2012 burden of disease results.
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All fractures
The annual total burden of fractures related to osteoporosis and osteopenia for 2013 to 2022 are shown in Tables 39 (population) 
and 40 (total cost). The total number of fractures incudes both new (or first) fractures and re-fractures13 (that occur following  
a previous fracture as the model progresses over time). The total number of fractures is likely to increase from 144,312 in 2013  
to 183,105 (representing an increase of 27% over this 10-year period). New fractures are predicted to represent 94% of the  
total fracture burden and re-fractures 6% by 2022. The results show that the total number of fractures was predicted to grow  
by 26% in women and 28% in men over the 10-year period. 
The annual total cost of all fractures shown in Table 40 includes direct and indirect costs of both new fractures and re-fractures 
from 2013 to 2022. The total cost relating to fractures in 2022 is predicted to be $2.591 billion (2012AUD). This represents an 
increase of 31% from over the period 2013 to 2022 (in constant dollars). Although women aged 70 years and over experience  
less than half of the total fractures (43%), they continue to have the highest fracture-related costs (54% of total costs), and 
predicted to increase by 36% to $1.4 billion in 2022.
Table 39: Annual number of all fractures (new fractures and re-fractures) by gender, age group and total, 2013-2022
Number of Fractures
Year All Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years All Fractures
2013 New Fractures 41,656  53,647  20,969  19,444  135,716 
Re-fractures  1,736  3,999  1,502  1,360  8,596 
Total all Fractures (2013)  43,392  57,645  22,471  20,804  144,312 
2014 New Fractures  42,477  55,221  21,343  20,139  139,179 
Re-fractures  1,737  3,914  1,618  1,427  8,695 
Total all Fractures (2014)  44,214  59,134  22,961  21,566  147,875 
2015 New Fractures  43,218  56,998  21,675  20,936  142,828 
Re-fractures  1,759  3,973  1,666  1,458  8,856 
Total all Fractures (2015)  44,977  60,972  23,341  22,394  151,684 
2016 New Fractures  43,891  58,856  21,967  21,794  146,507 
Re-fractures  1,798  4,130  1,701  1,533  9,163 
Total all Fractures (2016)  45,689  62,986  23,669  23,327  155,670 
2017 New Fractures  44,229  61,586  22,111  22,980  150,906 
Re-fractures  1,826  4,264  1,725  1,596  9,411 
Total all Fractures (2017)  46,055  65,850  23,837  24,576  160,317 
2018 New Fractures  44,719  63,925  22,331  24,012  154,987 
Re-fractures  1,840  4,460  1,738  1,682  9,720 
Total all Fractures (2018)  46,559  68,384  24,069  25,694  164,707 
2019 New Fractures  45,318  66,200  22,612  24,981  159,110 
Re-fractures  1,861  4,630  1,755  1,758  10,004 
Total all Fractures (2019)  47,178  70,830  24,367  26,738  169,114 
2020 New Fractures  45,887  68,623  22,893  25,989  163,393 
Re-fractures  1,885  4,796  1,777  1,829  10,287 
Total all Fractures (2020)  47,773  73,419  24,670  27,818  173,679 
2021 New Fractures  46,610  71,033  23,238  26,977  167,857 
Re-fractures  1,909  4,971  1,799  1,903  10,582 
Total all Fractures (2021)  48,519  76,004  25,036  28,880  178,439 
2022 New Fractures  47,282  73,422  23,559  27,957  172,219 
Re-fractures  1,939  5,146  1,825  1,975  10,885 
Total all Fractures (2022)  49,221  78,568  25,384  29,932  183,105
13  Re-fractures were not included in the 2012 annual burden but have been carried forward from the 2012 fracture cohort and new fractures added each year. 
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Table 40: Annual total cost of all fractures (direct and indirect costs) by gender, age group and total, 2013-2022 (2012$)
Total Cost of All Fractures (2012$)
Year All Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years All Fractures ($)
2013 Total Direct Costs 359,903,383  937,397,550  177,507,592  334,838,040  1,809,646,565
Total Indirect Costs  29,782,804  90,514,219  15,018,851  34,409,801  169,725,676 
Total Cost – All Fractures  389,686,188  1,027,911,769  192,526,443  369,247,841  1,979,372,241 
2014 Total Direct Costs  366,729,314  961,442,779  181,312,301  347,114,460  1,856,598,854 
Total Indirect Costs  30,346,755  92,852,130  15,336,052  35,672,245  174,207,182 
Total Cost – All Fractures  397,076,068  1,054,294,909  196,648,353  382,786,704  2,030,806,035 
2015 Total Direct Costs 373,061,650  991,201,577  184,268,254  360,416,646  1,908,948,128 
Total Indirect Costs  30,870,506  95,731,785  15,584,174  37,040,684  179,227,149 
Total Cost – All Fractures  403,932,156  1,086,933,362  199,852,428  397,457,330  2,088,175,277 
2016 Total Direct Costs 378,961,822  1,023,920,579  186,848,610  375,419,322  1,965,150,334 
Total Indirect Costs  31,358,781  98,892,072  15,801,995  38,582,610  184,635,458 
Total Cost – All Fractures  410,320,603  1,122,812,652  202,650,605  414,001,932  2,149,785,792 
2017 Total Direct Costs 381,999,270  1,070,418,837  188,174,359  395,509,799  2,036,102,265 
Total Indirect Costs  31,610,291  103,386,941  15,914,159  40,647,953  191,559,345 
Total Cost – All Fractures  413,609,561  1,173,805,778  204,088,519  436,157,752  2,227,661,609 
2018 Total Direct Costs 386,184,208  1,111,659,170  190,007,683  413,513,184  2,101,364,245 
Total Indirect Costs  31,956,518  107,367,688  16,069,033  42,497,740  197,890,978 
Total Cost – All Fractures  418,140,726  1,219,026,858  206,076,716  456,010,924  2,299,255,223 
2019 Total Direct Costs 391,317,058  1,151,436,929  192,358,204  430,325,056  2,165,437,247 
Total Indirect Costs  32,381,205  111,208,739  16,267,737  44,225,331  204,083,012 
Total Cost – All Fractures  423,698,263  1,262,645,669  208,625,940  474,550,387  2,369,520,260 
2020 Total Direct Costs 396,249,829  1,193,507,459  194,747,172  447,696,583  2,232,201,043 
Total Indirect Costs  32,789,408  115,272,373  16,469,795  46,010,672  210,542,247 
Total Cost – All Fractures  429,039,236  1,308,779,832  211,216,967  493,707,255  2,442,743,291 
2021 Total Direct Costs 402,440,903  1,235,533,008  197,640,391  464,783,876  2,300,398,178 
Total Indirect Costs  33,301,644  119,330,849  16,714,409  47,766,657  217,113,559 
Total Cost – All Fractures  435,742,547  1,354,863,857  214,354,800  512,550,533  2,517,511,737 
2022 Total Direct Costs 408,263,423  1,277,227,849  200,382,437  481,723,338  2,367,597,047 
Total Indirect Costs  33,783,484  123,357,333  16,946,357  49,507,478  223,594,652 
Total Cost – All Fractures  442,046,907  1,400,585,182  217,328,794  531,230,816  2,591,191,699
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Hip fractures
Table 41 shows the annual predicted number of hip fractures by age group and gender. By 2022 there are expected to be  
32,413 hip fractures in that year attributable to osteoporosis and osteopenia. This represents a percentage increase of 35% over 
the period 2013 to 2022. Sixty three per cent of hip fractures are likely to occur in women aged over 70 years (n=20,535), and 
each year the number of hip fractures in this group is likely to increase by an average of 3.3% in women and 3.6% in men aged 
70 years and over.
The total annual cost of hip fractures is likely to increase by 36% from $829 million in 2013 to $1.27 billion in 2022 (Table 42). 
Women aged 70 years and over represent approximately 66% of the total annual cost of hip fractures. Eight per cent of the total 
annual cost is indirect costs due to lost productivity. Younger men aged 50-69 years represent only 4% of the total annual cost of 
hip fractures.
Table 41: Annual number of hip fractures (new fracture and re-fractures) by gender, age group and total, 2013-2022
Number of Fractures
Year Hip Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years Hip Fractures
2013 New Fractures 1,576  13,999  1,253  5,491  22,319 
Re-fractures  77  1,084  107  404  1,671 
Total Hip Fractures (2013)  1,653  15,082  1,360  5,895  23,990 
2014 New Fractures  1,608  14,418  1,276  5,690  22,991 
Re-fractures  75  1,045  110  420  1,649 
Total Hip Fractures (2014)  1,683  15,462  1,385  6,110  24,640 
2015 New Fractures  1,636  14,881  1,296  5,915  23,729 
Re-fractures  75  1,056  110  427  1,668 
Total Hip Fractures (2015)  1,711  15,937  1,406  6,342  25,396 
2016 New Fractures  1,662  15,366  1,313  6,157  24,499 
Re-fractures  77  1,097  112  449  1,734 
Total Hip Fractures (2016)  1,738  16,463  1,425  6,606  26,232 
2017 New Fractures  1,675  16,076  1,322  6,492  25,565 
Re-fractures  78  1,132  113  467  1,790 
Total Hip Fractures (2017)  1,753  17,208  1,435  6,959  27,355 
2018 New Fractures  1,693  16,688  1,335  6,784  26,500 
Re-fractures  78  1,184  114  492  1,869 
Total Hip Fractures (2018)  1,772  17,873  1,449  7,276  28,370 
2019 New Fractures  1,716  17,283  1,352  7,058  27,408 
Re-fractures  79  1,230  115  515  1,939 
Total Hip Fractures (2019)  1,795  18,513  1,467  7,572  29,347 
2020 New Fractures  1,738  17,915  1,369  7,343  28,364 
Re-fractures  80  1,273  117  535  2,006 
Total Hip Fractures (2020)  1,818  19,189  1,485  7,878  30,370 
2021 New Fractures  1,765  18,545  1,389  7,622  29,320 
Re-fractures  81  1,320  118  557  2,076 
Total Hip Fractures (2021)  1,846  19,865  1,507  8,179  31,397 
2022 New Fractures  1,790  19,169  1,408  7,899  30,266 
Re-fractures  83  1,366  120  578  2,147 
Total Hip Fractures (2022)  1,873  20,535  1,528  8,477  32,413
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Table 42: Annual total cost of hip fractures (direct and indirect costs) by gender, age group and total, 2013-2022 (2012$)
Total Cost of Hip Fractures (2012$)
Year Hip Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years All Hip Fractures ($)
2013 Total Direct Costs 38,472,038  506,399,138  31,600,960  186,062,848  762,534,983 
Total Indirect Costs  3,874,950  42,570,732  3,329,144  17,080,960  66,855,786 
Total Hip Fracture Cost  42,346,989  548,969,870  34,930,103  203,143,807  829,390,770 
2014 Total Direct Costs  39,167,734  519,158,793  32,197,484  192,841,337  783,365,348 
Total Indirect Costs  3,945,022  43,643,380  3,391,987  17,703,239  68,683,628 
Total Hip Fracture Cost  43,112,756  562,802,173  35,589,471  210,544,577  852,048,976 
2015 Total Direct Costs  39,833,332  535,101,875  32,674,160  200,174,544  807,783,912 
Total Indirect Costs  4,012,062  44,983,644  3,442,205  18,376,443  70,814,354 
Total Hip Fracture Cost  43,845,394  580,085,519  36,116,365  218,550,988  878,598,266 
2016 Total Direct Costs  40,464,947  552,752,685  33,120,964  208,503,727  834,842,323 
Total Indirect Costs  4,075,678  46,467,470  3,489,275  19,141,080  73,173,503 
Total Hip Fracture Cost  44,540,625  599,220,154  36,610,240  227,644,807  908,015,826 
2017 Total Direct Costs  40,795,980  577,780,709  33,356,287  219,637,854  871,570,831 
Total Indirect Costs  4,109,021  48,571,465  3,514,066  20,163,216  76,357,768 
Total Hip Fracture Cost  44,905,001  626,352,174  36,870,354  239,801,070  947,928,598 
2018 Total Direct Costs  41,239,845  600,085,862  33,677,593  229,654,832  904,658,131 
Total Indirect Costs  4,153,727  50,446,560  3,547,916  21,082,796  79,230,999 
Total Hip Fracture Cost  45,393,572  650,532,422  37,225,509  250,737,628  983,889,130 
2019 Total Direct Costs  41,785,811  621,574,104  34,092,435  238,999,840  936,452,190 
Total Indirect Costs  4,208,718  52,252,981  3,591,619  21,940,687  81,994,005 
Total Hip Fracture Cost  45,994,529  673,827,085  37,684,055  260,940,527  1,018,446,195 
2020 Total Direct Costs  42,313,315  644,278,294  34,516,310  248,646,447  969,754,366 
Total Indirect Costs  4,261,848  54,161,622  3,636,274  22,826,266  84,886,010 
Total Hip Fracture Cost  46,575,163  698,439,916  38,152,584  271,472,713  1,054,640,376 
2021 Total Direct Costs  42,971,547  666,973,024  35,027,792  258,140,918  1,003,113,281 
Total Indirect Costs  4,328,146  56,069,467  3,690,159  23,697,878  87,785,650 
Total Hip Fracture Cost  47,299,694  723,042,491  38,717,951  281,838,796  1,090,898,931 
2022 Total Direct Costs 43,594,503  689,490,426  35,514,872  267,552,158  1,036,151,960 
Total Indirect Costs  4,390,891  57,962,406  3,741,472  24,561,850  90,656,619 
Total Hip Fracture Cost  47,985,394  747,452,832  39,256,344  292,114,008  1,126,808,578
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Wrist fractures
Table 43 shows the predicted annual number of wrist fractures by gender and age group from 2013 to 2022. The total increase 
from 2013 to 2022 was predicted to be 26%, with an average annual increase of 2.6% in women and 2.8% in men. Women 
aged 70 years and over are predicted to represent approximately 50% of all wrist fractures attributable to osteoporosis and 
osteopenia in 2022.
The annual total cost of wrist fractures is predicted to increase from $130 million to $160 million in 2022 in AUD 2012 (Table 44). 
Women in both age groups represent 58% of the total cost and this is predicted to be relatively constant over the 10 year period 
(2012 to 2022).
Table 43: Annual number of wrist fractures (new fractures and re-fractures) by gender, age group and total, 2013-2022
Number of Fractures
Year Wrist Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years Wrist Fractures
2013 New Fractures  8,136  8,703  1,091  1,076  19,006 
Re-fractures  317  571  74  66  1,029 
Total Wrist Fractures (2013)  8,453  9,274  1,165  1,142  20,034 
2014 New Fractures  8,294  8,950  1,111  1,114  19,468 
Re-fractures  323  585  81  72  1,063 
Total Wrist Fractures (2014)  8,617  9,536  1,192  1,186  20,531 
2015 New Fractures  8,438  9,239  1,128  1,158  19,962 
Re-fractures  328  598  84  75  1,086 
Total Wrist Fractures (2015)  8,766  9,837  1,212  1,232  21,048 
2016 New Fractures  8,569  9,540  1,143  1,205  20,457 
Re-fractures  336  622  86  79  1,122 
Total Wrist Fractures (2016)  8,905  10,162  1,229  1,284  21,580 
2017 New Fractures  8,635  9,985  1,151  1,271  21,041 
Re-fractures  341  642  87  82  1,152 
Total Wrist Fractures (2017)  8,976  10,628  1,238  1,353  22,194 
2018 New Fractures  8,731  10,363  1,162  1,328  21,584 
Re-fractures  344  671  88  86  1,189 
Total Wrist Fractures (2018)  9,074  11,034  1,250  1,414  22,773 
2019 New Fractures  8,848  10,731  1,177  1,381  22,137 
Re-fractures  347  697  89  90  1,224 
Total Wrist Fractures (2019)  9,195  11,428  1,266  1,471  23,360 
2020 New Fractures  8,959  11,124  1,191  1,437  22,711 
Re-fractures  352  722  90  94  1,258 
Total Wrist Fractures (2020)  9,311  11,846  1,281  1,531  23,969 
2021 New Fractures  9,100  11,514  1,209  1,492  23,315 
Re-fractures  356  749  91  97  1,294 
Total Wrist Fractures (2021)  9,457  12,263  1,300  1,589  24,609 
2022 New Fractures  9,231  11,901  1,226  1,546  23,904 
Re-fractures  362  775  92  101  1,331 
Total Wrist Fractures (2022)  9,593  12,676  1,318  1,647  25,235
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Table 44: Annual total cost of wrist fractures (direct and indirect costs) by gender, age group and total, 2013-2022 (2012$)
Total Cost of Wrist Fractures (2012$)
Year Wrist Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years All Wrist Fractures ($)
2013 Total Direct Costs  44,703,582  65,696,378  5,110,857  5,878,103  121,388,920 
Total Indirect Costs  3,177,410  4,913,180  379,641  480,144  8,950,375 
Total Wrist Fracture Cost  47,880,992  70,609,558  5,490,499  6,358,247  130,339,295 
2014 Total Direct Costs  45,570,673  67,548,372  5,228,016  6,104,964  124,452,025 
Total Indirect Costs  3,239,041  5,051,683  388,344  498,674  9,177,742 
Total Wrist Fracture Cost  48,809,714  72,600,055  5,616,360  6,603,638  133,629,767 
2015 Total Direct Costs  46,361,134  69,683,313  5,316,165  6,342,845  127,703,456 
Total Indirect Costs  3,295,224  5,211,347  394,892  518,105  9,419,569 
Total Wrist Fracture Cost  49,656,358  74,894,660  5,711,056  6,860,951  137,123,025 
2016 Total Direct Costs  47,093,574  71,985,053  5,391,230  6,607,012  131,076,869 
Total Indirect Costs  3,347,284  5,383,486  400,468  539,683  9,670,921 
Total Wrist Fracture Cost  50,440,858  77,368,539  5,791,698  7,146,695  140,747,790 
2017 Total Direct Costs  47,468,258  75,283,627  5,429,408  6,962,048  135,143,341 
Total Indirect Costs  3,373,916  5,630,173  403,304  568,684  9,976,077 
Total Wrist Fracture Cost  50,842,174  80,913,800  5,832,712  7,530,732  145,119,418 
2018 Total Direct Costs  47,989,592  78,165,679  5,482,578  7,277,790  138,915,639 
Total Indirect Costs  3,410,971  5,845,711  407,253  594,475  10,258,410 
Total Wrist Fracture Cost  51,400,563  84,011,390  5,889,831  7,872,265  149,174,049 
2019 Total Direct Costs  48,628,304  80,956,668  5,550,526  7,573,193  142,708,691 
Total Indirect Costs  3,456,369  6,054,438  412,300  618,604  10,541,712 
Total Wrist Fracture Cost  52,084,673  87,011,106  5,962,826  8,191,797  153,250,403 
2020 Total Direct Costs  49,240,964  83,917,247  5,619,424  7,878,994  146,656,629 
Total Indirect Costs  3,499,915  6,275,849  417,418  643,583  10,836,765 
Total Wrist Fracture Cost  52,740,879  90,193,096  6,036,842  8,522,577  157,493,394 
2021 Total Direct Costs  50,011,510  86,868,611  5,703,012  8,179,444  150,762,577 
Total Indirect Costs  3,554,683  6,496,570  423,627  668,125  11,143,006 
Total Wrist Fracture Cost  53,566,194  93,365,180  6,126,639  8,847,570  161,905,583 
2022 Total Direct Costs  50,734,549  89,796,364  5,782,049  8,477,365  154,790,327 
Total Indirect Costs  3,606,075  6,715,525  429,498  692,460  11,443,559 
Total Wrist Fracture Cost  54,340,624  96,511,889  6,211,547  9,169,825  166,233,886
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Vertebral fractures
Table 45 shows the predicted number of vertebral fractures in men and women aged 50 years and over from 2013 to 2022. By 
2022 there are predicted to be 35,044 vertebral fractures, representing an average annual increase in vertebral fractures of  
2.8% in women and 3.1% in men over the same period. Women aged 70 years and over represent the largest single population 
group with 19,147 vertebral fractures predicted by 2022, which is 55% of the total number of vertebral fractures. Overall 77% of 
all vertebral fractures will occur in women aged 50 years and over by 2022.
The total annual costs of vertebral fractures are shown in Table 46. The costs of vertebral fractures are predicted to increase by 
30% to $295 million between 2013 and 2022. The annual increase in costs is likely to be 31% for women and 39% for men aged 
50 years and over, for the next 10 years from 2013 to 2022. Vertebral fractures in women aged 50 years and over are likely to be 
almost $240 million by 2022, 81% of the total costs attributable to vertebral fractures.
Table 45: Annual number of vertebral fractures (new fractures and re-fractures) by gender, age group and total, 2013-2022
Number of Fractures
Year Vertebral Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years Vertebral Fractures
2013 New Fractures 6,443  12,946  2,242  3,503  25,134 
Re-fractures  349  1,158  212  302  2,021 
Total Vertebral Fractures (2013)  6,792  14,104  2,455  3,805  27,155 
2014 New Fractures  6,579  13,343  2,284  3,631  25,836 
Re-fractures  327  1,077  208  306  1,917 
Total Vertebral Fractures (2014)  6,905  14,420  2,492  3,937  27,754 
2015 New Fractures  6,694  13,772  2,320  3,774  26,561 
Re-fractures  328  1,087  209  311  1,935 
Total Vertebral Fractures (2015)  7,022  14,859  2,529  4,086  28,496 
2016 New Fractures  6,799  14,221  2,351  3,929  27,299 
Re-fractures  335  1,130  212  327  2,005 
Total Vertebral Fractures (2016)  7,134  15,351  2,564  4,256  29,304 
2017 New Fractures  6,853  14,874  2,367  4,142  28,236 
Re-fractures  340  1,167  215  341  2,063 
Total Vertebral Fractures (2017)  7,193  16,041  2,582  4,482  30,298 
2018 New Fractures  6,928  15,442  2,390  4,328  29,089 
Re-fractures  343  1,221  216  359  2,140 
Total Vertebral Fractures (2018)  7,271  16,663  2,607  4,688  31,229 
2019 New Fractures  7,020  15,993  2,420  4,503  29,937 
Re-fractures  347  1,267  218  375  2,208 
Total Vertebral Fractures (2019)  7,367  17,261  2,639  4,879  32,145 
2020 New Fractures  7,109  16,578  2,450  4,685  30,823 
Re-fractures  351  1,312  221  390  2,276 
Total Vertebral Fractures (2020)  7,460  17,891  2,672  5,076  33,098 
2021 New Fractures  7,220  17,161  2,487  4,863  31,732 
Re-fractures  356  1,360  224  406  2,346 
Total Vertebral Fractures (2021)  7,576  18,522  2,711  5,270  34,078 
2022 New Fractures  7,324  17,739  2,522  5,040  32,625 
Re-fractures  362  1,408  227  422  2,419 
Total Vertebral Fractures (2022)  7,686  19,147  2,749  5,462  35,044
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Table 46: Annual total cost of vertebral fractures (direct and indirect costs) by gender, age group and total, 2013-2022 (2012$)
Total Cost of Vertebral Fractures (2012$)
Year Vertebral Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years All Vertebral Fractures ($)
2013 Total Direct Costs 38,383,939  129,413,073  17,439,693  21,420,323  206,657,029 
Total Indirect Costs  3,177,329  12,290,817  1,739,876  2,474,508  19,682,531 
Total Vertebral Fracture Cost  41,561,268  141,703,891  19,179,570  23,894,832  226,339,560 
2014 Total Direct Costs  39,024,056  132,315,238  17,703,276  22,163,395  211,205,966 
Total Indirect Costs  3,230,316  12,566,446  1,766,173  2,560,349  20,123,285 
Total Vertebral Fracture Cost  42,254,373  144,881,684  19,469,449  24,723,744  231,329,250 
2015 Total Direct Costs  39,685,847  136,345,660  17,966,920  23,000,103  216,998,530 
Total Indirect Costs  3,285,098  12,949,230  1,792,475  2,657,007  20,683,810 
Total Vertebral Fracture Cost  42,970,944  149,294,890  19,759,395  25,657,110  237,682,339 
2016 Total Direct Costs  40,316,951  140,853,778  18,213,668  23,960,590  223,344,987 
Total Indirect Costs  3,337,339  13,377,382  1,817,092  2,767,964  21,299,777 
Total Vertebral Fracture Cost  43,654,291  154,231,160  20,030,760  26,728,554  244,644,764 
2017 Total Direct Costs  40,651,112  147,187,261  18,344,474  25,234,502  231,417,349 
Total Indirect Costs  3,365,000  13,978,895  1,830,142  2,915,128  22,089,165 
Total Vertebral Fracture Cost  44,016,112  161,166,156  20,174,616  28,149,630  253,506,515 
2018 Total Direct Costs  41,091,241  152,898,201  18,520,016  26,389,839  238,899,298 
Total Indirect Costs  3,401,433  14,521,283  1,847,655  3,048,594  22,818,965 
Total Vertebral Fracture Cost  44,492,674  167,419,484  20,367,671  29,438,433  261,718,263 
2019 Total Direct Costs  41,633,986  158,381,062  18,747,735  27,465,490  246,228,273 
Total Indirect Costs  3,446,360  15,042,010  1,870,373  3,172,855  23,531,599 
Total Vertebral Fracture Cost  45,080,346  173,423,072  20,618,108  30,638,346  269,759,871 
2020 Total Direct Costs  42,160,120  164,162,284  18,981,011  28,573,879  253,877,294 
Total Indirect Costs  3,489,912  15,591,073  1,893,646  3,300,898  24,275,529 
Total Vertebral Fracture Cost  45,650,032  179,753,357  20,874,657  31,874,777  278,152,824 
2021 Total Direct Costs  42,814,083  169,950,440  19,261,674  29,666,104  261,692,301 
Total Indirect Costs  3,544,046  16,140,795  1,921,647  3,427,073  25,033,560 
Total Vertebral Fracture Cost  46,358,129  186,091,234  21,183,320  33,093,177  286,725,861 
2022 Total Direct Costs  43,435,643  175,693,573  19,529,958  30,748,436  269,407,610 
Total Indirect Costs  3,595,497  16,686,240  1,948,412  3,552,106  25,782,255 
Total Vertebral Fracture Cost  47,031,140  192,379,813  21,478,370  34,300,543  295,189,865
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‘Other’ fractures
Table 47 shows the annual trend in ‘other’ fractures likely to be attributable to osteoporosis or osteopenia. The number of ‘other’ 
fractures is predicted to increase to 90,413 by 2022 (an increase of 24% from 2013). These ‘other’ fractures represent almost 
50% of the fracture burden associated with these conditions. Although women experience the largest number (n=56,000), 
‘other’ fractures in men aged 50-69 years are predicted to represent 22% by 2022. The predicted average annual growth rate  
in these fractures is 2.4% in women and 2.5% in men. 
Table 48 shows the total cost of this low trauma fracture group likely to be attributable to osteoporosis/osteopenia. Although ‘other’ 
fractures represent almost 50% of all fracture numbers, they represent just 39% of the total costs of all fractures. From 2013 to 
2022 the number of these fractures is predicted to increase by 36%, with the cost increasing to just over $1 billion. Most of these 
fractures occur in women in both age groups (65% of the total). 
Table 47: Annual number of ‘other’ fractures (new fractures and re-fractures) by gender, age group and total, 2013-2022
Number of Fractures
Year Other Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years Other Fractures
2013 New Fractures  25,502  17,999  16,383  9,374  69,258 
Re-fractures  993  1,186  1,109  587  3,875 
Total Other Fractures (2013)  26,495  19,185  17,491  9,961  73,133 
2014 New Fractures  25,997  18,510  16,672  9,705  70,884 
Re-fractures  1,012  1,207  1,220  628  4,067 
Total Other Fractures (2014)  27,009  19,716  17,892  10,333  74,950 
2015 New Fractures  26,450  19,106  16,931  10,089  72,577 
Re-fractures  1,027  1,232  1,263  645  4,167 
Total Other Fractures (2015)  27,477  20,339  18,194  10,734  76,744 
2016 New Fractures  26,861  19,729  17,160  10,502  74,252 
Re-fractures  1,050  1,281  1,291  679  4,301 
Total Other Fractures (2016)  27,911  21,010  18,451  11,181  78,553 
2017 New Fractures  27,066  20,650  17,272  11,076  76,064 
Re-fractures  1,067  1,323  1,310  706  4,406 
Total Other Fractures (2017)  28,133  21,973  18,582  11,782  80,470 
2018 New Fractures  27,367  21,432  17,444  11,572  77,814 
Re-fractures  1,076  1,383  1,320  744  4,522 
Total Other Fractures (2018)  28,442  22,814  18,764  12,316  82,336 
2019 New Fractures  27,734  22,193  17,663  12,038  79,628 
Re-fractures  1,087  1,436  1,333  778  4,634 
Total Other Fractures (2019)  28,821  23,629  18,996  12,816  84,262 
2020 New Fractures  28,082  23,006  17,883  12,524  81,495 
Re-fractures  1,102  1,487  1,349  810  4,747 
Total Other Fractures (2020)  29,184  24,493  19,232  13,334  86,242 
2021 New Fractures  28,525  23,813  18,152  13,000  83,490 
Re-fractures  1,116  1,542  1,366  842  4,865 
Total Other Fractures (2021)  29,641  25,354  19,518  13,842  88,355 
2022 New Fractures  28,936  24,613  18,403  13,472  85,423 
Re-fractures  1,133  1,596  1,386  874  4,989 
Total Other Fractures (2022)  30,069  26,209  19,788  14,346  90,413
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Table 48: Annual total cost of ‘other’ fractures (direct and indirect costs) by gender, age group and total, 2013-2022 (2012$)
Total Cost of Other Fractures (2012$)
Year Other Fractures
Women Men Total
50-69 years 70+ years 50-69 years 70+ years All Other Fractures ($)
2013 Total Direct Costs  238,343,824  235,888,961  123,356,081  121,476,766  719,065,632 
Total Indirect Costs  19,553,115  30,739,490  9,570,190  14,374,190  74,236,984 
Total Other Fracture Cost  257,896,939  266,628,450  132,926,271  135,850,956  793,302,616 
2014 Total Direct Costs  242,966,849  242,420,376  126,183,526  126,004,764  737,575,515 
Total Indirect Costs  19,932,376  31,590,621  9,789,548  14,909,982  76,222,526 
Total Other Fracture Cost  262,899,225  274,010,997  135,973,074  140,914,746  813,798,041 
2015 Total Direct Costs  247,181,338  250,070,729  128,311,010  130,899,154  756,462,230 
Total Indirect Costs  20,278,122  32,587,564  9,954,602  15,489,129  78,309,417 
Total Other Fracture Cost  267,459,460  282,658,293  138,265,612  146,388,282  834,771,646 
2016 Total Direct Costs  251,086,351  258,329,063  130,122,748  136,347,993  775,886,155 
Total Indirect Costs  20,598,479  33,663,736  10,095,160  16,133,883  80,491,257 
Total Other Fracture Cost  271,684,830  291,992,799  140,217,908  152,481,876  856,377,412 
2017 Total Direct Costs  253,083,919  270,167,240  131,044,189  143,675,395  797,970,743 
Total Indirect Costs  20,762,354  35,206,408  10,166,647  17,000,925  83,136,335 
Total Other Fracture Cost  273,846,273  305,373,648  141,210,837  160,676,320  881,107,078 
2018 Total Direct Costs  255,863,530  280,509,428  132,327,496  150,190,723  818,891,177 
Total Indirect Costs  20,990,387  36,554,134  10,266,209  17,771,875  85,582,604 
Total Other Fracture Cost  276,853,917  317,063,562  142,593,705  167,962,598  904,473,781 
2019 Total Direct Costs  259,268,957  290,525,096  133,967,507  156,286,533  840,048,093 
Total Indirect Costs  21,269,759  37,859,310  10,393,444  18,493,184  88,015,697 
Total Other Fracture Cost  280,538,716  328,384,406  144,360,951  174,779,717  928,063,790 
2020 Total Direct Costs  262,535,430  301,149,634  135,630,428  162,597,262  861,912,754 
Total Indirect Costs  21,537,732  39,243,829  10,522,456  19,239,925  90,543,942 
Total Other Fracture Cost  284,073,162  340,393,463  146,152,884  181,837,187  952,456,696 
2021 Total Direct Costs  266,643,762  311,740,934  137,647,914  168,797,410  884,830,019 
Total Indirect Costs  21,874,769  40,624,017  10,678,976  19,973,580  93,151,343 
Total Other Fracture Cost  288,518,531  352,364,951  148,326,890  188,770,990  977,981,362 
2022 Total Direct Costs  270,498,729  322,247,485  139,555,558  174,945,379  907,247,150 
Total Indirect Costs  22,191,021  41,993,162  10,826,975  20,701,062  95,712,219 
Total Other Fracture Cost  292,689,749  364,240,647  150,382,533  195,646,440  1,002,959,369
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Community Service Costs for Osteoporosis and Osteopenia
The projected total cost for community services in the Australian population aged 50 years and over with osteoporosis or 
osteopenia is almost $1.25 billion which represents 35% of the total direct costs of osteoporosis and osteopenia in 2022  
(Table 49). The total cost of routine pathology and general practitioner attendance represent over half the total cost of community 
services. The growth in osteoporosis medication is likely to increase by 50% to $275 million by 2022 based on the assumptions 
made in this model. The costs of DXA and vitamin D tests are 34% and 23% respectively of the total cost by 2022. Ongoing 
residential care costs following a fracture have been included for the 2012 cohort assumed to go into residential care as a  
result of the fracture, and following subsequent fractures that occur over the 10 year period of the model. 
Table 50 provides an annual summary of all costs attributed to osteoporosis, osteopenia and fractures over the period 2012 to 
2022. The results of the 2012 annual burden of disease model are included in Table 50 for comparability. In the 2012 model 
re-fractures were not included, and only residential care for the fracture population in the year that the fracture occurred was 
included. All other cost categories can be compared between 2012 and 2022. The total costs are predicted to increase by  
30% to $3.62 billion by 2022, or (with residential care and re-fractures included) to $3.84 billion (in 2012$). The direct  
costs of treating first fractures are predicted to increase to $2.221 billion by 2022, and for treating re-fractures the cost is to  
reach almost $150 million. Table 51 provides an annual summary of total direct and indirect costs inflated to future dollars using 
an inflation rate of 3.4%. For the 2012 comparison, the total direct and indirect costs ranged from $2.7 billion (in 2012$) to 
almost $5 billion (in 2022$). The cost increases to $5.4 billion (in 2022$) with the inclusion of re-fractures and residential care. 
Figure 4 shows the increase in direct and total (direct and indirect) costs from 2012 to 2022 with re-fracture costs and residential 
care included.
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Figure 4: Annual change in direct and total costs, 2013 to 2022, 2012$ ($millions)
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Table 49: Total annual costs of community services for osteoporosis and osteopenia (irrespective of fracture),  
2013-2022 (2012$)
Community 
Health Care 
Service 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Bisphosphonates 186,673,169 216,894,065 226,507,293 232,543,973 239,652,306 246,561,307 253,384,682 260,432,993 267,744,136 274,991,882
DXA 34,908,103 35,944,475 37,038,573 38,184,173 39,711,593 41,108,895 42,465,875 43,882,791 45,316,095 46,732,225
Vitamin D Test 98,471,790 100,957,180 103,333,781 105,682,261 108,138,986 110,575,259 113,095,626 115,682,944 118,450,187 121,152,981
Routine 
Pathology Test 137,683,989 141,159,079 144,482,060 147,765,722 151,200,734 154,607,148 158,131,145 161,748,752 165,617,931 169,396,998
Community  
GP Visits 430,905,494 441,781,383 452,181,217 462,457,997 473,208,450 483,869,403 494,898,352 506,220,269 518,329,524 530,156,759
Nursing Home – 
previous fracture 13,258,394 25,879,743 37,680,690 48,794,883 59,317,879 69,536,075 79,379,528 88,860,210 98,049,330 106,969,796
All Total Cost 901,900,939 962,615,926 1,001,223,615 1,035,429,009 1,071,229,948 1,106,258,086 1,141,355,207 1,176,827,960 1,213,507,202 1,249,400,641
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Table 50: Total annual direct and indirect costs for osteoporosis, osteopenia and fractures, 2012-2022 (2012$)  Table 50: continued
Total Cost (2012$) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Total Direct New Fracture Cost  $1,759,572,690  $1,695,549,074  $1,742,267,149  $1,792,761,620  $1,844,620,850  $1,911,960,550  $1,972,422,764  $2,032,180,554  $2,094,729,021  $2,158,506,623  $2,221,227,955 
- Hip fractures  $731,203,094  $709,131,348  $730,749,028  $754,556,645  $779,474,104  $814,371,603  $844,874,994  $874,399,801  $905,518,964  $936,576,380  $967,317,819 
- Wrist fractures  $122,122,418  $114,999,943  $117,864,765  $120,974,834  $124,112,635  $127,986,181  $131,512,802  $135,078,561  $138,801,413  $142,672,554  $146,459,012 
- Vertebral fractures  $194,484,545  $190,851,205  $196,279,042  $201,932,505  $207,730,361  $215,343,382  $222,197,826  $228,973,580  $236,079,031  $243,320,412  $250,454,904 
- Other fractures  $711,762,633  $680,566,577  $697,374,314  $715,297,636  $733,303,750  $754,259,385  $773,837,141  $793,728,612  $814,329,614  $835,937,277  $856,996,220 
Total Direct Non-fracture Costs  $829,645,097  $888,642,545  $936,736,182  $963,542,925  $986,634,126  $1,011,912,069  $1,036,722,011  $1,061,975,679  $1,087,967,749  $1,115,457,872  $1,142,430,845 
- Pharmaceuticals – bone health 
(includes bisphosphonates)  $179,315,417  $186,673,169  $216,894,065  $226,507,293  $232,543,973  $239,652,306  $246,561,307  $253,384,682  $260,432,993  $267,744,136  $274,991,882 
- DXA  $23,625,769  $34,908,103  $35,944,475  $37,038,573  $38,184,173  $39,711,593  $41,108,895  $42,465,875  $43,882,791  $45,316,095  $46,732,225 
- Routine medical and pathology  
(includes Vitamin D tests)  $626,703,911  $667,061,273  $683,897,642  $699,997,058  $715,905,980  $732,548,170  $749,051,809  $766,125,123  $783,651,965  $802,397,641  $820,706,738 
TOTAL DIRECT COSTS  
(for 2012 comparison)  $2,589,217,788  $2,584,191,619  $2,679,003,331  $2,756,304,545  $2,831,254,976  $2,923,872,619  $3,009,144,775  $3,094,156,233  $3,182,696,770  $3,273,964,496  $3,363,658,800 
Total Direct Re-fracture Cost -  $114,097,490  $114,331,704  $116,186,508  $120,529,484  $124,141,714  $128,941,481  $133,256,694  $137,472,023  $141,891,554  $146,369,092 
- Hip fractures -  $53,403,635  $52,616,320  $53,227,267  $55,368,219  $57,199,227  $59,783,137  $62,052,389  $64,235,403  $66,536,901  $68,834,141 
- Wrist fractures -  $6,388,977  $6,587,259  $6,728,622  $6,964,234  $7,157,161  $7,402,837  $7,630,130  $7,855,216  $8,090,023  $8,331,314 
- Vertebral fractures -  $15,805,824  $14,926,924  $15,066,025  $15,614,626  $16,073,968  $16,701,471  $17,254,693  $17,798,263  $18,371,888  $18,952,706 
- Other fractures -  $38,499,055  $40,201,201  $41,164,594  $42,582,405  $43,711,358  $45,054,036  $46,319,481  $47,583,140  $48,892,742  $50,250,930 
Direct Non-fracture Costs 
(Residential Care only) -  $13,258,394  $25,879,743  $37,680,690  $48,794,883  $59,317,879  $69,536,075  $79,379,528  $88,860,210  $98,049,330  $106,969,796 
TOTAL DIRECT COSTS (with  
re-fractures and residential care)* -  $2,711,547,504  $2,819,214,779  $2,910,171,743  $3,000,579,343  $3,107,332,212  $3,207,622,331  $3,306,792,455  $3,409,029,002  $3,513,905,380  $3,616,997,688 
Total Indirect Cost (Productivity Loss 
due to New Fractures)  $165,173,079  $158,974,217  $163,418,172  $168,259,841  $173,250,941  $179,826,980  $185,692,556  $191,466,149  $197,517,913  $203,662,028  $209,711,443 
- Hip fractures  $64,033,917  $62,185,079  $64,074,760  $66,151,942  $68,324,321  $71,349,052  $73,998,305  $76,564,228  $79,266,519  $81,966,301  $84,637,603 
- Wrist fractures  $9,003,419  $8,476,597  $8,689,056  $8,920,338  $9,154,080  $9,444,800  $9,708,660  $9,974,900  $10,253,083  $10,541,718  $10,824,206 
- Vertebral fractures  $18,497,828  $18,163,263  $18,685,641  $19,232,446  $19,794,820  $20,539,305  $21,207,489  $21,865,903  $22,556,691  $23,258,632  $23,950,655 
- Other fractures  $73,637,915  $70,149,277  $71,968,715  $73,955,115  $75,977,720  $78,493,823  $80,778,101  $83,061,118  $85,441,621  $87,895,377  $90,298,980 
TOTAL DIRECT and INDIRECT COST 
(for 2012 comparison)  $2,754,390,866  $2,743,165,836  $2,842,421,504  $2,924,564,386  $3,004,505,917  $3,103,699,599  $3,194,837,330  $3,285,622,382  $3,380,214,683  $3,477,626,523  $3,573,370,243 
Total Indirect Cost (Productivity Loss 
due to Re-fractures) -  $10,751,460  $10,789,009  $10,967,308  $11,384,518  $11,732,365  $12,198,423  $12,616,863  $13,024,334  $13,451,532  $13,883,209 
- Hip fractures -  $4,670,707  $4,608,868  $4,662,412  $4,849,182  $5,008,715  $5,232,694  $5,429,777  $5,619,491  $5,819,350  $6,019,016 
- Wrist fractures -  $473,778  $488,687  $499,231  $516,841  $531,277  $549,750  $566,812  $583,682  $601,288  $619,353 
- Vertebral fractures -  $1,519,268  $1,437,644  $1,451,363  $1,504,957  $1,549,860  $1,611,476  $1,665,696  $1,718,839  $1,774,928  $1,831,601 
- Other fractures -  $4,087,707  $4,253,811  $4,354,302  $4,513,537  $4,642,512  $4,804,503  $4,954,579  $5,102,321  $5,255,966  $5,413,239 
TOTAL DIRECT and INDIRECT COST 
(with re-fractures and residential care)* -  $2,881,273,180  $2,993,421,961  $3,089,398,892  $3,185,214,802  $3,298,891,557  $3,405,513,309  $3,510,875,467  $3,619,571,250  $3,731,018,939  $3,840,592,339
* Total direct cost (with re-fracture costs and residential care is not comparable with 2012 costs)
Table 51: Inflated total annual direct and indirect costs for osteoporosis, osteopenia and fractures, 2012-2022 ($current)  Table 51: continued
Total Cost ($) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
TOTAL DIRECT and INDIRECT COST 
(for 2012 comparison) $2,754,390,866  $2,836,433,474  $3,038,992,005  $3,233,127,289  $3,434,434,346  $3,668,448,055  $3,904,558,939  $4,152,038,956  $4,416,808,745  $4,698,592,578  $4,992,101,468 
TOTAL DIRECT and INDIRECT COST 
(with re-fractures and residential care)* - $2,979,236,468  $3,200,435,050  $3,415,353,040  $3,641,001,688  $3,899,157,096  $4,162,035,828  $4,436,691,140  $4,729,567,630  $5,040,948,986  $5,365,418,457 
* Total direct cost (with re-fracture costs and residential care is not comparable with 2012 costs)      
  Inflation rate=3.4% for each year 
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Table 50: Total annual direct and indirect costs for osteoporosis, osteopenia and fractures, 2012-2022 (2012$)  Table 50: continued
Total Cost (2012$) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Total Direct New Fracture Cost  $1,759,572,690  $1,695,549,074  $1,742,267,149  $1,792,761,620  $1,844,620,850  $1,911,960,550  $1,972,422,764  $2,032,180,554  $2,094,729,021  $2,158,506,623  $2,221,227,955 
- Hip fractures  $731,203,094  $709,131,348  $730,749,028  $754,556,645  $779,474,104  $814,371,603  $844,874,994  $874,399,801  $905,518,964  $936,576,380  $967,317,819 
- Wrist fractures  $122,122,418  $114,999,943  $117,864,765  $120,974,834  $124,112,635  $127,986,181  $131,512,802  $135,078,561  $138,801,413  $142,672,554  $146,459,012 
- Vertebral fractures  $194,484,545  $190,851,205  $196,279,042  $201,932,505  $207,730,361  $215,343,382  $222,197,826  $228,973,580  $236,079,031  $243,320,412  $250,454,904 
- Other fractures  $711,762,633  $680,566,577  $697,374,314  $715,297,636  $733,303,750  $754,259,385  $773,837,141  $793,728,612  $814,329,614  $835,937,277  $856,996,220 
Total Direct Non-fracture Costs  $829,645,097  $888,642,545  $936,736,182  $963,542,925  $986,634,126  $1,011,912,069  $1,036,722,011  $1,061,975,679  $1,087,967,749  $1,115,457,872  $1,142,430,845 
- Pharmaceuticals – bone health 
(includes bisphosphonates)  $179,315,417  $186,673,169  $216,894,065  $226,507,293  $232,543,973  $239,652,306  $246,561,307  $253,384,682  $260,432,993  $267,744,136  $274,991,882 
- DXA  $23,625,769  $34,908,103  $35,944,475  $37,038,573  $38,184,173  $39,711,593  $41,108,895  $42,465,875  $43,882,791  $45,316,095  $46,732,225 
- Routine medical and pathology  
(includes Vitamin D tests)  $626,703,911  $667,061,273  $683,897,642  $699,997,058  $715,905,980  $732,548,170  $749,051,809  $766,125,123  $783,651,965  $802,397,641  $820,706,738 
TOTAL DIRECT COSTS  
(for 2012 comparison)  $2,589,217,788  $2,584,191,619  $2,679,003,331  $2,756,304,545  $2,831,254,976  $2,923,872,619  $3,009,144,775  $3,094,156,233  $3,182,696,770  $3,273,964,496  $3,363,658,800 
Total Direct Re-fracture Cost -  $114,097,490  $114,331,704  $116,186,508  $120,529,484  $124,141,714  $128,941,481  $133,256,694  $137,472,023  $141,891,554  $146,369,092 
- Hip fractures -  $53,403,635  $52,616,320  $53,227,267  $55,368,219  $57,199,227  $59,783,137  $62,052,389  $64,235,403  $66,536,901  $68,834,141 
- Wrist fractures -  $6,388,977  $6,587,259  $6,728,622  $6,964,234  $7,157,161  $7,402,837  $7,630,130  $7,855,216  $8,090,023  $8,331,314 
- Vertebral fractures -  $15,805,824  $14,926,924  $15,066,025  $15,614,626  $16,073,968  $16,701,471  $17,254,693  $17,798,263  $18,371,888  $18,952,706 
- Other fractures -  $38,499,055  $40,201,201  $41,164,594  $42,582,405  $43,711,358  $45,054,036  $46,319,481  $47,583,140  $48,892,742  $50,250,930 
Direct Non-fracture Costs 
(Residential Care only) -  $13,258,394  $25,879,743  $37,680,690  $48,794,883  $59,317,879  $69,536,075  $79,379,528  $88,860,210  $98,049,330  $106,969,796 
TOTAL DIRECT COSTS (with  
re-fractures and residential care)* -  $2,711,547,504  $2,819,214,779  $2,910,171,743  $3,000,579,343  $3,107,332,212  $3,207,622,331  $3,306,792,455  $3,409,029,002  $3,513,905,380  $3,616,997,688 
Total Indirect Cost (Productivity Loss 
due to New Fractures)  $165,173,079  $158,974,217  $163,418,172  $168,259,841  $173,250,941  $179,826,980  $185,692,556  $191,466,149  $197,517,913  $203,662,028  $209,711,443 
- Hip fractures  $64,033,917  $62,185,079  $64,074,760  $66,151,942  $68,324,321  $71,349,052  $73,998,305  $76,564,228  $79,266,519  $81,966,301  $84,637,603 
- Wrist fractures  $9,003,419  $8,476,597  $8,689,056  $8,920,338  $9,154,080  $9,444,800  $9,708,660  $9,974,900  $10,253,083  $10,541,718  $10,824,206 
- Vertebral fractures  $18,497,828  $18,163,263  $18,685,641  $19,232,446  $19,794,820  $20,539,305  $21,207,489  $21,865,903  $22,556,691  $23,258,632  $23,950,655 
- Other fractures  $73,637,915  $70,149,277  $71,968,715  $73,955,115  $75,977,720  $78,493,823  $80,778,101  $83,061,118  $85,441,621  $87,895,377  $90,298,980 
TOTAL DIRECT and INDIRECT COST 
(for 2012 comparison)  $2,754,390,866  $2,743,165,836  $2,842,421,504  $2,924,564,386  $3,004,505,917  $3,103,699,599  $3,194,837,330  $3,285,622,382  $3,380,214,683  $3,477,626,523  $3,573,370,243 
Total Indirect Cost (Productivity Loss 
due to Re-fractures) -  $10,751,460  $10,789,009  $10,967,308  $11,384,518  $11,732,365  $12,198,423  $12,616,863  $13,024,334  $13,451,532  $13,883,209 
- Hip fractures -  $4,670,707  $4,608,868  $4,662,412  $4,849,182  $5,008,715  $5,232,694  $5,429,777  $5,619,491  $5,819,350  $6,019,016 
- Wrist fractures -  $473,778  $488,687  $499,231  $516,841  $531,277  $549,750  $566,812  $583,682  $601,288  $619,353 
- Vertebral fractures -  $1,519,268  $1,437,644  $1,451,363  $1,504,957  $1,549,860  $1,611,476  $1,665,696  $1,718,839  $1,774,928  $1,831,601 
- Other fractures -  $4,087,707  $4,253,811  $4,354,302  $4,513,537  $4,642,512  $4,804,503  $4,954,579  $5,102,321  $5,255,966  $5,413,239 
TOTAL DIRECT and INDIRECT COST 
(with re-fractures and residential care)* -  $2,881,273,180  $2,993,421,961  $3,089,398,892  $3,185,214,802  $3,298,891,557  $3,405,513,309  $3,510,875,467  $3,619,571,250  $3,731,018,939  $3,840,592,339
* Total direct cost (with re-fracture costs and residential care is not comparable with 2012 costs)
Table 51: Inflated total annual direct and indirect costs for osteoporosis, osteopenia and fractures, 2012-2022 ($current)  Table 51: continued
Total Cost ($) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
TOTAL DIRECT and INDIRECT COST 
(for 2012 comparison) $2,754,390,866  $2,836,433,474  $3,038,992,005  $3,233,127,289  $3,434,434,346  $3,668,448,055  $3,904,558,939  $4,152,038,956  $4,416,808,745  $4,698,592,578  $4,992,101,468 
TOTAL DIRECT and INDIRECT COST 
(with re-fractures and residential care)* - $2,979,236,468  $3,200,435,050  $3,415,353,040  $3,641,001,688  $3,899,157,096  $4,162,035,828  $4,436,691,140  $4,729,567,630  $5,040,948,986  $5,365,418,457 
* Total direct cost (with re-fracture costs and residential care is not comparable with 2012 costs)      
  Inflation rate=3.4% for each year 
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Fractures Averted due to Osteoporosis (Bone Active) Pharmaceuticals
Relatively conservative assumptions were made concerning the use of osteoporosis bone active pharmaceuticals in the 2012 
population. Yet despite these assumptions, the prediction is that there will be between 13,500 and 17,500 fractures averted 
annually directly attributable to osteoporosis bone active pharmaceuticals (Table 52). Over the 10 year period the total number  
of fractures averted is predicted to be 153,400. Women aged 70 years and over are likely to experience the greatest number  
of averted fractures, from 6,200 in 2013 to 8,670 in 2022. 
The annual savings in direct health care costs attributable to averted fractures is predicted to range from $140 million in 2013  
to $187 million in 2022 ($2012). Over the 10 year period the total savings is predicted to be $1.6 billion in direct health care  
costs (Table 52). Just from the hip fractures averted alone the annual savings are predicted to be $61 million ($2012).
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Table 52: Number of fractures avoided and associated direct health care cost due to osteoporosis  
(bone active pharmaceuticals), 2012-2022 (2012$)
Year
Fracture 
Type
Number of Fractures Avoided
Total 
Fractures 
Avoided
Direct Health Care Cost of Fractures Avoided $2012 Total Direct 
Health Care 
Cost of 
Fractures
Women Men Women Men
50-69 years 70+ years 50-69 years 70+ years 50-69 years 70+ years 50-69 years 70+ years
2013 Hip 96  1,296  81  339  1,812  2,220,276  35,550,489  1,882,210  9,316,465  48,969,441 
Wrist  789  1,319  112  108  2,328  3,913,252  8,150,379  488,668  554,037  13,106,336 
Vertebral  282  869  105  160  1,416  1,142,825  5,652,269  569,492  809,062  8,173,647 
Other  2,473  2,732  1,681  951  7,836  19,824,017  29,307,636  10,496,967  9,548,890  69,177,510 
Total  3,641  6,215  1,979  1,558  13,393  27,100,370  78,660,773  13,437,337 20,228,454 139,426,933 
2014 Hip 105  1,421  93  383  2,001  2,419,456  38,980,129  2,151,383  10,510,594  54,061,562 
Wrist  801  1,328  108  111  2,347  3,969,494  8,206,505  470,402  566,591  13,212,991 
Vertebral  335  1,059  144  204  1,743  1,358,615  6,885,668  785,909  1,030,592  10,060,783 
Other  2,509  2,743  1,618  961  7,831  20,110,139  29,425,470  10,104,825  9,654,941  69,295,375 
Total  3,750  6,550  1,963  1,659  13,922  27,857,703  83,497,772  13,512,518  21,762,718  146,630,712 
2015 Hip  107  1,467  95  399  2,068  2,475,672  40,257,314  2,210,320  10,946,962  55,890,268 
Wrist  816  1,366  109  115  2,407  4,047,428  8,444,157  477,497  586,773  13,555,855 
Vertebral  343  1,091  146  212  1,791  1,388,474  7,090,029  792,596  1,068,728  10,339,827 
Other  2,558  2,822  1,643  995  8,018  20,505,010  30,275,186  10,257,258  9,995,715  71,033,170 
Total  3,824  6,746  1,993  1,720  14,283  28,416,585 86,066,686 13,737,670 22,598,178 150,819,120 
2016 Hip 109  1,514  97  414  2,134  2,519,835  41,538,397  2,245,643  11,378,781  57,682,655 
Wrist  831  1,410  111  119  2,471  4,118,664  8,714,341  485,276  610,086  13,928,367 
Vertebral  349  1,125  148  220  1,842  1,413,492  7,314,308  805,623  1,110,570  10,643,993 
Other  2,603  2,912  1,669  1,035  8,219  20,865,905  31,243,739  10,424,363  10,392,654  72,926,661 
Total  3,892  6,961  2,025  1,788  14,666  28,917,896  88,810,784  13,960,905  23,492,090  155,181,676 
2017 Hip  111  1,563  98  431  2,203  2,559,624  42,886,952  2,276,602  11,842,750  59,565,928 
Wrist  844  1,456  113  124  2,537  4,183,099  8,997,899  491,916  635,071  14,307,984 
Vertebral  354  1,162  150  229  1,895  1,436,018  7,551,409  816,991  1,155,726  10,960,143 
Other  2,644  3,007  1,692  1,077  8,420  21,192,345  32,260,366  10,566,987  10,818,252  74,837,951 
Total  3,953  7,187  2,053  1,861  15,055  29,371,085  91,696,625  14,152,496  24,451,800  159,672,007 
2018 Hip 112  1,632  99  454  2,297  2,581,666  44,789,137  2,293,983  12,469,560  62,134,346 
Wrist  851  1,522  113  131  2,617  4,216,781  9,406,905  495,107  669,525  14,788,318 
Vertebral  358  1,212  151  241  1,962  1,449,216  7,877,677  823,973  1,215,373  11,366,239 
Other  2,665  3,143  1,703  1,135  8,647  21,362,995  33,726,705  10,635,530  11,405,115  77,130,345 
Total  3,985  7,510  2,067  1,961  15,523  29,610,657  95,800,424  14,248,593  25,759,573  165,419,247 
2019 Hip  113  1,696  100  475  2,384  2,609,465  46,534,956  2,315,826  13,041,366  64,501,612 
Wrist  860  1,581  115  137  2,692  4,262,953  9,768,714  500,058  699,690  15,231,414 
Vertebral  361  1,260  153  252  2,026  1,464,488  8,189,678  831,377  1,272,251  11,757,794 
Other  2,694  3,264  1,720  1,187  8,865  21,596,909  35,023,943  10,741,883  11,918,987  79,281,722 
Total  4,029  7,801  2,087  2,050  15,967  29,933,815  99,517,291  14,389,143  26,932,293  170,772,543 
2020 Hip 114  1,757  101  494  2,467  2,643,645  48,212,574  2,343,912  13,574,775  66,774,906 
Wrist  871  1,637  116  142  2,767  4,319,565  10,118,337  506,382  727,947  15,672,231 
Vertebral  366  1,305  155  262  2,089  1,483,413  8,486,799  841,202  1,324,842  12,136,255 
Other  2,730  3,381  1,742  1,235  9,088  21,883,711  36,277,474  10,877,738  12,400,351  81,439,273 
Total  4,082  8,081  2,114  2,133  16,410  30,330,334  103,095,184  14,569,234  28,027,914  176,022,666 
2021 Hip  116  1,821  102  514  2,554  2,677,076  49,972,499  2,373,004  14,123,154  69,145,733 
Wrist  882  1,697  118  148  2,845  4,374,018  10,488,184  512,679  757,327  16,132,208 
Vertebral  371  1,353  157  273  2,153  1,502,251  8,796,006  851,688  1,378,348  12,528,293 
Other  2,764  3,505  1,764  1,284  9,317  22,159,584  37,603,487  11,012,996  12,900,841  83,676,906 
Total  4,134  8,376  2,140  2,220  16,869  30,712,929  106,860,176  14,750,366  29,159,670  181,483,140 
2022 Hip  118  1,885  104  534  2,641  2,718,288  51,737,385  2,407,768  14,663,688  71,527,130 
Wrist  896  1,757  119  154  2,926  4,442,303  10,857,442  520,417  786,139  16,606,301 
Vertebral  376  1,401  159  283  2,220  1,525,030  9,107,710  863,868  1,431,418  12,928,027 
Other  2,808  3,628  1,790  1,333  9,559  22,505,521  38,927,406  11,179,222  13,391,654  86,003,803 
Total  4,198  8,671  2,172  2,304  17,346  31,191,142 110,629,944 14,971,275 30,272,899 187,065,261
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Discussion
This report demonstrates that the economic costs associated 
with osteoporosis and osteopenia among Australians aged 50 
years and over, is significant, has previously been underestimated 
and is likely to represent an increasing burden due to the 
high prevalence of osteoporosis in our ageing population. 
The total cost associated with osteoporosis, osteopenia and 
the consequent fractures in 2012 was estimated to be $AUD 
2.75 billion. Although there is no previous Australian burden of 
illness study using similar methodology, the direct health costs 
of osteoporosis in 2000-2001 was estimated to be $1.9 billion.37 
This earlier report was only able to estimate the burden of 
hospitalised fractures irrespective of bone density and included 
all adults aged 20 years and over. By comparison the current 
report, in line with other international cost of osteoporosis, 
targets adults from 50 years and older studies.5, 34, 63-66 Using 
Australian epidemiologic and cost data, the current analysis 
confines the burden of osteoporosis to adults with low bone 
density and has included direct and indirect costs from both 
hospitalised and non-hospitalised fractures. The estimates appear 
consistent with other similar population profiles. A recent burden  
of illness of osteoporosis in Canada estimates the total cost  
at $2.3 billion or 1.3% of Canada’s health care expenditures.65  
In Sweden fractures account for 1 to 2% of the total health care 
costs and the annual burden of osteoporosis is estimated at  
€0.5 billion.40, 41 In 2005 the burden of osteoporosis in the USA 
was estimated at $US17 billion with more than 2 million incident 
fractures in adults aged 50 years and older.63
As other studies have found, the large burden of disease 
attributable to osteoporosis is predominantly due to associated 
fractures. This study found that the burden from fractures 
represented 64% of the total direct costs. This is without 
accounting for the impact on disability and quality of life. The 
flow on effects from fractures include mortality, nursing home 
residential care, impact on households through lost productivity 
and informal care requirements, and the ongoing need for 
community services. This study has attempted to capture all 
these downstream use of resources (health sector and broader 
community services). Whilst the unit costs of treating fractures  
in hospital and subacute care are likely to be high relative to 
similar fractures from other causes, due to age, frailty and  
co-morbidities, the total burden of osteoporosis is likely driven 
by the large population prevalence of osteoporosis and 
osteopenia. This was emphasised when the number of hip 
fractures was assumed to change by 25% in the sensitivity 
analyses, this change impacted total costs by 7% (and by 10% 
when considering just the cost of all fractures). Whilst this is 
not insignificant, the increasing burden of osteoporosis and 
osteopenia will not just be related to fractures. 
The community costs of managing osteoporosis and osteopenia 
(without including the costs of fractures) were $829 million 
(34% of direct total costs). This was slightly higher than the 
burden attributable to hip fractures. By 2022 the community 
costs of managing osteoporosis and osteopenia are predicted 
to increase by 33% to 1.25 billion, 35% of the total direct cost. 
This is even with our conservative assumptions concerning the 
use of anti-osteoporosis pharmaceuticals, medical practitioner 
visits, DXA and vitamin D tests. If current trends in osteoporosis 
and osteopenia continue, the total expenditure will be driven by a 
population effect rather than the effect of any single unit cost or 
service. This adds support for funding directed towards lifestyle 
changes to promote bone health among young Australians so 
that the prevalence of osteopenia in those aged 50 years and 
over, is reduced compared with the prevalence in 2012.
Cost of Management of Osteoporosis 
and Osteopenia
Approximately $830 million or 30% of this relates to the cost of 
management and prevention of further bone loss in Australians 
with either osteoporosis or osteopenia. This cost of management 
of osteoporosis is almost two-fold higher in the age group 
50 to 69 years compared to those aged 70 years and older 
($621 million vs $390 million, respectively), largely driven by 
high number of osteopenic adults in the younger age group 
(2.6 million). This cost is equally distributed between women 
and men aged 50 to 69 years. Similarly there are an equal 
number of women and men with osteopenia in those aged over 
70 years, totalling another one million adults. Despite this the 
cost of osteoporosis management is 36% higher for women 
than men in the 70+ year old group driven by increased longevity 
and a four-fold higher number of older women with osteoporosis 
compared with men. 
The costs contributing to the management of osteoporosis and 
osteopenia were derived from the PBS reported number of 
prescriptions for anti-osteoporosis pharmaceuticals, 2.4 GP visits 
to prescribe these therapies, a standard blood test to assess 
serum calcium and renal function, once-a-year blood test for 
vitamin D status, a DXA scan once every three years and calcium 
and vitamin D supplements in 39% of the population with 
osteoporosis and osteopenia. 
Costs Related to Fracture Treatment  
and Subsequent Care
In 2012 the annual cost of all treatment and consequences  
of fracture in the 4.7 million Australians aged 50 years and  
over with osteoporosis and osteopenia comprised 64% or  
$2.05 billion of the total cost of the disorder. Eighty percent 
of this or $1.6 billion, were direct costs of health care and 
community services utilised as a consequence of the fracture 
event. As expected hip fracture was the most costly fracture 
type. This was true both on an average ‘per fracture’ basis 
($27,500) and as the total proportional cost burden of all 
fractures accounting for 42% of the direct cost of fractures but 
representing only 16% of all osteoporotic fractures. In the USA 
hip fractures have been estimated to account for 72% of total 
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hospital costs and represent only 14% of all fractures63 while in 
Canada hip fractures account for 53% of acute care costs and 
represent 50% of hospitalisations attributable to osteoporotic 
fractures.65 In Australia hip fracture cases had the longest LOS  
in an acute hospital setting (50 to 69 year olds and 70+ year 
old, respectively: mean LOS in days, Hip: 7 and 11.5 days; 
Wrist: 1.6 and 2.4 days; Vertebral: 0 and 5.4 days; ‘Other’ sites: 
4.5 and 11.1 days). Mean health care costs were approximately 
five-fold higher than wrist or vertebral fractures and three-fold 
higher than the mean cost of fractures grouped as ‘other’ sites. 
Hip fractures cost $23,000 and $27,000 in those aged 50 to  
69 years and 70 years and over, respectively. In Canada, the 
mean LOS for hip fracture was 14.5 days although the median 
LOS was 7 days63 similar to Australian data.
Fractures at Sites other than Hip,  
Wrist and Vertebrae
Although hip (43%), wrist (7%) and vertebral fractures (10%) 
together account for 60% of the direct costs of fracture 
treatment, the economic burden of osteoporosis would be 
significantly underestimated by not including the 40% direct 
costs used in the treatment and management of fractures  
at other sites. Grouped together ‘other’ fractures represent 
51% of all fractures. In USA, Tarride and colleagues report 
these ‘other’ fractures accounted for almost 20% of direct 
costs65 and represent 40% of all fractures.63
Our results indicate that osteoporosis was responsible for  
almost 90,000 hospitalisations (acute inpatient) in 2012 at  
a cost of almost $1.14 billion. This is equivalent to a rate of  
12.6 hospitalisations per 1,000 Australians adults aged over  
50 years or 18.9 hospitalisations per 1,000 older Australians 
with low bone density (osteoporosis or osteopenia). The previous 
Australian estimate was 4.48 per 1,000 adults aged over  
20 years.37 The mean cost of each acute inpatient episode  
was $12,700.
Irrespective of fracture site, the mean LOS was approximately 
double that in the older age group (70+ year group: mean LOS  
in days, 11.5 hip; 2.4 wrist; 5 vertebral and 11 days for fractures 
at ‘other’ sites). 
Projections 2013 to 2022
The projection analysis shows that the total annual direct and 
indirect costs for osteoporosis, osteopenia and associated 
fractures will steadily escalate from $2.9 billion in 2012 to an 
estimated $3.8 billion in 2022. One of the most notable aspects 
for the projections analysis is the significant saving on averted 
fractures and associated costs attributable to osteoporosis 
medication. Using conservative assumptions regarding the use 
of osteoporosis pharmaceuticals, it is projected that over the 
ten year period, over 150,000 fractures could be averted with 
a predicted annual saving ranging from $140 million in 2013 
to $187 million in 2022. Obviously the predicted total saving 
of $1.6 billion over this period could be significantly increased 
by improvements in any of the contributing factors such as 
drug efficacy in reducing fracture rates, medication uptake and 
persistence rates. Landfeldt and colleagues have estimated 
that the estimated additional fracture-related costs associated 
with poor persistence were larger than the current total annual 
expenditure on all osteoporosis medications in Sweden.67 Our 
analysis demonstrates the proportion of total fracture numbers 
occurring in older adults with osteopenia is 12% higher than in 
adults with osteoporosis (2012: 74,353 vs 66,469). As was the case 
in 2012, the predictions analysis demonstrates the largest absolute 
increase will be in the number of women and men with osteopenia 
aged 50 to 69 years. Our assumptions on osteoporosis medications 
have conservatively assumed that adults with osteopenia but without 
fracture would not be commenced on osteoporosis medication. 
In Australia the projected burden of fractures and costs is 
estimated to increase in the next ten-year period to 2022, by  
27% and 31% respectively. This is proportionally more than the 
projected burden of annual fractures and costs in the USA which  
has been estimated for a 20-year period (2005 to 2025)  
to grow by approximately 50%.63 Men currently account for  
29% fractures and about 27% costs in both Australia and  
the USA. In Australia this proportion will increase slightly to  
be 30% of fractures and 29% of associated costs.
Strengths of the Analysis
The strengths of the study include: 
1 The prevalence of osteoporosis and osteopenia has been  
taken from an Australian study that measured BMD in a 
representative age-stratified sample of the population6  
rather than self-reported prevalence from the AHS; 
2 The derivation of unit costs was taken from accredited 
Commonwealth and state government reimbursement fees  
such as Medicare Scheduled fee and PBS; 
3 The costing for hospital utilisation was derived from a ‘bottom-up’ 
approach using patient level data rather than using DRG costing; 
4 Health and community care service utilisation were derived  
from a prospective observational study that is currently 
collecting this data from adults with incident fracture in  
five states across Australia (AusICUROS); 
5 The burden of fractures is not restricted to hip fractures or 
hospitalised fracture cases but includes all fractures other 
than fingers, toes, facial and skull. Furthermore, the estimate 
is conservative since low trauma fractures occurring in adults 
with BMD in the normal range (T-score above -1) have not been 
included. The burden attributable to hip fractures has been 
reduced by incorporating recent reports of a 15% decline in 
hip fracture rate (not numbers).5 A decrease in hip fracture rate 
has been reported in other Australian11, 19, 20, 68 and international 
studies.69, 70 It has been proposed that recent increases in 
adiposity and consequent increase in hip BMD may have 
contributed to this decline.20
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Limitations of the Study
Important limitations of the study include the data sources used 
in the model regarding: 
1 Both prevalence of osteoporosis and osteopenia, and fracture 
incidence are taken from one large region located in south 
eastern Victoria; 
2 We have assumed the age and gender-specific distribution  
of fracture sites is not different in the group of adults with  
low bone density compared with all adults irrespective of 
bone density; 
3 Although hip fracture rates appear to have declined over the 
past ten to twenty years, there is no published Australian 
data to identify change in fractures occurring at other sites. 
While some data suggest the decline is restricted to hip 
fracture incidence there are few if any recent international 
studies published using reliable data for incidence of non-hip 
fractures27, 69 while recent Canadian data suggest declines in 
other major osteoporotic fracture sites;70 
4 It is likely that there are differences in fracture rates among 
Indigenous Australians consistent with racial differences 
identified in the USA between Black Americans, Hispanic  
and Caucasian Americans,71 however there is no reliable 
published Australian data available to incorporate such 
differences into the analysis. The Australian Indigenous 
population accounts for less than 1.2% of Australian adults 
aged 50 years and over;72 
5 Mortality within the first 12 months following fracture has 
been extrapolated from the AusICUROS data. This may 
represent an underestimate as some fracture participants 
‘lost to follow-up’ may have died; 
6 The burden of ‘other’ fractures grouped could be overestimated 
since AusICUROS recruitment was through a combination of 
emergency department and inpatient wards. Fractures of a less 
serious nature may have been managed without visiting an 
emergency department; 
7 The projection results were dependent on ABS population 
projections in conjunction with projected changes in 
prescription rates for anti-osteoporotic therapy. Furthermore 
the anticipated anti-fracture efficacy of this therapy is 
highly dependent on several important variables including 
medication compliance. We have used well cited published 
data to support our assumptions but recognise the highly 
variable nature of this aspect of the report. Sensitivity 
analyses have not been done to assess the impact of 
significant deviations in our assumptions, other than by 
varying the total number of hip fractures. A report of the 
burden of osteoporosis in USA by Burge and colleagues 
has reported that changes in all non-hip fracture rates of 
±25% results in 21% change in total fracture rates but only 
±7% differences in cost.63 This is similar to our results when 
varying the number of hip fractures by ±25%.
Conclusion
The projected increase in the number of older Australians will 
translate to an increased population at significant risk of falls and 
fracture. This new information on the current and future costs 
of osteoporosis in Australia will aid clinicians, government policy 
makers, researchers and health care organisations and funding 
bodies to assess the economic importance of osteoporosis in 
reducing both osteoporosis-related fractures and associated 
costs, promoting bone health and to identify further resource 
needs. The high population-at-risk in the age group 50 to 
69 years translates to a significant burden of fractures and 
associated costs in this age group. Although hip, wrist and 
vertebral fractures and the associated costs account for the most 
significant burden of osteoporosis and osteopenia, fractures at 
other sites account for 40% of all fractures and should not be 
ignored in future planning of resource needs and implementation 
of osteoporosis prevention and treatment modalities. It is not  
only a disease affecting women, men account for 25 to 30%  
of all fractures related to osteoporosis and osteopenia, and their 
associated costs. 
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Appendix
Appendix A: Utilisation Rates for Service use Following Fractures, by Fracture Type, Age and Gender
Post Fracture Utilisation Rates
50-69 years 70+ years
Men Women Men Women
Hospitalisation (AusICUROS) Hip 1.00 1.00 1.00 1.00
Wrist 0.39 0.45 0.50 0.63
Vertebral 0.50 0.33 0.50 0.67
Other 0.43 0.58 0.67 0.72
Ambulance Paramedic (AusICUROS) Hip 1.00 0.90 1.00 0.93
Wrist 0.13 0.14 0.36 0.31
Vertebral 0.58 0.67 0.40 0.53
Other 0.38 0.32 0.75 0.53
ED Presentation (not admitted) (AusICUROS) Hip 0.00 0.00 0.00 0.00
Wrist 0.53 0.53 0.48 0.35
Vertebral 0.48 0.58 0.48 0.31
Other 0.55 0.40 0.31 0.26
Hospital Outpatient Fracture Clinic (AusICUROS) Hip 0.61 0.61 0.61 0.61
Wrist 0.35 0.35 0.35 0.35
Vertebral 0.41 0.41 0.41 0.41
Other 0.39 0.39 0.39 0.39
Non-admitted Fracture Management (GP, X-ray) (AusICUROS) Hip 0.00 0.00 0.00 0.00
Wrist 0.08 0.03 0.02 0.02
Vertebral 0.02 0.09 0.02 0.02
Other 0.02 0.02 0.02 0.02
Orthopaedic Specialist (AusICUROS) Hip 0.37 0.37 0.37 0.37
Wrist 0.30 0.30 0.30 0.30
Vertebral 0.28 0.28 0.28 0.28
Other 0.30 0.30 0.30 0.30
Community Physiotherapy (AusICUROS) Hip 0.65 0.65 0.65 0.65
Wrist 0.58 0.58 0.58 0.58
Vertebral 0.46 0.46 0.46 0.46
Other 0.66 0.66 0.66 0.66
Rehabilitation/Subacute Care (AusICUROS) Hip 0.39 0.39 0.32 0.32
Non-hip 0.18 0.18 0.14 0.14
Residential Aged Care Hip (AIHW) 0.00 0.00 0.11 0.11
Non-hip (AusICUROS) 0.00 0.00 0.01 0.01
Community-based Services (AusICUROS) Home help Hip 0.00 0.08 0.27 0.33
Wrist 0.00 0.02 0.06 0.14
Vertebral 0.00 0.17 0.05 0.43
Other 0.02 0.13 0.17 0.28
Meals on wheels Hip 0.00 0.00 0.03 0.06
Wrist 0.00 0.00 0.00 0.01
Vertebral 0.00 0.00 0.05 0.10
Other 0.00 0.00 0.13 0.05
Informal community care Hip 0.02 0.05 0.08 0.28
Wrist 0.02 0.05 0.00 0.11
Vertebral 0.13 0.13 0.10 0.27
Other 0.17 0.17 0.33 0.22
Mortality (post fracture) (AusICUROS) Hip 0.01 0.01 0.08 0.08
Non-hip 0.01 0.01 0.05 0.05
(Note that 1 assumes 100%)
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Appendix B: Unit Costs, Source and Assumptions for Each Component of the Model
Parameter 
Unit Cost 
(2012 AUD) Units Assumptions re use Data Source
Ambulance $688.50
per 
transport
Same average cost for both metropolitan and 
rural/remote regions Ambulance Victoria Annual Report 2011-2012 47
Emergency 
Department (Non-
admitted) Wrist 
fractures $251.00 per visit ED non admitted Triage 5 Injury Source: 48
ED (Non-admitted) 
Non-wrist, non-hip 
fractures $361.00 per visit ED non admitted Triage 4 Injury Source: 48
Fracture or 
Orthopaedic Hospital 
Outpatient Clinic $190.88 per visit
3 visits post-fracture, all age groups, for admitted 
patients or non-admitted with ED visit, if attended 
hospital clinic then no community physiotherapy Source: 48
General Practitioner $35.60 per visit
2.4 visits per year for osteoporosis/osteopenia 
management 
3 visits post fracture if no hospital attendance
MBS Online 2012 Item 23;51 
Average number of visits for osteoporosis AusICUROS; 
Expert opinion for fracture management
Medical specialist $83.95 per visit
2.5 visits post fracture to medical specialist if 
seen in ED but no OPD, fracture population only
MBS Online 2012 Item 104; 51 Recommended 
Schedule fee 
Average number of visits from AusICUROS
Routine pathology 
test $13.65
per group 
of 3 tests
Based on 3 tests for renal function (urea and 
creatinine) and serum calcium; 2 groups of  
3 tests/year per person
MBS Online 2012 Item 66506; 51  
Expert opinion
Serum Vitamin D 
Test $39.05 per Test
Based on full blood examination; assume 1 every 
two years for everyone (fracture and non-fracture 
population)
MBS Online 2012 Item 66608; 51  
Expert opinion
Diagnostic Imaging 
for community 
managed fractures:
Hip $47.15 per X-ray Where no ED or admission, 1 X-ray
MBS Online 2012 Item 57712,  
Diagnostic imaging with referral
Hand, wrist, forearm, 
elbow, humerus $29.75 per X-ray Where no ED or admission, 1 X-ray
MBS Online 2012 Item 57506,  
Diagnostic imaging no referral
Spine (4 regions) $110.00 per X-ray Where no ED or admission, 1 X-ray
MBS Online 2012 Item 58108,  
Diagnostic imaging with referral
Foot, ankle, knee  
or femur $32.50 per X-ray Where no ED or admission, 1 X-ray
MBS Online 2012 Item 57518,  
Diagnostic imaging no referral 51
Physiotherapist 
(community) $62.25
per 
session
9 sessions for hip fractures, wrist (5), vertebral 
(4) other (6) if no Outpatient Fracture Clinic
MBS Item No. 10960, number of sessions from 
AusICUROS
Rehabilitation costs $12,375
per 
episode Mean episode cost all fractures; both age groups Barwon cost data (N=30; SD=$8557)
Residential aged 
care $162.94 per day
Annual cost of Nursing Home was $42872 for low 
care in 2010, inflated to 2012 prices, assumed 
LOS 6 mths
Cost; 50  
Admission rate and length of stay, AusICUROS
Home help $25 per hour Casual hourly rate for home help Level 3 Source: 57
Home care  
(informal care) $25 per hour Cost assumed as for PCA/Home help Source: 57
Meals on wheels $16.50 per day Casual 
Geelong City Council communication for  
daily cost
Wage rate (adult 
population) $151.24 per day
Average fulltime adult wage rate (seasonally 
adjusted), May 2012 (7-day week) Source: 58
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Appendix C1: Unit Costs, Source and Assumptions for Pharmaceuticals/Supplements  
used for Osteoporosis/Osteopenia, 2012
Table C1.1: Pharmaceuticals fracture management
Pharmaceuticals – 
Fracture Management
Unit Cost 2012$
Assumptions re Use Data SourceCost (as needed) Cost (routine)
- Hip 8.77 80.79 Drugs taken as needed were costed for 14 days. 
Drugs taken on a routine basis were costed over 122 
days (4 months)
Pharmaceutical online 
website (price)- Wrist 14.37 38.27
- Vertebral 13.78 43.41
- Other 9.71 54.45
Table C1.2: Supplements (calcium and vitamin D) for osteoporosis prevention 
Osteoporosis Prevention 
Supplements
Population Rate 
of Use
Cost 12 months 
(2012$)
Assumptions re Use Data SourceWomen Men Women Men
All Fractures 0.39 0.39 191.73 191.73
Osteoporosis supplements (Calcium and Vitamin D) 
were costed over 12 months
Pharmaceutical online 
website (price)
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Appendix C2: List of Osteoporosis (bone-active) Pharmaceuticals used for Osteoporosis/ 
Osteopenia, 2012
Medication Group Name, form and strength Frequency PBS Item Code (2012)
Unit (Script) 
Price ($2012)
Alendronate Alendronate tablet 70mg Weekly 8511Y 27.62
Alendronate with Cholecalciferol
Alendronate 70mg + Cholecalciferol 70 micrograms, tablet Weekly 9012H 45.26
Alendronate 70mg + Cholecalciferol 140 micrograms, tablet Weekly 9183H 45.26
Alendronate with Cholecalciferol and Calcium Carbonate 
Alendronate 70mg + Cholecalciferol 140 micrograms tablet 
and Calcium Carbonate (500mg Ca) tablet Weekly (alendronate) 9351E 45.26
Denosumab Denosumab, injection 60mg/ml 6 Monthly 5457F 304.97
Etidronate* Disodium Etidronate, tablet 200mg Daily 2920Q 115.27
Disodium Etidronate, tablet 200mg and Calcium Carbonate 
sachets 1.25g (500mg Ca) Daily (etidronate) 8056B 70.79
Raloxifene Raloxifene 60mg Daily 8363E 57.97
Risedronate Risedronate Sodium, tablet 5mg Daily 4443W, 8481J 46.65
Risedronate Sodium, tablet 35mg Weekly 4444X, 8621R, 8972F 46.65
Risedronate Sodium, tablet 150mg Monthly 9391G 49.63
Risedronate Sodium and Calcium Carbonate
Risedronate Sodium, tablet 35mg and Calcium Carbonate, 
tablet 1.25g (500mg Ca) Weekly (risedronate) 8899J, 8973G 46.65
Risedronate Sodium and Calcium Carbonate with Cholecalciferol
Risedronate Sodium, tablet 35mg and Calcium Carbonate 
with Cholecalciferol, sachets 2.5g (1g calcium) with 
Cholecalciferol 22 micrograms Weekly (risedronate) 4380M, 8974H, 9147K 46.65
Strontium Ranelate Strontium, sachets 2g granules Weekly 3036T 53.44
Teriparatide Teriparatide, injection 20 microgram Daily 9411H 488.47
Zoledronic Acid Zoledronic acid, injection 5mg/100ml Once a year 9288W 589.27
* Etidronate was available on the PBS in 2012 but has been removed from the PBS in 2013.
Appendix C2.1: More on Osteoporosis (bone active) Pharmaceuticals
Bone remodelling cycle:
Bone is a living tissue that forms new bone while replacing older bone. Bone is continually renewed and changed through 
a process called remodelling, which consist of bone resorption (break down or removal) and bone formation. Usually, the 
two processes of bone remodelling are balanced. Imbalance results into bone loss, eventually leading to osteoporosis and 
osteoporotic fractures.
Types of osteoporosis medications
1 Antiresorptive medication that slow bone loss;
2 Non-antiresorptive medications include drugs that increase the rate of bone formation (anabolic drugs) and drugs with  
both formation and resorption. 
Antiresorptive medications
These include bisphosphonates, calcitonin, denosumab and estrogen type medications. These slow down the loss of bone  
during the breakdown part of bone remodelling, hence important in reducing fracture risk.
Non-resorptive medications
Teriparatide is an anabolic drug that increases the rate of bone formation, while Strontium Ranelate effects on both bone 
formation and resorption.
Source, National Institutes of Health.73
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Appendix D: Clinical Pathway for Hip Fracture: Men, Aged 50-69 Years, with Osteoporosis
Private Orthopaedic 
Specialist
N=90
(37%)
Hospital Outpatient 
Department
N=148
(61%)
No OPD or 
Medical Specialist
N=5
(2%)
Private Orthopaedic 
Specialist
N=58
(37%)
No OPD or 
Medical Specialist
N=99
(63%)
Men
Hip fracture
Osteoporosis
Age: 50-69 years
N=404
(from Figure 2b)
Community 
Physiotherapist
N=58
(65%)
No 
Physiotherapy 
N=31
(35%)
Community 
Physiotherapist
N=3
(65%)
No 
Physiotherapy
N=2
(35%)
Community 
Physiotherapist
N=38
(65%)
No 
Physiotherapy
N=20
(35%)
Community 
Physiotherapist
N=64
(65%)
No 
Physiotherapy
N=35
(35%)
Ambulance
N=404
(100%)
No Ambulance
N=0
(0%)
Discharge Home
N=242
(60%)
Rehabilitation
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Appendices F: Annual Cost (Direct and Indirect) Breakdown for New Fractures  
and Re-fractures, by Fracture Type, Gender and Age Group, 2013-2022
2013 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 36,680,112  470,014,934  29,117,357  173,318,945  709,131,348 
- Re-fractures  1,791,926  36,384,204  2,483,603  12,743,902  53,403,635 
Total Direct Costs  38,472,038  506,399,138  31,600,960  186,062,848  762,534,983 39%
Indirect costs: - New Fractures 3,694,465  39,512,073  3,067,497  15,911,043  62,185,079 
- Re-fractures  180,485  3,058,659  261,646  1,169,917  4,670,707 
Total Indirect Costs  3,874,950  42,570,732  3,329,144  17,080,960  66,855,786 3%
Total cost: - New Fractures 40,374,577  509,527,008  32,184,854  189,229,988  771,316,428 
- Re-fractures  1,972,411  39,442,863  2,745,249  13,913,819  58,074,342 
Total Hip Fracture Cost  42,346,989  548,969,870  34,930,103  203,143,807  829,390,770 42%
Wrist 
Direct costs: - New Fractures 43,026,014  61,650,649  4,786,778  5,536,503  114,999,943 
- Re-fractures  1,677,569  4,045,729  324,080  341,600  6,388,977 
Total Direct Costs  44,703,582  65,696,378  5,110,857  5,878,103  121,388,920 6%
Indirect costs: - New Fractures 3,058,173  4,610,615  355,568  452,241  8,476,597 
- Re-fractures  119,237  302,565  24,073  27,903  473,778 
Total Indirect Costs  3,177,410  4,913,180  379,641  480,144  8,950,375 0.5%
Total cost: - New Fractures 46,084,187  66,261,265  5,142,346  5,988,743  123,476,540 
- Re-fractures  1,796,806  4,348,293  348,153  369,503  6,862,755 
Total Wrist Fracture Cost  47,880,992  70,609,558  5,490,499  6,358,247  130,339,295 7%
Vertebral
Direct costs: - New Fractures 36,410,320  118,791,890  15,930,654  19,718,341  190,851,205 
- Re-fractures  1,973,619  10,621,183  1,509,039  1,701,982  15,805,824 
Total Direct Costs  38,383,939  129,413,073  17,439,693  21,420,323  206,657,029 10%
Indirect costs: - New Fractures  3,013,958  11,282,086  1,589,327  2,277,893  18,163,263 
- Re-fractures  163,371  1,008,731  150,550  196,616  1,519,268 
Total Indirect Costs  3,177,329  12,290,817  1,739,876  2,474,508  19,682,531 1%
Total cost: - New Fractures  39,424,277  130,073,976  17,519,981  21,996,234  209,014,469 
- Re-fractures  2,136,991  11,629,914  1,659,589  1,898,598  17,325,092 
Total Vertebral Fracture Cost  41,561,268  141,703,891  19,179,570  23,894,832  226,339,560 11%
Other Fracture
Direct costs: - New Fractures 229,413,685  221,301,816  115,537,747  114,313,329  680,566,577 
- Re-fractures  8,930,138  14,587,145  7,818,334  7,163,437  38,499,055 
Total Direct Costs  238,343,824  235,888,961  123,356,081  121,476,766  719,065,632 36%
Indirect costs: - New Fractures  18,820,509  28,838,589  8,963,629  13,526,549  70,149,277 
- Re-fractures  732,606  1,900,900  606,561  847,640  4,087,707 
Total Indirect Costs  19,553,115  30,739,490  9,570,190  14,374,190  74,236,984 4%
Total cost: - New Fractures  248,234,195  250,140,405  124,501,376  127,839,878  750,715,854 
- Re-fractures  9,662,744  16,488,045  8,424,895  8,011,077  42,586,761 
Total ‘Other’ Fracture Cost  257,896,939  266,628,450  132,926,271  135,850,956  793,302,616 40%
All Fractures
Direct costs: - New Fractures 345,530,131  871,759,290  165,372,536  312,887,118  1,695,549,074 86%
- Re-fractures  14,373,252  65,638,260  12,135,056  21,950,922  114,097,490 6%
Total Direct Costs  359,903,383  937,397,550  177,507,592  334,838,040  1,809,646,565 91%
Indirect costs: - New Fractures  28,587,105  84,243,364  13,976,021  32,167,726  158,974,217 8%
- Re-fractures  1,195,699  6,270,855  1,042,830  2,242,076  10,751,460 1%
Total Indirect Costs  29,782,804  90,514,219  15,018,851  34,409,801  169,725,676 9%
Total cost: - New Fractures  374,117,236  956,002,654  179,348,557  345,054,844  1,854,523,291 94%
- Re-fractures  15,568,951  71,909,115  13,177,886  24,192,998  124,848,950 6%
TOTAL COST – ALL FRACTURES  389,686,188  1,027,911,769  192,526,443  369,247,841  1,979,372,241 100%
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2014 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures  37,433,375  484,080,834  29,651,469  179,583,351  730,749,028 
- Re-fractures  1,734,360  35,077,959  2,546,015  13,257,986  52,616,320 
Total Direct Costs 39,167,734  519,158,793  32,197,484  192,841,337  783,365,348 39%
Indirect costs: - New Fractures 3,770,335  40,694,531  3,123,766  16,486,129  64,074,760 
- Re-fractures  174,687  2,948,849  268,221  1,217,111  4,608,868 
Total Indirect Costs  3,945,022  43,643,380  3,391,987  17,703,239  68,683,628 3%
Total cost: - New Fractures 41,203,710  524,775,366  32,775,234  196,069,479  794,823,789 
- Re-fractures  1,909,047  38,026,807  2,814,236  14,475,097  57,225,188 
Total Hip Fracture Cost  43,112,756  562,802,173  35,589,471  210,544,577  852,048,976 42%
Wrist 
Direct costs: - New Fractures 43,860,481  63,401,077  4,871,404  5,731,803  117,864,765 
- Re-fractures  1,710,192  4,147,295  356,612  373,161  6,587,259 
Total Direct Costs  45,570,673  67,548,372  5,228,016  6,104,964  124,452,025 6%
Indirect costs: - New Fractures 3,117,485  4,741,523  361,854  468,193  8,689,056 
- Re-fractures  121,556  310,160  26,490  30,481  488,687 
Total Indirect Costs  3,239,041  5,051,683  388,344  498,674  9,177,742 0.5%
Total cost: - New Fractures 46,977,966  68,142,600  5,233,259  6,199,996  126,553,821 
- Re-fractures  1,831,748  4,457,455  383,101  403,642  7,075,946 
Total Wrist Fracture Cost  48,809,714  72,600,055  5,616,360  6,603,638  133,629,767 7%
Vertebral
Direct costs: - New Fractures 37,178,126  122,433,499  16,228,037  20,439,380  196,279,042 
- Re-fractures  1,845,931  9,881,739  1,475,239  1,724,015  14,926,924 
Total Direct Costs  39,024,056  132,315,238  17,703,276  22,163,395  211,205,966 10%
Indirect costs: - New Fractures  3,077,515  11,627,943  1,618,995  2,361,188  18,685,641 
- Re-fractures  152,802  938,504  147,178  199,161  1,437,644 
Total Indirect Costs  3,230,316  12,566,446  1,766,173  2,560,349  20,123,285 1%
Total cost: - New Fractures 40,255,640  134,061,442  17,847,032  22,800,568  214,964,682 
- Re-fractures  1,998,733  10,820,242  1,622,417  1,923,176  16,364,568 
Total Vertebral Fracture Cost  42,254,373  144,881,684  19,469,449  24,723,744  231,329,250 11%
Other Fracture
Direct costs: - New Fractures  233,863,047  227,585,170  117,580,369  118,345,729  697,374,314 
- Re-fractures  9,103,802  14,835,206  8,603,157  7,659,035  40,201,201 
Total Direct Costs  242,966,849  242,420,376  126,183,526  126,004,764  737,575,515 36%
Indirect costs: - New Fractures  19,185,523  29,657,395  9,122,100  14,003,698  71,968,715 
- Re-fractures  746,853  1,933,226  667,449  906,284  4,253,811 
Total Indirect Costs  19,932,376  31,590,621  9,789,548  14,909,982  76,222,526 4%
Total cost: - New Fractures  253,048,570  257,242,564  126,702,468  132,349,427  769,343,029 
- Re-fractures  9,850,655  16,768,432  9,270,606  8,565,319  44,455,012 
Total ‘Other’ Fracture Cost  262,899,225  274,010,997  135,973,074  140,914,746  813,798,041 40%
All Fractures
Direct costs: - New Fractures  352,335,028  897,500,580  168,331,279  324,100,262  1,742,267,149 86%
- Re-fractures  14,394,285  63,942,199  12,981,023  23,014,198  114,331,704 6%
Total Direct Costs  366,729,314  961,442,779  181,312,301  347,114,460  1,856,598,854 91%
Indirect costs: - New Fractures 29,150,858  86,721,392  14,226,715  33,319,208  163,418,172 8%
- Re-fractures  1,195,897  6,130,739  1,109,337  2,353,037  10,789,009 1%
Total Indirect Costs  30,346,755  92,852,130  15,336,052  35,672,245  174,207,182 9%
Total cost: - New Fractures 381,485,886  984,221,972  182,557,993  357,419,470  1,905,685,322 94%
- Re-fractures  15,590,182  70,072,937  14,090,360  25,367,234  125,120,714 6%
TOTAL COST – ALL FRACTURES  397,076,068 1,054,294,909  196,648,353  382,786,704  2,030,806,035 100%
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2015 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures  38,089,362  499,658,834  30,113,604  186,694,845  754,556,645 
- Re-fractures  1,743,971  35,443,041  2,560,556  13,479,700  53,227,267 
Total Direct Costs  39,833,332  535,101,875  32,674,160  200,174,544  807,783,912 39%
Indirect costs: - New Fractures 3,836,407  42,004,105  3,172,452  17,138,979  66,151,942 
- Re-fractures  175,655  2,979,539  269,753  1,237,465  4,662,412 
Total Indirect Costs  4,012,062  44,983,644  3,442,205  18,376,443  70,814,354 3%
Total cost: - New Fractures 41,925,768  541,662,939  33,286,056  203,833,824  820,708,586 
- Re-fractures  1,919,626  38,422,580  2,830,309  14,717,164  57,889,679 
Total Hip Fracture Cost  43,845,394  580,085,519  36,116,365  218,550,988  878,598,266 42%
Wrist 
Direct costs: - New Fractures 44,625,005  65,443,920  4,947,042  5,958,866  120,974,834 
- Re-fractures  1,736,129  4,239,392  369,123  383,979  6,728,622 
Total Direct Costs  46,361,134  69,683,313  5,316,165  6,342,845  127,703,456 6%
Indirect costs: - New Fractures 3,171,825  4,894,300  367,473  486,741  8,920,338 
- Re-fractures  123,399  317,048  27,419  31,365  499,231 
Total Indirect Costs  3,295,224  5,211,347  394,892  518,105  9,419,569 0.5%
Total cost: - New Fractures 47,796,830  70,338,220  5,314,515  6,445,607  129,895,172 
- Re-fractures  1,859,528  4,556,440  396,542  415,343  7,227,853 
Total Wrist Fracture Cost  49,656,358  74,894,660  5,711,056  6,860,951  137,123,025 7%
Vertebral
Direct costs: - New Fractures  37,831,313  126,371,136  16,481,425  21,248,632  201,932,505 
- Re-fractures  1,854,534  9,974,525  1,485,495  1,751,471  15,066,025 
Total Direct Costs  39,685,847  136,345,660  17,966,920  23,000,103  216,998,530 10%
Indirect costs: - New Fractures 3,131,584  12,001,914  1,644,274  2,454,674  19,232,446 
- Re-fractures  153,514  947,316  148,201  202,333  1,451,363 
Total Indirect Costs  3,285,098  12,949,230  1,792,475  2,657,007  20,683,810 1%
Total cost: - New Fractures  40,962,897  138,373,049  18,125,699  23,703,306  221,164,952 
- Re-fractures  2,008,047  10,921,841  1,633,696  1,953,804  16,517,388 
Total Vertebral Fracture Cost  42,970,944  149,294,890  19,759,395  25,657,110  237,682,339 11%
Other Fracture
Direct costs: - New Fractures  237,939,469  234,918,182  119,406,023  123,033,962  715,297,636 
- Re-fractures  9,241,869  15,152,547  8,904,987  7,865,191  41,164,594 
Total Direct Costs  247,181,338  250,070,729  128,311,010  130,899,154  756,462,230 36%
Indirect costs: - New Fractures 19,519,943  30,612,984  9,263,737  14,558,451  73,955,115 
- Re-fractures  758,179  1,974,580  690,865  930,678  4,354,302 
Total Indirect Costs  20,278,122  32,587,564  9,954,602  15,489,129  78,309,417 4%
Total cost: - New Fractures  257,459,412  265,531,166  128,669,760  137,592,413  789,252,751 
- Re-fractures  10,000,048  17,127,127  9,595,852  8,795,869  45,518,896 
Total ‘Other’ Fracture Cost  267,459,460  282,658,293  138,265,612  146,388,282  834,771,646 40%
All Fractures
Direct costs: - New Fractures  358,485,149  926,392,072  170,948,094  336,936,305  1,792,761,620 86%
- Re-fractures  14,576,501  64,809,505  13,320,160  23,480,341  116,186,508 6%
Total Direct Costs  373,061,650  991,201,577  184,268,254  360,416,646  1,908,948,128 91%
Indirect costs: - New Fractures 29,659,758  89,513,302  14,447,936  34,638,844  168,259,841 8%
- Re-fractures  1,210,747  6,218,483  1,136,238  2,401,840  10,967,308 1%
Total Indirect Costs  30,870,506  95,731,785  15,584,174  37,040,684  179,227,149 9%
Total cost: - New Fractures  388,144,907  1,015,905,374  185,396,030  371,575,149  1,961,021,461 94%
- Re-fractures  15,787,249  71,027,988  14,456,398  25,882,181  127,153,816 6%
TOTAL COST – ALL FRACTURES  403,932,156 1,086,933,362  199,852,428  397,457,330  2,088,175,277 100%
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2016 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 38,683,147  515,933,913  30,521,132  194,335,912  779,474,104 
- Re-fractures  1,781,799  36,818,772  2,599,832  14,167,816  55,368,219 
Total Direct Costs  40,464,947  552,752,685  33,120,964  208,503,727  834,842,323 39%
Indirect costs: - New Fractures  3,896,213  43,372,278  3,215,384  17,840,445  68,324,321 
- Re-fractures  179,465  3,095,191  273,891  1,300,635  4,849,182 
Total Indirect Costs  4,075,678  46,467,470  3,489,275  19,141,080  73,173,503 3%
Total cost: - New Fractures 42,579,361  559,306,191  33,736,516  212,176,356  847,798,425 
- Re-fractures  1,961,264  39,913,963  2,873,723  15,468,451  60,217,402 
Total Hip Fracture Cost  44,540,625  599,220,154  36,610,240  227,644,807  908,015,826 42%
Wrist 
Direct costs: - New Fractures 45,318,377  67,577,545  5,013,797  6,202,916  124,112,635 
- Re-fractures  1,775,196  4,407,508  377,433  404,096  6,964,234 
Total Direct Costs  47,093,574  71,985,053  5,391,230  6,607,012  131,076,869 6%
Indirect costs: - New Fractures 3,221,108  5,053,865  372,431  506,676  9,154,080 
- Re-fractures  126,176  329,621  28,036  33,008  516,841 
Total Indirect Costs  3,347,284  5,383,486  400,468  539,683  9,670,921 0.4%
Total cost: - New Fractures 48,539,485  72,631,410  5,386,228  6,709,591  133,266,715 
- Re-fractures  1,901,373  4,737,129  405,470  437,104  7,481,075 
Total Wrist Fracture Cost  50,440,858  77,368,539  5,791,698  7,146,695  140,747,790 7%
Vertebral
Direct costs: - New Fractures  38,422,016  130,485,549  16,704,783  22,118,013  207,730,361 
- Re-fractures  1,894,935  10,368,229  1,508,885  1,842,577  15,614,626 
Total Direct Costs  40,316,951  140,853,778  18,213,668  23,960,590  223,344,987 10%
Indirect costs: - New Fractures 3,180,481  12,392,674  1,666,558  2,555,107  19,794,820 
- Re-fractures  156,858  984,707  150,534  212,857  1,504,957 
Total Indirect Costs  3,337,339  13,377,382  1,817,092  2,767,964  21,299,777 1%
Total cost: - New Fractures  41,602,497  142,878,224  18,371,341  24,673,120  227,525,181 
- Re-fractures  2,051,794  11,352,936  1,659,420  2,055,434  17,119,583 
Total Vertebral Fracture Cost  43,654,291  154,231,160  20,030,760  26,728,554  244,644,764 11%
Other Fracture
Direct costs: - New Fractures  241,636,514  242,577,064  121,017,271  128,072,901  733,303,750 
- Re-fractures  9,449,837  15,752,000  9,105,476  8,275,092  42,582,405 
Total Direct Costs  251,086,351  258,329,063  130,122,748  136,347,993  775,886,155 36%
Indirect costs: - New Fractures 19,823,239  31,611,039  9,388,741  15,154,702  75,977,720 
- Re-fractures  775,240  2,052,696  706,419  979,181  4,513,537 
Total Indirect Costs  20,598,479  33,663,736  10,095,160  16,133,883  80,491,257 4%
Total cost: - New Fractures 261,459,752  274,188,103  130,406,012  143,227,603  809,281,470 
- Re-fractures  10,225,077  17,804,696  9,811,896  9,254,273  47,095,942 
Total ‘Other’ Fracture Cost  271,684,830  291,992,799  140,217,908  152,481,876  856,377,412 40%
All Fractures
Direct costs: - New Fractures 364,060,054  956,574,071  173,256,983  350,729,742  1,844,620,850 86%
- Re-fractures  14,901,768  67,346,509  13,591,627  24,689,580  120,529,484 6%
Total Direct Costs  378,961,822  1,023,920,579  186,848,610  375,419,322  1,965,150,334 91%
Indirect costs: - New Fractures  30,121,041  92,429,857  14,643,114  36,056,928  173,250,941 8%
- Re-fractures  1,237,740  6,462,215  1,158,881  2,525,681  11,384,518 1%
Total Indirect Costs  31,358,781  98,892,072  15,801,995  38,582,610  184,635,458 9%
Total cost: - New Fractures 394,181,095  1,049,003,928  187,900,097  386,786,670  2,017,871,791 94%
- Re-fractures  16,139,508  73,808,724  14,750,508  27,215,261  131,914,002 6%
TOTAL COST – ALL FRACTURES  410,320,603  1,122,812,652  202,650,605  414,001,932  2,149,785,792 100%
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2017 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 38,986,762  539,767,381  30,723,972  204,893,489  814,371,603 
- Re-fractures  1,809,218  38,013,328  2,632,316  14,744,365  57,199,227 
Total Direct Costs  40,795,980  577,780,709  33,356,287  219,637,854  871,570,831 39%
Indirect costs: - New Fractures 3,926,794  45,375,853  3,236,753  18,809,652  71,349,052 
- Re-fractures  182,227  3,195,612  277,313  1,353,564  5,008,715 
Total Indirect Costs  4,109,021  48,571,465  3,514,066  20,163,216  76,357,768 3%
Total cost: - New Fractures 42,913,556  585,143,234  33,960,725  223,703,141  885,720,655 
- Re-fractures  1,991,445  41,208,940  2,909,629  16,097,929  62,207,943 
Total Hip Fracture Cost  44,905,001  626,352,174  36,870,354  239,801,070  947,928,598 43%
Wrist 
Direct costs: - New Fractures 45,665,323  70,732,903  5,046,496  6,541,459  127,986,181 
- Re-fractures  1,802,936  4,550,723  382,913  420,589  7,157,161 
Total Direct Costs  47,468,258  75,283,627  5,429,408  6,962,048  135,143,341 6%
Indirect costs: - New Fractures 3,245,768  5,289,842  374,860  534,329  9,444,800 
- Re-fractures  128,148  340,331  28,443  34,355  531,277 
Total Indirect Costs  3,373,916  5,630,173  403,304  568,684  9,976,077 0.4%
Total cost: - New Fractures 48,911,091  76,022,745  5,421,356  7,075,788  137,430,980 
- Re-fractures  1,931,084  4,891,055  411,356  454,944  7,688,438 
Total Wrist Fracture Cost  50,842,174  80,913,800  5,832,712  7,530,732  145,119,418 7%
Vertebral
Direct costs: - New Fractures 38,727,158  136,482,515  16,816,810  23,316,898  215,343,382 
- Re-fractures  1,923,954  10,704,746  1,527,664  1,917,604  16,073,968 
Total Direct Costs  40,651,112  147,187,261  18,344,474  25,234,502  231,417,349 10%
Indirect costs: - New Fractures  3,205,740  12,962,227  1,677,734  2,693,604  20,539,305 
- Re-fractures  159,260  1,016,668  152,408  221,525  1,549,860 
Total Indirect Costs  3,365,000  13,978,895  1,830,142  2,915,128  22,089,165 1%
Total cost: - New Fractures 41,932,898  149,444,742  18,494,544  26,010,502  235,882,687 
- Re-fractures  2,083,214  11,721,414  1,680,072  2,139,128  17,623,828 
Total Vertebral Fracture Cost  44,016,112  161,166,156  20,174,616  28,149,630  253,506,515 11%
Other Fracture
Direct costs: - New Fractures 243,486,418  253,903,569  121,806,521  135,062,876  754,259,385 
- Re-fractures  9,597,501  16,263,671  9,237,668  8,612,519  43,711,358 
Total Direct Costs  253,083,919  270,167,240  131,044,189  143,675,395  797,970,743 36%
Indirect costs: - New Fractures 19,975,000  33,087,034  9,449,972  15,981,816  78,493,823 
- Re-fractures  787,354  2,119,374  716,675  1,019,108  4,642,512 
Total Indirect Costs  20,762,354  35,206,408  10,166,647  17,000,925  83,136,335 4%
Total cost: - New Fractures 263,461,418  286,990,604  131,256,493  151,044,693  832,753,208 
- Re-fractures  10,384,855  18,383,045  9,954,343  9,631,627  48,353,870 
Total ‘Other’ Fracture Cost  273,846,273  305,373,648  141,210,837  160,676,320  881,107,078 40%
All Fractures
Direct costs: - New Fractures 366,865,661  1,000,886,368  174,393,799  369,814,722  1,911,960,550 86%
- Re-fractures  15,133,609  69,532,468  13,780,561  25,695,076  124,141,714 6%
Total Direct Costs  381,999,270  1,070,418,837  188,174,359  395,509,799  2,036,102,265 91%
Indirect costs: - New Fractures 30,353,302  96,714,957  14,739,320  38,019,401  179,826,980 8%
- Re-fractures  1,256,989  6,671,985  1,174,839  2,628,552  11,732,365 1%
Total Indirect Costs  31,610,291  103,386,941  15,914,159  40,647,953  191,559,345 9%
Total cost: - New Fractures 397,218,963  1,097,601,325  189,133,119  407,834,124  2,091,787,530 94%
- Re-fractures  16,390,598  76,204,453  14,955,400  28,323,628  135,874,079 6%
TOTAL COST – ALL FRACTURES  413,609,561  1,173,805,778  204,088,519  436,157,752  2,227,661,609 100%
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2018 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 39,416,928  560,316,963  31,028,321  214,112,782  844,874,994 
- Re-fractures  1,822,917  39,768,899  2,649,272  15,542,050  59,783,137 
Total Direct Costs  41,239,845  600,085,862  33,677,593  229,654,832  904,658,131 39%
Indirect costs: - New Fractures 3,970,121  47,103,365  3,268,816  19,656,003  73,998,305 
- Re-fractures  183,606  3,343,195  279,099  1,426,793  5,232,694 
Total Indirect Costs  4,153,727  50,446,560  3,547,916  21,082,796  79,230,999 3%
Total cost: - New Fractures  43,387,049  607,420,328  34,297,137  233,768,785  918,873,299 
- Re-fractures  2,006,523  43,112,094  2,928,372  16,968,843  65,015,831 
Total Hip Fracture Cost  45,393,572  650,532,422  37,225,509  250,737,628  983,889,130 43%
Wrist 
Direct costs: - New Fractures 46,172,072  73,409,216  5,096,735  6,834,779  131,512,802 
- Re-fractures  1,817,519  4,756,464  385,843  443,011  7,402,837 
Total Direct Costs  47,989,592  78,165,679  5,482,578  7,277,790  138,915,639 6%
Indirect costs: - New Fractures 3,281,787  5,489,993  378,592  558,288  9,708,660 
- Re-fractures  129,184  355,718  28,661  36,187  549,750 
Total Indirect Costs  3,410,971  5,845,711  407,253  594,475  10,258,410 0.4%
Total cost: - New Fractures 49,453,859  78,899,209  5,475,327  7,393,067  141,221,463 
- Re-fractures  1,946,704  5,112,181  414,504  479,197  7,952,586 
Total Wrist Fracture Cost  51,400,563  84,011,390  5,889,831  7,872,265  149,174,049 6%
Vertebral
Direct costs: - New Fractures 39,153,276  141,693,740  16,982,992  24,367,818  222,197,826 
- Re-fractures  1,937,965  11,204,462  1,537,024  2,022,021  16,701,471 
Total Direct Costs  41,091,241  152,898,201  18,520,016  26,389,839  238,899,298 10%
Indirect costs: - New Fractures  3,241,013  13,457,156  1,694,313  2,815,007  21,207,489 
- Re-fractures  160,420  1,064,127  153,342  233,587  1,611,476 
Total Indirect Costs  3,401,433  14,521,283  1,847,655  3,048,594  22,818,965 1%
Total cost: - New Fractures 42,394,289  155,150,895  18,677,305  27,182,826  243,405,316 
- Re-fractures  2,098,385  12,268,589  1,690,366  2,255,608  18,312,947 
Total Vertebral Fracture Cost  44,492,674  167,419,484  20,367,671  29,438,433  261,718,263 11%
Other Fracture
Direct costs: - New Fractures  246,188,396  263,510,490  123,019,142  141,119,113  773,837,141 
- Re-fractures  9,675,134  16,998,938  9,308,354  9,071,610  45,054,036 
Total Direct Costs  255,863,530  280,509,428  132,327,496  150,190,723  818,891,177 36%
Indirect costs: - New Fractures 20,196,663  34,338,945  9,544,050  16,698,443  80,778,101 
- Re-fractures  793,723  2,215,189  722,159  1,073,432  4,804,503 
Total Indirect Costs  20,990,387  36,554,134  10,266,209  17,771,875  85,582,604 4%
Total cost: - New Fractures 266,385,060  297,849,435  132,563,192  157,817,556  854,615,242 
- Re-fractures  10,468,857  19,214,127  10,030,513  10,145,042  49,858,539 
Total ‘Other’ Fracture Cost  276,853,917  317,063,562  142,593,705  167,962,598  904,473,781 39%
All Fractures
Direct costs: - New Fractures 370,930,673  1,038,930,408  176,127,190  386,434,492  1,972,422,764 86%
- Re-fractures  15,253,535  72,728,762  13,880,493  27,078,692  128,941,481 6%
Total Direct Costs  386,184,208  1,111,659,170  190,007,683  413,513,184  2,101,364,245 91%
Indirect costs: - New Fractures 30,689,584  100,389,459  14,885,772  39,727,742  185,692,556 8%
- Re-fractures  1,266,934  6,978,229  1,183,261  2,769,998  12,198,423 1%
Total Indirect Costs  31,956,518  107,367,688  16,069,033  42,497,740  197,890,978 9%
Total cost: - New Fractures 401,620,257  1,139,319,867  191,012,962  426,162,234  2,158,115,319 94%
- Re-fractures  16,520,469  79,706,991  15,063,754  29,848,690  141,139,904 6%
TOTAL COST – ALL FRACTURES  418,140,726  1,219,026,858  206,076,716  456,010,924 2,299,255,223 100%
72
2019 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures  39,942,772  580,284,646  31,417,629  222,754,754  874,399,801 
- Re-fractures  1,843,039  41,289,458  2,674,807  16,245,086  62,052,389 
Total Direct Costs  41,785,811  621,574,104  34,092,435  238,999,840  936,452,190 40%
Indirect costs: - New Fractures  4,023,084  48,781,960  3,309,830  20,449,354  76,564,228 
- Re-fractures  185,633  3,471,022  281,789  1,491,333  5,429,777 
Total Indirect Costs  4,208,718  52,252,981  3,591,619  21,940,687  81,994,005 3%
Total cost: - New Fractures 43,965,857  629,066,605  34,727,459  243,204,108  950,964,029 
- Re-fractures  2,028,672  44,760,480  2,956,596  17,736,419  67,482,166 
Total Hip Fracture Cost  45,994,529  673,827,085  37,684,055  260,940,527  1,018,446,195 43%
Wrist 
Direct costs: - New Fractures 46,790,908  76,016,729  5,160,938  7,109,985  135,078,561 
- Re-fractures  1,837,396  4,939,938  389,588  463,208  7,630,130 
Total Direct Costs  48,628,304  80,956,668  5,550,526  7,573,193  142,708,691 6%
Indirect costs: - New Fractures 3,325,772  5,684,999  383,361  580,768  9,974,900 
- Re-fractures  130,597  369,439  28,939  37,836  566,812 
Total Indirect Costs  3,456,369  6,054,438  412,300  618,604  10,541,712 0.4%
Total cost: - New Fractures  50,116,680  81,701,729  5,544,299  7,690,753  145,053,461 
- Re-fractures  1,967,993  5,309,377  418,527  501,044  8,196,942 
Total Wrist Fracture Cost  52,084,673  87,011,106  5,962,826  8,191,797  153,250,403 6%
Vertebral
Direct costs: - New Fractures 39,674,428  146,751,003  17,195,661  25,352,487  228,973,580 
- Re-fractures  1,959,558  11,630,059  1,552,074  2,113,003  17,254,693 
Total Direct Costs  41,633,986  158,381,062  18,747,735  27,465,490  246,228,273 10%
Indirect costs: - New Fractures  3,284,153  13,937,462  1,715,530  2,928,758  21,865,903 
- Re-fractures  162,207  1,104,548  154,843  244,097  1,665,696 
Total Indirect Costs  3,446,360  15,042,010  1,870,373  3,172,855  23,531,599 1%
Total cost: - New Fractures 42,958,580  160,688,465  18,911,192  28,281,245  250,839,483 
- Re-fractures  2,121,765  12,734,606  1,706,917  2,357,101  18,920,389 
Total Vertebral Fracture Cost  45,080,346  173,423,072  20,618,108  30,638,346  269,759,871 11%
Other Fracture
Direct costs: - New Fractures 249,488,014  272,870,447  124,568,800  146,801,351  793,728,612 
- Re-fractures  9,780,943  17,654,649  9,398,707  9,485,182  46,319,481 
Total Direct Costs  259,268,957  290,525,096  133,967,507  156,286,533  840,048,093 35%
Indirect costs: - New Fractures  20,467,356  35,558,672  9,664,275  17,370,815  83,061,118 
- Re-fractures  802,403  2,300,637  729,169  1,122,369  4,954,579 
Total Indirect Costs  21,269,759  37,859,310  10,393,444  18,493,184  88,015,697 4%
Total cost: - New Fractures  269,955,370  308,429,119  134,233,075  164,172,166  876,789,730 
- Re-fractures  10,583,346  19,955,287  10,127,876  10,607,551  51,274,060 
Total ‘Other’ Fracture Cost  280,538,716  328,384,406  144,360,951  174,779,717  928,063,790 39%
All Fractures
Direct costs: - New Fractures 375,896,122  1,075,922,825  178,343,028  402,018,578  2,032,180,554 86%
- Re-fractures  15,420,935  75,514,104  14,015,175  28,306,479  133,256,694 6%
Total Direct Costs  391,317,058  1,151,436,929  192,358,204  430,325,056  2,165,437,247 91%
Indirect costs: - New Fractures 31,100,364  103,963,093  15,072,996  41,329,695  191,466,149 8%
- Re-fractures  1,280,841  7,245,646  1,194,740  2,895,636  12,616,863 1%
Total Indirect Costs  32,381,205  111,208,739  16,267,737  44,225,331  204,083,012 9%
Total cost: - New Fractures 406,996,487  1,179,885,918  193,416,025  443,348,273  2,223,646,702 94%
- Re-fractures  16,701,777  82,759,750  15,209,916  31,202,115  145,873,557 6%
TOTAL COST – ALL FRACTURES  423,698,263 1,262,645,669  208,625,940  474,550,387  2,369,520,260 100%
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2020 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 40,445,510  601,519,988  31,808,149  231,745,316  905,518,964 
- Re-fractures  1,867,805  42,758,306  2,708,161  16,901,131  64,235,403 
Total Direct Costs  42,313,315  644,278,294  34,516,310  248,646,447  969,754,366 40%
Indirect costs: - New Fractures 4,073,721  50,567,121  3,350,971  21,274,706  79,266,519 
- Re-fractures  188,128  3,594,501  285,303  1,551,559  5,619,491 
Total Indirect Costs  4,261,848  54,161,622  3,636,274  22,826,266  84,886,010 3%
Total cost: - New Fractures 44,519,231  652,087,109  35,159,120  253,020,023  984,785,482 
- Re-fractures  2,055,933  46,352,807  2,993,464  18,452,690  69,854,894 
Total Hip Fracture Cost  46,575,163  698,439,916  38,152,584  271,472,713  1,054,640,376 43%
Wrist 
Direct costs: - New Fractures 47,379,195  78,800,218  5,225,094  7,396,905  138,801,413 
- Re-fractures  1,861,769  5,117,029  394,330  482,089  7,855,216 
Total Direct Costs  49,240,964  83,917,247  5,619,424  7,878,994  146,656,629 6%
Indirect costs: - New Fractures 3,367,586  5,893,166  388,127  604,205  10,253,083 
- Re-fractures  132,330  382,683  29,291  39,379  583,682 
Total Indirect Costs  3,499,915  6,275,849  417,418  643,583  10,836,765 0.4%
Total cost: - New Fractures 50,746,781  84,693,384  5,613,221  8,001,110  149,054,495 
- Re-fractures  1,994,098  5,499,712  423,621  521,467  8,438,899 
Total Wrist Fracture Cost  52,740,879  90,193,096  6,036,842  8,522,577  157,493,394 6%
Vertebral
Direct costs: - New Fractures 40,174,052  152,119,775  17,409,393  26,375,811  236,079,031 
- Re-fractures  1,986,068  12,042,509  1,571,618  2,198,068  17,798,263 
Total Direct Costs  42,160,120  164,162,284  18,981,011  28,573,879  253,877,294 10%
Indirect costs: - New Fractures  3,325,510  14,447,353  1,736,853  3,046,974  22,556,691 
- Re-fractures  164,402  1,143,720  156,793  253,924  1,718,839 
Total Indirect Costs  3,489,912  15,591,073  1,893,646  3,300,898  24,275,529 1%
Total cost: - New Fractures 43,499,562  166,567,128  19,146,247  29,422,785  258,635,722 
- Re-fractures  2,150,470  13,186,229  1,728,411  2,451,992  19,517,102 
Total Vertebral Fracture Cost  45,650,032  179,753,357  20,874,657  31,874,777  278,152,824 11%
Other Fracture
Direct costs: - New Fractures 252,624,745  282,862,088  126,117,327  152,725,454  814,329,614 
- Re-fractures  9,910,685  18,287,546  9,513,100  9,871,808  47,583,140 
Total Direct Costs  262,535,430  301,149,634  135,630,428  162,597,262  861,912,754 35%
Indirect costs: - New Fractures 20,724,685  36,860,717  9,784,412  18,071,807  85,441,621 
- Re-fractures  813,047  2,383,112  738,044  1,168,118  5,102,321 
Total Indirect Costs  21,537,732  39,243,829  10,522,456  19,239,925  90,543,942 4%
Total cost: - New Fractures 273,349,430  319,722,805  135,901,740  170,797,261  899,771,234 
- Re-fractures  10,723,732  20,670,658  10,251,144  11,039,927  52,685,461 
Total ‘Other’ Fracture Cost  284,073,162  340,393,463  146,152,884  181,837,187  952,456,696 39%
All Fractures
Direct costs: - New Fractures 380,623,501  1,115,302,069  180,559,963  418,243,487  2,094,729,021 86%
- Re-fractures  15,626,327  78,205,390  14,187,209  29,453,096  137,472,023 6%
Total Direct Costs  396,249,829  1,193,507,459  194,747,172  447,696,583  2,232,201,043 91%
Indirect costs: - New Fractures 31,491,501  107,768,357  15,260,364  42,997,692  197,517,913 8%
- Re-fractures  1,297,906  7,504,016  1,209,431  3,012,981  13,024,334 1%
Total Indirect Costs  32,789,408  115,272,373  16,469,795  46,010,672  210,542,247 9%
Total cost: - New Fractures 412,115,003  1,223,070,425  195,820,327  461,241,178  2,292,246,934 94%
- Re-fractures  16,924,234  85,709,406  15,396,640  32,466,077  150,496,357 6%
TOTAL COST – ALL FRACTURES  429,039,236  1,308,779,832  211,216,967  493,707,255  2,442,743,291 100%
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2021 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 41,080,220  622,651,840  32,285,873  240,558,446  936,576,380 
- Re-fractures  1,891,327  44,321,183  2,741,919  17,582,471  66,536,901 
Total Direct Costs  42,971,547  666,973,024  35,027,792  258,140,918  1,003,113,281 40%
Indirect costs: - New Fractures 4,137,650  52,343,582  3,401,299  22,083,770  81,966,301 
- Re-fractures  190,497  3,725,886  288,860  1,614,108  5,819,350 
Total Indirect Costs  4,328,146  56,069,467  3,690,159  23,697,878  87,785,650 3%
Total cost: - New Fractures 45,217,870  674,995,422  35,687,172  262,642,217  1,018,542,681 
- Re-fractures  2,081,824  48,047,069  3,030,779  19,196,579  72,356,251 
Total Hip Fracture Cost  47,299,694  723,042,491  38,717,951  281,838,796  1,090,898,931 43%
Wrist 
Direct costs: - New Fractures 48,126,266  81,564,600  5,303,807  7,677,881  142,672,554 
- Re-fractures  1,885,244  5,304,011  399,205  501,563  8,090,023 
Total Direct Costs  50,011,510  86,868,611  5,703,012  8,179,444  150,762,577 6%
Indirect costs: - New Fractures 3,420,685  6,099,903  393,974  627,156  10,541,718 
- Re-fractures  133,998  396,667  29,653  40,969  601,288 
Total Indirect Costs  3,554,683  6,496,570  423,627  668,125  11,143,006 0.4%
Total cost: - New Fractures 51,546,952  87,664,503  5,697,781  8,305,037  153,214,272 
- Re-fractures  2,019,242  5,700,677  428,858  542,533  8,691,311 
Total Wrist Fracture Cost  53,566,194  93,365,180  6,126,639  8,847,570  161,905,583 6%
Vertebral
Direct costs: - New Fractures 40,803,050  157,467,455  17,670,478  27,379,429  243,320,412 
- Re-fractures  2,011,033  12,482,985  1,591,196  2,286,674  18,371,888 
Total Direct Costs  42,814,083  169,950,440  19,261,674  29,666,104  261,692,301 10%
Indirect costs: - New Fractures 3,377,577  14,955,241  1,762,901  3,162,913  23,258,632 
- Re-fractures  166,468  1,185,553  158,746  264,160  1,774,928 
Total Indirect Costs  3,544,046  16,140,795  1,921,647  3,427,073  25,033,560 1%
Total cost: - New Fractures 44,180,627  172,422,697  19,433,378  30,542,343  266,579,045 
- Re-fractures  2,177,502  13,668,538  1,749,942  2,550,835  20,146,816 
Total Vertebral Fracture Cost  46,358,129  186,091,234  21,183,320  33,093,177  286,725,861 11%
Other Fracture
Direct costs: - New Fractures 256,608,111  292,785,141  128,017,211  158,526,813  835,937,277 
- Re-fractures  10,035,650  18,955,793  9,630,702  10,270,596  48,892,742 
Total Direct Costs  266,643,762  311,740,934  137,647,914  168,797,410  884,830,019 35%
Indirect costs: - New Fractures 21,051,470  38,153,824  9,931,809  18,758,274  87,895,377 
- Re-fractures  823,299  2,470,194  747,167  1,215,306  5,255,966 
Total Indirect Costs  21,874,769  40,624,017  10,678,976  19,973,580  93,151,343 4%
Total cost: - New Fractures 277,659,581  330,938,965  137,949,020  177,285,087  923,832,654 
- Re-fractures  10,858,949  21,425,986  10,377,870  11,485,903  54,148,708 
Total ‘Other’ Fracture Cost  288,518,531  352,364,951  148,326,890  188,770,990  977,981,362 39%
All Fractures
Direct costs: - New Fractures 386,617,648  1,154,469,037  183,277,369  434,142,570  2,158,506,623 86%
- Re-fractures  15,823,255  81,063,971  14,363,022  30,641,306  141,891,554 6%
Total Direct Costs  402,440,903 1,235,533,008  197,640,391  464,783,876  2,300,398,178 91%
Indirect costs: - New Fractures 31,987,382  111,552,550  15,489,982  44,632,113  203,662,028 8%
- Re-fractures  1,314,262  7,778,299  1,224,427  3,134,544  13,451,532 1%
Total Indirect Costs  33,301,644  119,330,849  16,714,409  47,766,657  217,113,559 9%
Total cost: - New Fractures 418,605,030  1,266,021,587  198,767,351  478,774,683  2,362,168,651 94%
- Re-fractures  17,137,517  88,842,270  15,587,449  33,775,850  155,343,086 6%
TOTAL COST – ALL FRACTURES  435,742,547 1,354,863,857  214,354,800  512,550,533  2,517,511,737 100%
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2022 Total Cost of of Fractures (2012$)
Women Men All % Total Cost – 
All FracturesFracture Type 50-69 years 70+ years 50-69 years 70+ years
Hip 
Direct costs: - New Fractures 41,673,321  643,612,013  32,731,890  249,300,594  967,317,819 
- Re-fractures  1,921,182  45,878,413  2,782,981  18,251,565  68,834,141 
Total Direct Costs  43,594,503  689,490,426  35,514,872  267,552,158  1,036,151,960 40%
Indirect costs: - New Fractures 4,197,387  54,105,611  3,448,287  22,886,318  84,637,603 
- Re-fractures  193,504  3,856,795  293,186  1,675,532  6,019,016 
Total Indirect Costs  4,390,891  57,962,406  3,741,472  24,561,850  90,656,619 3%
Total cost: - New Fractures 45,870,709  697,717,624  36,180,177  272,186,911  1,051,955,421 
- Re-fractures  2,114,686  49,735,208  3,076,167  19,927,097  74,853,157 
Total Hip Fracture Cost  47,985,394  747,452,832  39,256,344  292,114,008  1,126,808,578 43%
Wrist 
Direct costs: - New Fractures 48,819,903  84,305,490  5,376,981  7,956,639  146,459,012 
- Re-fractures  1,914,646  5,490,874  405,068  520,726  8,331,314 
Total Direct Costs  50,734,549  89,796,364  5,782,049  8,477,365  154,790,327 6%
Indirect costs: - New Fractures 3,469,987  6,304,884  399,409  649,926  10,824,206 
- Re-fractures  136,088  410,641  30,089  42,535  619,353 
Total Indirect Costs  3,606,075  6,715,525  429,498  692,460  11,443,559 0.4%
Total cost: - New Fractures 52,289,890  90,610,374  5,776,390  8,606,565  157,283,218 
- Re-fractures  2,050,734  5,901,516  435,157  563,261  8,950,667 
Total Wrist Fracture Cost  54,340,624  96,511,889  6,211,547  9,169,825  166,233,886 6%
Vertebral
Direct costs: - New Fractures  41,392,637  162,772,637  17,914,745  28,374,885  250,454,904 
- Re-fractures  2,043,006  12,920,936  1,615,213  2,373,551  18,952,706 
Total Direct Costs  43,435,643  175,693,573  19,529,958  30,748,436  269,407,610 10%
Indirect costs: - New Fractures  3,426,382  15,459,093  1,787,270  3,277,910  23,950,655 
- Re-fractures  169,115  1,227,147  161,142  274,196  1,831,601 
Total Indirect Costs  3,595,497  16,686,240  1,948,412  3,552,106  25,782,255 1%
Total cost: - New Fractures 44,819,019  178,231,730  19,702,015  31,652,795  274,405,558 
- Re-fractures  2,212,121  14,148,083  1,776,355  2,647,747  20,784,307 
Total Vertebral Fracture Cost  47,031,140  192,379,813  21,478,370  34,300,543  295,189,865 11%
Other Fracture
Direct costs: - New Fractures  260,306,564  302,623,869  129,783,401  164,282,386  856,996,220 
- Re-fractures  10,192,165  19,623,616  9,772,157  10,662,992  50,250,930 
Total Direct Costs  270,498,729  322,247,485  139,555,558  174,945,379  907,247,150 35%
Indirect costs: - New Fractures 21,354,882  39,435,942  10,068,833  19,439,323  90,298,980 
- Re-fractures  836,139  2,557,220  758,142  1,261,738  5,413,239 
Total Indirect Costs  22,191,021  41,993,162  10,826,975  20,701,062  95,712,219 4%
Total cost: - New Fractures 281,661,445  342,059,811  139,852,234  183,721,710  947,295,200 
- Re-fractures  11,028,304  22,180,836  10,530,298  11,924,731  55,664,169 
Total ‘Other’ Fracture Cost  292,689,749  364,240,647  150,382,533  195,646,440  1,002,959,369 39%
All Fractures
Direct costs: - New Fractures  392,192,424  1,193,314,009  185,807,018  449,914,504  2,221,227,955 86%
- Re-fractures  16,070,999  83,913,840  14,575,419  31,808,834  146,369,092 6%
Total Direct Costs  408,263,423  1,277,227,849  200,382,437  481,723,338  2,367,597,047 91%
Indirect costs: - New Fractures 32,448,638  115,305,530  15,703,799  46,253,477  209,711,443 8%
- Re-fractures  1,334,846  8,051,803  1,242,558  3,254,001  13,883,209 1%
Total Indirect Costs  33,783,484  123,357,333  16,946,357  49,507,478  223,594,652 9%
Total cost: - New Fractures  424,641,062  1,308,619,539  201,510,817  496,167,981  2,430,939,398 94%
- Re-fractures  17,405,845  91,965,643  15,817,977  35,062,836  160,252,301 6%
TOTAL COST – ALL FRACTURES  442,046,907  1,400,585,182  217,328,794  531,230,816  2,591,191,699 100%
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